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A B S T R A C T
Background
Contractures are a common complication of neurological and non-neurological conditions, and are characterised by a reduction in joint
mobility. Stretch is widely used for the treatment and prevention of contractures. However, it is not clear whether stretch is effective.
This review is an update of the original 2010 version of this review.
Objectives
The aim of this review was to determine the effects of stretch on contractures in people with, or at risk of developing, contractures.The
outcomes of interest were joint mobility, quality of life, pain, activity limitations, participation restrictions, spasticity and adverse events.
Search methods
In November 2015 we searched CENTRAL, DARE, HTA; MEDLINE; Embase; CINAHL; SCI-EXPANDED; PEDro and trials
registries.
Selection criteria
We included randomised controlled trials and controlled clinical trials of stretch applied for the purpose of treating or preventing
contractures.
Data collection and analysis
Two review authors independently selected trials, extracted data, and assessed risk of bias. The outcomes of interest were joint mobility,
quality of life, pain, activity limitations, participation restrictions and adverse events. We evaluated outcomes in the short term (up
to one week after the last stretch) and in the long term (more than one week). We expressed effects as mean differences (MD) or
standardised mean differences (SMD) with 95% confidence intervals (CI). We conducted meta-analyses with a random-effects model.
We assessed the quality of the body of evidence for the main outcomes using GRADE.
1Stretch for the treatment and prevention of contractures (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Main results
Forty-nine studies with 2135 participants met the inclusion criteria. No study performed stretch for more than seven months. Just over
half the studies (51%) were at low risk of selection bias; all studies were at risk of detection bias for self reported outcomes such as pain
and at risk of performance bias due to difficulty of blinding the intervention. However, most studies were at low risk of detection bias
for objective outcomes including range of motion, and the majority of studies were free from attrition and selective reporting biases.
The effect of these biases were unlikely to be important, given that there was little benefit with treatment. There was high-quality
evidence that stretch did not have clinically important short-term effects on joint mobility in people with neurological conditions (MD
2°; 95% CI 0° to 3°; 26 studies with 699 participants) or non-neurological conditions (SMD 0.2, 95% CI 0 to 0.3, 19 studies with
925 participants).
In people with neurological conditions, it was uncertain whether stretch had clinically important short-term effects on pain (SMD
0.2; 95% CI -0.1 to 0.5; 5 studies with 174 participants) or activity limitations (SMD 0.2; 95% CI -0.1 to 0.5; 8 studies with
247 participants). No trials examined the short-term effects of stretch on quality of life or participation restrictions in people with
neurological conditions. Five studies involving 145 participants reported eight adverse events including skin breakdown, bruising,
blisters and pain but it was not possible to statistically analyse these data.
In people with non-neurological conditions, there was high-quality evidence that stretch did not have clinically important short-term
effects on pain (SMD -0.2, 95%CI -0.4 to 0.1; 7 studies with 422 participants) and moderate-quality evidence that stretch did not have
clinically important short-term effects on quality of life (SMD 0.3, 95% CI -0.1 to 0.7; 2 studies with 97 participants). The short-term
effect of stretch on activity limitations (SMD 0.1; 95% CI -0.2 to 0.3; 5 studies with 356 participants) and participation restrictions
were uncertain (SMD -0.2; 95% CI -0.6 to 0.1; 2 studies with 192 participants). Nine studies involving 635 participants reported
41 adverse events including numbness, pain, Raynauds’ phenomenon, venous thrombosis, need for manipulation under anaesthesia,
wound infections, haematoma, flexion deficits and swelling but it was not possible to statistically analyse these data.
Authors’ conclusions
There was high-quality evidence that stretch did not have clinically important effects on joint mobility in people with or without
neurological conditions if performed for less than seven months. Sensitivity analyses indicate results were robust in studies at risk
of selection and detection biases in comparison to studies at low risk of bias. Sub-group analyses also suggest the effect of stretch is
consistent in people with different types of neurological or non-neurological conditions. The effects of stretch performed for periods
longer than sevenmonths have not been investigated. There was moderate- and high-quality evidence that stretch did not have clinically
important short-term effects on quality of life or pain in people with non-neurological conditions, respectively. The short-term effects
of stretch on quality of life and pain in people with neurological conditions, and the short-term effects of stretch on activity limitations
and participation restrictions for people with and without neurological conditions are uncertain.
P L A I N L A N G U A G E S U M M A R Y
Is stretch effective for treating and preventing joint deformities?
Review question: we reviewed the evidence about the effect of stretch in people who had or were vulnerable to joint deformities.
Background:we wanted to know whether stretch interventions are effective for the treatment and prevention of joint deformities (also
known as contractures) in people with neurological and non-neurological conditions. Some of the conditions contained in this review
included people with fracture, stroke, brain injury, arthritis or burns.
Stretch can be administered with splints and positioning programmes, or with casts, which are changed at regular intervals (serial casts).
Alternatively, stretch can be self-administered or applied manually by therapists.
Study characteristics: this Cochrane review is current to November 2015. It includes the results of 49 randomised controlled trials
involving 2135 participants. The participants had a variety of neurological and non-neurological conditions including stroke, acquired
brain injury and spinal cord injury, arthritis, wrist fracture and burns.
Studies compared stretch to no stretch, often delivered with standard care for the disorder or another co-intervention such as exercise
or botulinum toxin injection in the case of spasticity.
The stretchwas administered in a variety of differentways including through passive stretching (self-administered, therapist-administered
and device-administered), positioning, splinting and serial casting.
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The stretch dosage was highly variable, ranging from five minutes to 24 hours per day (median 420 minutes, IQR 38 to 600) for
between two days and seven months (median 35 days, IQR 23 to 84). The total cumulative time that stretch was administered ranged
from 23 minutes to 1456 hours (median 168 hours, IQR 24 to 672).
The outcomes of interest were joint range of motion, spasticity, pain, ability to move, ability to participate in life, quality of life and
adverse events. The short-term (less than one week) and long-term (more than one week) effects were investigated separately.
Study funding sources: no study was funded by a drug manufacturer or by an agency with a commercial interest in the results of the
studies.
Key results:we found the following short-term effects up to one week after the last stretch intervention in studies that compared stretch
with no stretch:
Joint Mobility (high score is better outcome)
Neurological conditions: stretch improves joint mobility by 1% (0% to 2% better) or 2° (0° to 3°)
Non-neurological conditions: stretch improves joint mobility by 1% (0% to 3% better)
Quality of life (high score is better outcome)
Neurological conditions: no studies
Non-neurological conditions: stretch improves quality of life by 1% (0% to 3% better)
Pain (low score is better outcome)
Neurological conditions: stretch increases pain by 2% (1% worse to 6% worse)
Non-neurological conditions: stretch decreases pain by 1% (3% better to 1% worse)
Activity limitation (high score is better outcome)
Neurological conditions: stretch improves the ability to move by 1% (0% to 2% better)
Non-neurological conditions: stretch improves the ability to move by 1% (2% worse to 4% better)
Participation (high score is better outcome)
Neurological conditions: no studies
Non-neurological conditions: stretch decreases engagement in participation with life by 12% (31% worse to 6% better)
Adverse events
Neurological and non-neurological conditions: 49 adverse events were reported, including skin breakdown, pain , numbness, venous
thrombosis, wound infections, haematoma, flexion deficits and swelling . We could not calculate the risk of such events with stretch as
a dverse events were not r eported in all studies , or not reported for both the treatment and control groups .
Quality of the evidence: there was high-quality evidence that stretch does not have clinically important short-term effects on joint
mobility in people with neurological or non-neurological conditions. There was high quality evidence that stretch does not have
clinically important short-term effects on pain, and moderate-quality evidence that stretch does not have clinically important short-
term effects on quality of life in people with non-neurological conditions.
Conclusion: stretch is not effective for the treatment and prevention of contractures and does not have short-term effects on quality of
life and pain in people with non-neurological conditions. The short-term and long-term effects of stretch on other outcomes in people
with neurological and non-neurological conditions are not known.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Short- term effects of stretch for the treatment and prevention of contractures
Patient or population: people with neurological condit ions1
Settings: inpat ients and outpat ients
Intervention: short-term ef fects of stretch (< 1 week af ter the last stretch)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments, summary
statistics, NNTB and
absolute risk differ-
ence (ARD)Assumed risk Corresponding risk
Control Short- term effects of
stretch
Joint mobility
Range of motion
Scale f rom 0°-135°
(higher number ref lects
better outcome)
Mean joint mobility in
the control groups was
10°2
The mean joint mobil-
ity in the intervent ion
groups was 2° higher
(0° to 3° higher)
549
(18 studies)
⊕⊕⊕⊕
high3
Absolute change = 1%
better (0% to 2% better)
Relat ive change = 2%
better (0% to 3% better)
The results rule out
a clinically important
treatment ef fect equiv-
alent to 5°
Quality of life No studies measured quality of lif e Not est imable Not est imable Not est imable Not measured
Pain
10-point VAS
(lower score ref lects
better outcome)
The mean pain in the
control group was 0.
6 points on a 10-point
VAS4
This translates to an ab-
solute mean increase of
0.2 higher (-0.1 to 0.6)
points compared with
control group on a 10-
point scale.5
174
(5 studies)
⊕⊕©©
low3,6
SMD = 0.2 higher (0.1
lower to 0.5 higher)
Absolute change = 2%
worse (1% better to 6%
worse)
Relat ive change = 55%
worse (28% better to
138% worse)
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Activity limitations
18-point upper limb
scale
(higher score ref lects
better outcome)
The mean act ivity lim-
itat ion in the control
group was 0.9 points on
an 18-point upper limb
scale7
This translates to an ab-
solute mean increase of
0.1 (-0.1 to 0.3) points
compared with control
group on an 18-point
scale8
237
(7 studies)
⊕⊕©©
low3,9
SMD = 0.2 higher (0.1
lower to 0.5 higher)
Absolute change = 1%
better (0% to 2% better)
Relat ive change = 38%
better (26% worse to
104% better)
Participation restric-
tions
1 study measured part icipat ion restrict ions but it
did not provide useable data
Not est imable Not est imable Not est imable Not est imable
Adverse events Five studies involving 145 part icipants reported
8 adverse events that may have been related to
the intervent ion. These included skin breakdown,
bruising or blisters f rom plaster casts, and shoul-
der and wrist pain f rom stretches applied through
posit ioning
Not est imable Not est imable Not est imable Not est imable
* The assumed risk (e.g. the mean control group risk across studies) is based on one representat ive study chosen on the basis of its size and suscept ibility to bias. The
corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; NNTB: number needed to treat for an addit ional benef icial outcome; RR: risk rat io; SM D: standardised mean dif ference; VAS: visual analogue scale
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 All the studies included in this review and included in the ’Summary of f indings’ outcomes included people with the
following neurological condit ions: stroke, Charcot-Marie-Tooth disease, acquired brain injury, spinal cord injury and cerebral
palsy. The treatment ef fects were consistent across all types of neurological condit ions except acquired brain injury (see
Discussion).
2 Post data of the control group in Refshauge 2006 (the corresponding data in Analysis 1.1 is not raw data).
3 The quality of evidence was not downgraded due to risk of bias even though at least some of the included trials had select ion,
performance, detect ion, attrit ion and report ing bias. These types of bias would tend to exaggerate treatment ef fect iveness.
Given this review did not demonstrate treatment ef fect iveness these forms of bias are probably not important.
4 Post data of the control group in Horsley 2007 (the corresponding data in Analysis 4.1 is not post data).
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5 Calculat ions based on the control group baseline mean (SD) pain: 0.4 (1.1) points on a 0-10 scale (f rom Horsley 2007).
6 The quality of the evidence was downgraded due to indirectness and imprecision. The downgrading for indirectness was
because the results are only based on studies involving people with stroke and spinal cord injury thereby lim it ing their
generalisability. The downgrading for imprecision was because the 95% CI is wide, part icularly when the results are expressed
as a relat ive % change (the 95% CI is narrow when the results are expressed as an absolute risk dif f erence).
7 Post data of the control group in Horsley 2007 (the corresponding data in Analysis 6.1 is not post data).
8 Calculat ions based on the control group baseline mean (standard deviat ion) act ivity lim itat ion: 0.3 (0.6) points on an 18-
point Upper Limb Activity scale (f rom Horsley 2007).
9 The quality of the evidence was downgraded due to indirectness and imprecision. The downgrading for indirectness was
because the results are only based on studies involving people with stroke, cerebral palsy and Charcot-Marie-Tooth disease
thereby lim it ing their generalisability. The downgrading for imprecision was because the 95% CI was wide part icularly when
the results are expressed as a relat ive % change (the 95% CI is narrow when the results are expressed as an absolute risk
dif f erence).
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B A C K G R O U N D
Description of the condition
Contractures are common in people with neurological conditions
including stroke, spinal cord injury, acquired brain injury and
cerebral palsy (Diong 2012; Fergusson 2007; Kwah 2012). They
are also common in people with non-neurological conditions as-
sociated with various musculoskeletal conditions and diseases in-
cluding rheumatoid arthritis, surgery and burns (Fergusson 2007).
Contractures are characterised by a reduction in joint range of
motion or an increase in resistance to passive joint movement
(Fergusson 2007; Fox 2000), both limiting joint mobility.
The causes of contractures are not well known. However, it is
generally agreed that contractures are due to both neurally and
non-neurally mediated factors (Lieber 2004). Neurally mediated
factors refer to spasticity which directly limits the extensibility of
the muscle-tendon unit. Spasticity is only present in people with
neurological conditions and hence is only relevant in these indi-
viduals. In contrast, non-neurally mediated factors can play a role
in the development of contractures in people with all types of con-
ditions. The term is used to refer to structural changes in the mus-
cle-tendon unit and other soft tissue structures overlying joints
which together limit joint mobility. Debate exists over the rela-
tive contribution of different soft tissue structures to non-neurally
mediated contractures. Some animal studies indicate the impor-
tance of muscle fibre length (Tabary 1972; Williams 1978) while
other studies suggest that muscle tendons may also play a role
(Herbert 1997). Whilst the exact causes of contractures remain
an area of debate, the deleterious consequences of contractures are
clear. They interfere with activities of daily living and can cause
pain, sleep disturbances and pressure ulcers (Harvey 2002; Clavet
2015; Scott 1981). They can also result in unsightly deformities
and increase burden of care (Fergusson 2007; Harvey 2002). For
these reasons considerable time and therapeutic resources are di-
rected at treating and preventing contractures.
Description of the intervention
Stretch is widely used for the treatment and prevention of contrac-
tures. The aimof stretch is tomaintain or increase jointmobility by
influencing the extensibility of soft tissues spanning joints. Stretch
can be administered with splints and positioning programmes, or
with casts which are changed at regular intervals (serial casts). Al-
ternatively, stretch can be self-administered or applied manually
by therapists (for over 100 examples of techniques used to ad-
minister stretches see www.physiotherapyexercises.com). All tech-
niques involve themechanical elongation of soft tissues for varying
periods of time. Some techniques can only be applied for short
periods of time. For example, it is difficult for therapists to apply
stretches through their hands for more than a few minutes. Other
techniques, such as positioning, provide a way of administering
stretch for sustained periods of time. Splints or serial casts are used
to provide stretch for even longer periods and are sometimes used
to provide uninterrupted stretch for many days or even weeks.
How the intervention might work
To understand how stretch might work it is important to high-
light the difference between the transient and lasting effects of
stretch. The transient effects of stretch have been extensively exam-
ined in animals and humans, with and without contractures. An-
imal studies have shown immediate increases in the length of soft
tissues with stretch (Taylor 1990). Human studies have demon-
strated similar findings, with immediate increases in joint range
of motion and decreases in resistance to passive joint movement
(Bohannon 1984; Duong 2001; Magnusson 1995; Magnusson
1996a; Magnusson 1996b). This phenomenon is termed viscous
deformation (Magnusson 1995; Weppler 2010). Importantly, the
effects of viscous deformation only last briefly once the stretch is
removed (Duong 2001; Magnusson 1996b).
The lasting effects of stretch aremore important than any transient
effects for the treatment and prevention of contractures. Unfortu-
nately, the mechanisms underlying any possible lasting effects of
stretch are less understood. Current knowledge is based on animal
studies which indicate that soft tissues undergo structural adapta-
tions in response to regular and intensive stretch (Goldspink 1974;
Tabary 1972). These studies have primarily examined the effect
of stretch on sarcomeres, the basic units of muscle. For example,
studies on animal muscles have shown that four weeks of sustained
stretch increases the number of muscle sarcomeres that are in se-
ries (Tabary 1972), with sarcomere numbers returning to normal
four weeks after the last stretch (Goldspink 1974). Further animal
studies have also suggested that only 30 minutes of stretch per day
is required to prevent loss of sarcomeres in series (Williams 1990).
Thus it would appear that animal muscles are highly adaptable in
response to stretch.
On one level the results of animal studies appear to be consistent
with observations in humans, suggesting that stretch induces last-
ing changes in joint range of motion and soft tissue extensibil-
ity. For example, the extreme extensibility of yoga enthusiasts and
ballerinas is often attributed to the intensive stretch routines per-
formed by these individuals. Furthermore, a large number of hu-
man studies (many non-randomised) also indicate that stretch in-
creases joint range of motion and soft tissue extensibility (Decoster
2005; Leong 2002). However, these observations and results are
not based on high-quality evidence and in some cases any apparent
effects may be solely due to poor terminology (Weppler 2010).
Consequently, there is uncertainty and controversy about the ef-
fectiveness of stretch for the treatment and prevention of contrac-
tures in clinical populations.
While contractures are associated with a variety of different condi-
tions, there is no reason to believe that the effectiveness of stretch
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is determined by the underlying condition. However, the effec-
tiveness of stretch may be influenced by involvement of the ner-
vous system. For this reason, we have divided this review into two,
namely the effectiveness of stretch for neurological and non-neu-
rological conditions.
Why it is important to do this review
A large amount of healthcare resources are allocated to the admin-
istration of stretch for the treatment and prevention of contrac-
tures. A systematic review is required to determine what is known
of the effects of this intervention. It is hoped that the results of this
systematic review will guide clinical practice and future research.
O B J E C T I V E S
The aim of this review was to determine the effects of stretch
on contractures in people with, or at risk of developing, contrac-
tures.The outcomes of interest were joint mobility, quality of life,
pain, activity limitations, participation restrictions, spasticity and
adverse events.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included published and unpublished randomised controlled
trials (RCTs) and controlled clinical trials (CCTs). We included
studies regardless of language. Studies that used parallel-group
designs, within-subject designs or cross-over designs were all in-
cluded.
Types of participants
Participants could be of any age or either gender provided they had
existing contractures or were at risk of developing contractures.
Participants were deemed to be at risk of developing contractures
based on the clinical judgement of the Review authors, or if they
had one or more of the following conditions:
• neurological conditions (e.g. stroke, multiple sclerosis,
spinal cord injury, acquired brain injury, Guillain Barré
syndrome, Parkinson’s disease);
• advanced age (e.g. frailty);
• a history of trauma or surgery (e.g. burns, joint replacement
surgery);
• underlying joint or muscle pathology and disease processes
(e.g. inflammatory arthritis, osteoarthritis).
We separated participants according to their diagnoses, and then
categorised them as having either a neurological or non-neurolog-
ical condition.
Types of interventions
Interventions
We included any stretch intervention that aimed to maintain or
increase the mobility of any synovial joint. To be included, the
stretch needed to sustain the soft tissues in a lengthened position
for aminimum of 20 seconds onmore than one occasion. This was
considered to be the minimum plausible period of stretch that was
likely to affect joint mobility. Examples of stretch interventions
that were eligible, based on these criteria, were sustained passive
stretching, positioning, splinting and serial casting.
We excluded interventions that were described as moving joints
throughout range (that is, where the soft tissues were not sustained
in a lengthened position). Examples of interventions that were
excluded, based on this criterion, were joint mobilisation, joint
manipulation, continuous passivemotion, passivemovements and
active movements.
Comparisons
We included all studies that allowed the effects of stretch to be
isolated. We included studies if they compared:
• stretch versus no stretch;
• stretch versus placebo or sham stretch;
• stretch plus co-intervention versus co-intervention. We
accepted all co-interventions provided they were applied in the
same manner to both the treatment and control groups.
To reduce the complexity of the review we excluded studies that
compared the effectiveness of competing interventions. Therefore,
we excluded studies if they compared:
• stretch versus another stretch;
• stretch versus another active intervention.
Types of outcome measures
Outcomes included measures of impairment, activity limitations
and participation restrictions. To be included in this review stud-
ies needed to have measured joint mobility, the primary focus of
this review. This focus is justified because joint mobility is the key
outcome used to deem the success of stretch interventions. With-
out a change in joint mobility there is no known mechanism for
changes in activity limitations or participation restrictions.
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Major outcomes
Themajor outcomes of interest were joint mobility, quality of life,
pain (for example, visual analogue scale, Huskisson 1974), activ-
ity limitations (for example, Functional Independence Measure,
Keith 1987; or Motor Assessment Scale, Carr 1985), participation
restrictions (for example, return to work), and adverse events.
All measures of joint mobility were accepted. Some of the more
commonly used measures of joint mobility were:
• active joint range of motion (expressed in degrees);
• passive joint range of motion (expressed in degrees); and
• passive joint stiffness (expressed in degrees per unit of
torque).
Both uni-directional measures of joint range of motion (for ex-
ample, maximal ankle dorsiflexion) and bi-directional measures of
joint range ofmotion (for example, arc ofmovement betweenmax-
imal ankle dorsiflexion and maximal ankle plantarflexion) were
eligible for inclusion. Data were expressed inmillimetres in studies
that used linear measures to reflect range of motion (for example,
tests of combined hip and knee range of motion reflected by fin-
ger-tip to floor distance).
Quality of life provides a holistic measure of the effectiveness of
stretch. There may be people with contractures whose quality of
life does not improve even with improvements in joint mobility.
Therefore, we also selected quality of life as a major outcome.
Examples of commonly used quality-of-life measures include:
• Short Form 36 (Ware 1992); and
• Assessment of Quality of Life (Hawthorne 1999;
Hawthorne 2001).
Minor outcome
A minor outcome of interest was spasticity which was only rele-
vant for people with neurological conditions (for example, Tardieu
scale, Tardieu 1954; or modified Ashworth scale, Bohannon
1987).
Timing of outcome assessment
Outcomes could be measured at any time following intervention.
We grouped outcomes into two main categories which were clas-
sified according to the time after which the stretch intervention
was ceased:
• short-term effects following stretch (outcomes measured up
to one week after the last stretch ceased);
• long-term effects following stretch (outcomes measured
more than one week after the last stretch ceased).
If studies collected data at multiple points within one of the pre-
determined time periods then we used data collected at the latest
time.
Adverse outcomes
We classified adverse outcomes into the following groups: mus-
cle tears, joint subluxation or dislocation, heterotopic ossification,
pain or other adverse outcome.We contacted study authors for in-
complete reporting of adverse events and losses to follow-up where
possible. We asked them to explain why participants withdrew.
Search methods for identification of studies
Electronic searches
We conducted electronic searches to identify potential studies.
There was no language restriction applied to any component of the
search strategies. We searched the following electronic databases
(see appendices for details):
• Cochrane Central Register of Controlled Trials
(CENTRAL), The Database of Abstracts of Reviews of Effects
(DARE) and The Health Technology Assessment Database
(HTA) (The Cochrane Library 2015, Issue 11), (Appendix 1);
• MEDLINE (Ovid) (1950 to 19 November 2015),
(Appendix 2);
• Embase (Ovid) (1980 to 19 November 2015), (Appendix
3);
• CINAHL (Ovid) (1982 to 19 November 2015), (Appendix
4);
• SCI-EXPANDED (ISI Web of Knowledge) (1900 to 19
November 2015), (Appendix 5);
• PEDro (www.pedro.org.au), (inception to 19 November
2015), (Appendix 6).
Searching other resources
The electronic searches were complemented with a search of the
reference lists of included studies and relevant systematic reviews.
We also used forward citation tracking of included studies to search
for additional studies using the ISI Web of Knowledge. We con-
tacted authors of included studies for additional studies and un-
published data.
We also searched the World Health Organization International
Clinical Trials Registry Platform (www.who.int/trialsearch) and
clinicaltrials.gov/ to identify unpublished and ongoing trials.
Data collection and analysis
Selection of studies
Two review authors independently screened the titles and abstracts
of the search output to identify potentially relevant studies. We
retrieved full-length reports of all potentially relevant studies and
re-examined them to ensure that they met the inclusion criteria.
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The two review authors resolved any disagreements by discussion
and, when necessary, a third author arbitrated.
Data extraction and management
Two review authors independently extracted data from the in-
cluded studies using pre-constructed data extraction forms. They
extracted the following data:
• study design, inclusion criteria and exclusion criteria;
• characteristics of the participants including the type of
health condition, number of participants, age, gender, and
whether participants were at risk of developing contracture or
had existing contracture, or a combination of the two;
• characteristics of the intervention and comparison
including details of treatment and control interventions,
duration of intervention, frequency of intervention, intensity of
intervention, details of co-interventions, compliance with
treatment and treated joint;
• details of the primary and secondary outcomes:
◦ methods used to measure joint mobility,
◦ time between last stretch and outcome measurement,
◦ mean scores and standard deviations of outcomes for
each treatment group,
◦ direction of effect for each outcome; and
• adverse events.
We standardised the direction of effect for each outcome between
studies, with the direction of effect selected for each outcome as
follows.
• Joint mobility: positive between-group difference favoured
stretch.
• Quality of life: positive between-group difference favoured
stretch.
• Pain: negative between-group difference favoured stretch.
• Spasticity: negative between-group difference favoured
stretch.
• Activity limitations: positive between-group difference
favoured stretch.
• Participation restrictions: positive between-group difference
favoured stretch.
If outcomes were only reported graphically, we estimated means
and standard deviations from the graphs.We extractedANCOVA-
adjusted between-group means and standard deviations in prefer-
ence to change scores. However, if neither were provided, we used
post-intervention scores.
If studies reported data as medians and inter-quartile ranges, we
extracted medians and estimated standard deviations as 80% of
the interquartile range.
We extracted torque-controlled measures of joint mobility in pref-
erence to all other jointmobilitymeasures. If the studies did not re-
port torque-controlled measures, next in order of preference were
passive joint mobility measures. If passive joint mobility measures
were not reported, we extracted active joint mobility measures.
Differences in the data extracted by the two review authors were
resolved by discussion and, when necessary, arbitrated by a third
author. Review authors did not extract data on studies in which
they had been involved; data from these studies were extracted by
other authors.
Assessment of risk of bias in included studies
Two review authors independently assessed the risk of bias of the
included studies. As recommended in Chapter 8 of the Cochrane
Handbook for Systematic Reviews of Interventions ((Higgins
2011), we assessed the following methodological domains:
• sequence generation;
• allocation sequence concealment;
• blinding of participants and therapists;
• blinding of outcome assessors for objective outcomes;
• blinding of outcome assessors for self-report outcomes;
• incomplete outcome data;
• selective outcome reporting; and
• other potential threats to validity.
We judged these domains explicitly using the following criteria:
’Yes’ = low risk of bias; ’No’ = high risk of bias; ’Unclear’ = ei-
ther lack of information or uncertainty over the potential for bias.
When studies reported incomplete data in more than 15% of par-
ticipants, we deemed them to have high risk of bias from incom-
plete outcome data.
We resolved disagreements in quality ratings by discussion or,
when necessary, a third author arbitrated. Review authors did not
evaluate the risk of bias of studies in which they were involved;
these studies were evaluated by other authors.
Measures of treatment effect
No dichotomous outcomes were reported. For continuous out-
comes we reported the mean differences for each study to provide
a summary estimate of the effectiveness of stretch. For continuous
outcomes with the same units, we expressed effects as mean differ-
ences (MD) and 95% confidence intervals (CI). For continuous
outcomes with different units, we expressed effects as standardised
mean differences (SMD) and 95% CI. SMD was back-translated
to a typical scale (e.g. 0 to 10 for pain) by multiplying the SMD
by a typical among-person standard deviation (e.g. the standard
deviation of the control group at baseline from the most repre-
sentative trial) (as per Chapter 12 of the Cochrane Handbook for
Systematic Reviews of Interventions (Schünemann 2011).
In the ’Effects of intervention’ results section and the ’Comments’
column of the ’Summary of findings’ table, we have reported the
absolute percent difference, the relative percent change from base-
line, and the number needed to treat for an additional beneficial
outcome (NNTB) (we provided the NNTB only for the short-
term effect of jointmobility in peoplewith neurological conditions
because this was the sole outcome with a statistically significant
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difference). We calculated the NNTB for joint mobility using the
Wells calculator (available at the Cochrane Musculoskeletal edi-
torial office) using a minimally clinically important difference of
5°. We calculated the absolute benefit as the improvement in the
intervention group minus the improvement in the control group,
in the original units, expressed as a percentage. We calculated the
relative difference in the change from baseline as the absolute ben-
efit divided by the baseline mean of the control group, expressed
as a percentage.
Unit of analysis issues
Cross-over studies
We analysed cross-over studies using combined data from all study
periods (Fox 2000,McNee2007;Moseley 1997;Refshauge 2006).
We back-calculated the between-group standard deviations from
the presented data using the method described by Fleiss 1993.
Using combineddata yieldsmore accurate weighting for cross-over
studies in meta-analyses than using first period data only (Curtin
2002).
Studies with multiple treatment groups
In studies with more than two treatment groups, we only extracted
data from the two groups with the most different interventions.
Studies with multiple measures for the same joint
In studies with multiple measures for the same joint, we only
extracted data for the measure deemed most likely to reflect a
beneficial effect of stretch. For example, we used the data reflecting
shoulder rotation in studies that applied an aggressive stretch for
shoulder rotation but only a mild stretch for shoulder flexion.
Studies with measures on different joints
In studies where the effects of stretch were measured across differ-
ent joints, we only extracted data for the measure deemed most
likely to reflect a beneficial effect of stretch. For example, in studies
where the stretch involved shoulder, elbow and wrist positioning,
we only extracted one set of data for the joint that was deemed
most likely to respond to the stretch. Also, in instances where data
were reported for both right and left sides, we always extracted the
right side data in preference to the left side.
Dealing with missing data
We contacted authors of included studies when there was incom-
plete reporting of data. When authors of included studies were
unable to provide additional data we included all available data
in the review. Where possible, all analyses were performed on an
intention-to-treat basis.
Assessment of heterogeneity
When therewere at least two clinically homogeneous studies (stud-
ies that investigated the effect of similar interventions on similar
populations and reported similar outcomes) we considered meta-
analysis. In such circumstances we used the I2 statistic to quan-
tify the heterogeneity of outcomes and to inform decisions about
whether to pool data (Higgins 2003). Where heterogeneity was
substantial (I2 > 50%), we explored the possible causes of hetero-
geneity in sensitivity analyses, in which individual studies were
omitted one at a time or stratified by particular characteristics or,
where appropriate, with meta-regression (Deeks 2011).
Assessment of reporting biases
We used funnel plots to examine the possibility of small sample
bias in the estimates of the short-term effects of stretch on joint
mobility for people with neurological and non-neurological con-
ditions.
Data synthesis
We used a random-effects model to conduct meta-analyses and
analysed data using Review Manager 5.3 (RevMan) (RevMan
2014). We explored the effect of stretch on the subgroups out-
lined below using random-effects meta-regression (see ’Subgroup
analyses’). We used the user-written ’metareg routine’ in the Stata
Statistical Software package for this purpose.
GRADE and ’Summary of findings’ tables
We compiled two ’Summary of findings’ tables using GRADE-
pro software (GRADEpro GDT 2015); one for neurological and
the other for non-neurological conditions. Both summarised the
short-term effects of stretch on the following outcomes: joint mo-
bility, quality of life, pain, activity limitations, participant restric-
tions and adverse events.
We reported the NNTB or the NNTH, absolute and relative per
cent change in the Comments column of the ’Summary of Find-
ings’ table as described in the Measures of treatment effect section
above. We also reported if the pooled result ruled out a clinically
important treatment effect based on the 95% CI. The clinically
important treatment effect for joint mobility and pain was 5° and
2 points (on a 10-point visual analogue scale), respectively. We
did not articulate clinically important treatment effects for other
outcomes but instead used clinical reasoning after considering the
absolute and relative changes.
We used the GRADE approach to evaluate the quality of the
evidence (GRADE Working Group 2004; Guyatt 2008a; Guyatt
2008b; Schünemann 2011). The GRADE approach specifies four
levels of quality:
• high-quality, randomised trials or double-upgraded
observational studies;
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• medium-quality, downgraded randomised trials or
upgraded observational studies;
• low-quality, double-downgraded randomised trials or
observational studies; and
• very low-quality, triple-downgraded randomised trials,
downgraded observational studies or case series or case reports.
The quality of evidence was downgraded if:
• there were limitations in the design and implementation of
available studies, suggesting high likelihood of bias;
• there was indirectness of evidence (indirect population,
intervention, control, outcomes);
• there was unexplained heterogeneity or inconsistency of
results (including problems with subgroup analyses);
• there was imprecision of results (wide confidence intervals);
and
• there was a high probability of publication bias.
Subgroup analysis and investigation of heterogeneity
We conducted planned subgroup analyses to determine the fol-
lowing effects on joint mobility for people with neurological and
non-neurological conditions:
• compare the short-term effects following stretch (i.e. effects
present less than one week after the last stretch was ceased) with
the long-term effects following stretch (i.e. effect present more
than one week after the last stretch was ceased);
• compare the effects of stretch administered to different
populations (i.e. the effects of stretch administered to people
with stroke versus spinal cord injury versus acquired brain injury
versus cerebral palsy, etc.);
• determine the effects of different stretch dosages (i.e. total
stretch time);
• determine the effects of different stretch interventions (i.e.
the effects of stretch administered manually by therapists versus
the effects of self-administered stretch versus the effects of stretch
administered with positioning programmes versus the effects of
stretch administered with plaster casts versus the effects of stretch
administered with splints);
• determine the effects of stretch when administered to large
joints (e.g. shoulder, elbow, hip and knee) versus small joints
(e.g. wrist, ankle, hand and foot);
• determine the effects of stretch when outcomes could be
influenced by participants’ perceptions of discomfort (e.g.
measures of active range of motion, measures of passive range of
motion with a non-standardised measurement torque) versus
when outcomes could not be influenced by participants’
perceptions of discomfort (e.g. studies involving unconscious or
insensate people, measurements taken with a standardised
torque) (Harvey 2002; Weppler 2010);
• determine the effects of stretch administered for the
treatment of contractures versus the effects of stretch
administered for the prevention of contractures; and
• determine the effects of stretch when measurements were
taken less than one day after the last stretch versus when
measurements were taken more than one day after the last
stretch.
We used the formal test for subgroup interactions inRevMan 2014
to aid in the interpretation of subgroup analyses. We compared
the magnitude of the effects between the subgroups by assessing
the overlap of the CIs of the summary estimates. CIs that did not
overlap indicated statistical significance.
Sensitivity analysis
To examine the robustness of the findings to potential selection,
detection and attrition biases, we conducted sensitivity analyses.
The sensitivity analyses examined the effects on joint mobility of
randomisation (adequate versus inadequate sequence generation),
allocation concealment (concealed versus non-concealed alloca-
tion), blinding of assessors (blinding versus no blinding) and com-
pleteness of outcome data (complete versus incomplete outcome
data available).
R E S U L T S
Description of studies
Results of the search
The electronic searches, citation tracking and reference list searches
produced 5048 references. After screening titles and abstracts, we
identified 135 studies as potentially eligible. After inspecting the
full reports, we included 49 studies, with four studies awaiting
classification and one study ongoing (see Figure 1). We excluded
86 studies and have summarised the reasons for exclusion in the
Characteristics of excluded studies table.
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Figure 1. Study flow diagram1. These numbers are approximate only
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Included studies
We included 49 studies with a total of 2135 participants.
Twenty-eight studies with a total of 898 participants investi-
gated the effects of stretch in people with neurological con-
ditions (Ackman 2005; Ada 2005; Basaran 2012; Ben 2005;
Burge 2008; Copley 2013; Crowe 2000; De Jong 2006; Dean
2000; DiPasquale-Lehnerz 1994; Gustafsson 2006; Harvey 2000;
Harvey 2003;Harvey 2006;Hill 1994;Horsley 2007;Hyde 2000;
Krumlinde-Sundholm 2011; Lai 2009; Lannin 2003a; Lannin
2007a; Law 1991; McNee 2007; Moseley 1997; Refshauge 2006;
Rose 2010; Sheehan2006;Turton 2005) and includedpeoplewith
stroke, spinal cord injury, acquired brain injury, cerebral palsy,
Charcot-Marie-Tooth disease and Duchenne muscular dystrophy.
One study recruited people with spinal cord injury, acquired brain
injury and stroke (Harvey 2006). In this study, participants were
separated according to their diagnoses.
Twenty-one studies with a total of 1237 participants investi-
gated the effects of stretch in people with non-neurological con-
ditions (Aoki 2009; Buchbinder 1993; Bulstrode 1987; Collis
2013; Cox 2009; Fox 2000; Horton 2002; Hussein 2015; Jang
2015; Jerosch-Herold2011; John2011; Jongs 2012;Kemler2012;
Kolmus 2012; Lee 2007; Melegati 2003; Moseley 2005; Paul
2014; Seeger 1987; Steffen 1995; Zenios 2002) and included peo-
ple with osteoarthritis, Dupuytren’s contractures, frozen shoulder,
knee replacement surgery, wrist fracture, ankle fracture, hallux
limitus, anterior cruciate reconstruction surgery, ankle fracture,
ankylosing spondylitis, radiotherapy for breast cancer, burns, ra-
diotherapy to the jaw, systemic sclerosis and frailty.
The following types of stretchwere administered in all studies: pas-
sive stretching (self-administered, therapist-administered and de-
vice-administered), positioning, splinting and serial casting. The
stretch dosage was highly variable, ranging from fiveminutes to 24
hours per day (median 420 minutes, IQR 38 to 600) for between
two days and seven months (median 35 days, IQR 23 to 84). The
total cumulative time that stretch was administered ranged from
23 minutes to 1456 hours (median 168 hours, IQR 24 to 672).
All included studies reported joint mobility, while only three stud-
ies reported quality of life (Buchbinder 1993; Kolmus 2012; Lee
2007). Eighteen studies reported pain (Ada 2005; Aoki 2009;
Buchbinder 1993; Burge 2008; Cox 2009; Crowe 2000; De Jong
2006; Dean 2000; Fox 2000; Gustafsson 2006; Horsley 2007;
Hussein 2015; Kemler 2012; Lannin 2003a; Lannin 2007a; Lee
2007; Moseley 2005; Paul 2014) and eight studies reported spas-
ticity (Ackman 2005; Basaran 2012; Burge 2008; Copley 2013;
De Jong 2006; Hill 1994; Lai 2009; Lannin 2007a). Activity lim-
itations were reported in 21 studies (Ada 2005; Aoki 2009; Collis
2013; Crowe 2000; De Jong 2006; DiPasquale-Lehnerz 1994;
Gustafsson 2006; Hill 1994; Horsley 2007; Hussein 2015; Hyde
2000; Jerosch-Herold 2011; Jongs 2012; Kolmus 2012; Lannin
2003a; Lannin 2007a; Law 1991; McNee 2007; Moseley 2005;
Paul 2014; Rose 2010) and three studies reported participation
restrictions (Harvey 2006; Jongs 2012; Moseley 2005).
Forty-five studies investigated the short-term effects following
stretch (that is, outcomes were measured less than one week af-
ter the last stretch was ceased) (Ada 2005; Aoki 2009; Basaran
2012; Ben 2005;, Buchbinder 1993; Bulstrode 1987; Burge 2008;
Collis 2013; Copley 2013; Cox 2009; Crowe 2000;De Jong 2006;
Dean 2000; DiPasquale-Lehnerz 1994; Fox 2000; Gustafsson
2006; Harvey 2000; Harvey 2003; Harvey 2006; Hill 1994;
Horsley 2007; Horton 2002; Hussein 2015; Hyde 2000; Jang
2015; Jerosch-Herold2011; John2011; Jongs 2012;Kemler2012;
Kolmus 2012; Krumlinde-Sundholm 2011; Lai 2009; Lannin
2003a; Lannin 2007a; Law 1991; Lee 2007; Moseley 1997;
Moseley 2005; Paul 2014; Refshauge 2006; Rose 2010; Seeger
1987; Sheehan 2006; Steffen 1995; Turton 2005). Eighteen stud-
ies investigated the long-term effects following stretch (that is, out-
comes weremeasuredmore than one week after the last stretch was
ceased) (Ackman 2005; Bulstrode 1987; Copley 2013; Gustafsson
2006; Harvey 2000; Horsley 2007; Horton 2002; Hussein 2015;
Jerosch-Herold 2011; Jongs 2012; Kemler 2012; Lannin 2003a;
Lannin 2007a; Law 1991; McNee 2007; Melegati 2003; Moseley
2005; Zenios 2002).
Five studies (DiPasquale-Lehnerz 1994; Hill 1994; Hyde 2000;
Krumlinde-Sundholm 2011; Sheehan 2006) did not provide any
useable data for any of the analyses and are described qualitatively
in Characteristics of included studies. Characteristics of all other
included studies are also detailed in the ’Characteristics of included
studies’ tables.
Excluded studies
We excluded 86 studies (for reasons see Characteristics of excluded
studies).
Risk of bias in included studies
The risk of bias in the 49 included studies was variable. We have
summarised results in Figure 2, with further details about the risk
of bias in the included studies reported in the Characteristics of
included studies tables.
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Figure 2. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study
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Allocation
Thiry-one studies (63%) used adequate methods for generating
the randomisation sequencewhilst 25 studies (51%)used adequate
methods to conceal allocation (see Figure 2 and ’Characteristics
of included studies’ tables).
Blinding
Blinding of participants and therapists was not possible in any of
the studies due to the nature of the intervention. Thirty-six studies
(73%) blinded assessors of objective outcomes to group allocation
(see Figure 2 and ’Characteristics of included studies’ tables).
Incomplete outcome data
Thirty-one studies (63%) were free of selective outcome reporting
(see Figure 2 and ’Characteristics of included studies’ tables).
Selective reporting
Thirty-one studies (63%) had complete outcome data (see Figure
2 and ’Characteristics of included studies’ tables).
Other potential sources of bias
Twenty-six studies (53%) were free of other bias (see Figure 2 and
’Characteristics of included studies’ tables).
Effects of interventions
See: Summary of findings for the main comparison Short-term
effects of stretch for the treatment and prevention of contractures
in people with neurological conditions; Summary of findings 2
Short-term effects of stretch for the treatment and prevention of
contractures in people with non-neurological conditions
The included studies all compared stretch plus co-intervention
versus co-intervention. Co-interventions included usual care, bo-
tulinum toxin, passive stretches, exercise and therapy. The studies
applied the co-interventions in the same manner to both groups.
All but four studies measured joint mobility in degrees (
Buchbinder 1993; Cox 2009; Melegati 2003; Sheehan 2006). All
four studies involved people with non-neurological conditions and
hence we expressed the short- and long-term effects of stretch
for non-neurological conditions as standardised mean difference
(SMD). Quality of life, spasticity, activity limitations and partic-
ipation restrictions were measured using various scales and there-
fore we expressed results as SMDs and back-translated them to a
common scale. The exception was pain. In some analyses, pain
was uniformly measured using the 100 mm visual analogue scale.
We therefore expressed results for these analyses as mean differ-
ences (MD). When only one study was included in an analysis,
we reported the results as MDs using the scales of the study.
Where sufficient data were available we included all studies in
analyses; that is, where means and standard deviations could be
extracted or estimated. All analyses were initially restricted to each
sub-group of participants, however, there were no statistically sig-
nificant differences between sub-groups within the neurological
or non-neurological conditions for any outcome. Therefore we
pooled the results across the sub-groups within neurological and
non-neurological condition (see Analysis 1.1 to Analysis 9.1).
We evaluated the quality of evidence using the GRADE approach
for the short-term effect of stretch on joint mobility, quality of life,
pain, activity limitations, participation restrictions and adverse
events for neurological conditions (see Summary of findings for the
main comparison) and non-neurological conditions (see Summary
of findings 2). The results of all analyses are reported below.
Joint mobility
Short-term effects following stretch
Neurological conditions
Twenty-six studies with a total of 699 participants investigated the
short-term effects on joint mobility following stretch in people
with neurological conditions (Ada 2005; Basaran 2012; Ben 2005;
Burge 2008; Copley 2013; Crowe 2000; De Jong 2006; Dean
2000; DiPasquale-Lehnerz 1994; Gustafsson 2006; Harvey 2000;
Harvey 2003;Harvey 2006;Hill 1994;Horsley 2007;Hyde 2000;
Krumlinde-Sundholm 2011; Lai 2009; Lannin 2003a; Lannin
2007a; Law 1991; Moseley 1997; Refshauge 2006; Rose 2010;
Sheehan 2006; Turton 2005). Eighteen studies with a total of 549
participants provided sufficient data (Ada 2005; Basaran 2012;
Ben 2005; Copley 2013; De Jong 2006; Dean 2000; Gustafsson
2006; Harvey 2000; Harvey 2003; Harvey 2006; Horsley 2007;
Lai 2009; Lannin 2003a; Lannin 2007a;Moseley 1997; Refshauge
2006; Rose 2010; Turton 2005). The participants included people
with stroke, Charcot-Marie-Tooth disease, acquired brain injury
and spinal cord injury. The mean difference (MD) was 2° (95%
CI 0° to 3°; I2 = 37%; P = 0.009) (see Analysis 1.1; Figure 3;
Summary of findings for the main comparison). The GRADE
quality of evidence for this result was high.
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Figure 3. Forest plot of comparison: Joint mobility - short-term effects following stretch - neurological
conditions (degrees)
Non-neurological conditions
Nineteen studies with a total of 925 participants investigated the
short-term effects on joint mobility following stretch in people
with non-neurological conditions (Aoki 2009; Buchbinder 1993;
Bulstrode 1987; Collis 2013; Cox 2009; Fox 2000; Horton 2002;
Hussein 2015; Jang 2015; Jerosch-Herold 2011; John 2011; Jongs
2012; Kemler 2012; Kolmus 2012; Lee 2007;Moseley 2005; Paul
2014; Seeger 1987; Steffen 1995). All studies provided sufficient
data but two studies (Buchbinder 1993; Cox 2009) did not mea-
sure joint mobility in degrees and hence data were pooled us-
ing a SMD. There was substantial statistical heterogeneity be-
tween studies (I2 = 67%) and the SMD was 0.3 (95% CI 0.1
to 0.6). The main reason for this heterogeneity was the Hussein
2015 study. The results for two of its three outcomes included in
this review were between 5 and 30 times greater than the results
for any other study. There was no obvious explanation for this
but the extreme results all favouring the experimental condition
seemed implausible. Therefore 18 studies with a total of 865 par-
ticipants were included in the analyses (Aoki 2009; Buchbinder
1993; Bulstrode 1987; Collis 2013; Cox 2009; Fox 2000; Horton
2002; Jang 2015; Jerosch-Herold 2011; John 2011; Jongs 2012;
Kemler 2012; Kolmus 2012; Lee 2007;Moseley 2005; Paul 2014;
Seeger 1987; Steffen 1995). The participants included frail elderly
and people with ankle fracture, anklylosing spondylitis, oral sub-
mucous fibrosis, post-radiation therapy to the breast, post-radia-
tion therapy to jaw, progressive systemic sclerosis, total knee re-
placement, arthritis, Dupuytren’s contractures, shoulder adhesive
capsulitis/frozen shoulder, hallux limitus, wrist fracture and burns.
The SMD was 0.2 (95% CI 0.0 to 0.3; I2 = 28%; P = 0.05) (see
Analysis 1.2; Figure 4; Summary of findings 2).TheGRADE qual-
ity of evidence for this result was high.
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Figure 4. Forest plot of comparison: Joint mobility - short-term effects following stretch - non-neurological
conditions (SMD)
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Long-term effects following stretch
Neurological conditions
Nine studies with a total of 248 participants investigated the long-
term effects on joint mobility following stretch in people with
neurological conditions (Ackman 2005; Copley 2013; Gustafsson
2006; Harvey 2000; Horsley 2007; Lannin 2003a; Lannin 2007a;
Law 1991; McNee 2007). Eight studies with a total of 211 par-
ticipants provided sufficient data (Ackman 2005; Copley 2013;
Gustafsson 2006; Harvey 2000; Horsley 2007; Lannin 2003a;
Lannin 2007a; McNee 2007). The participants included people
with stroke, cerebral palsy, spinal cord injury and acquired brain
injury. The MD was 1° (95% CI -1 to 3; I2 = 17%; P = 0.50) (see
Analysis 2.1; Figure 5).
Figure 5. Forest plot of comparison: Joint mobility - long-term effects following stretch - neurological
conditions (degrees)
Non-neurological conditions
Nine studies with a total of 558 participants investigated the
long-term effects on joint mobility following stretch in people
with non-neurological conditions (Bulstrode 1987; Horton 2002;
Hussein 2015; Jerosch-Herold 2011; Jongs 2012; Kemler 2012;
Melegati 2003;Moseley 2005; Zenios 2002). Seven studies with a
total of 498 participants provided sufficient data (Hussein 2015;
Jerosch-Herold 2011; Jongs 2012; Kemler 2012; Melegati 2003;
Moseley 2005; Zenios 2002) but one study (Melegati 2003) did
not measure joint mobility in degrees and hence data were pooled
using a SMD. There was substantial statistical heterogeneity be-
tween studies (I2 = 94%) and the SMD was 0.6 (95% CI -0.2 to
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1.5). Themain reason for this heterogeneity was theHussein 2015
study. As indicated in the short-term effects following stretch sec-
tion, this study had very large, implausible effects so we decided to
omit it from the analysis. Therefore six studies with a total of 438
participants were included in the analyses (Jerosch-Herold 2011;
Jongs 2012; Kemler 2012; Melegati 2003; Moseley 2005; Zenios
2002). The participants included people with anterior cruciate
ligament reconstruction, ankle fracture, total knee replacement,
Dupuytren’s contracture and wrist fracture. The SMD was -0.1
(95% CI -0.4 to 0.2; I2 = 42%; P = 0.43) (see Analysis 2.2).
Quality of life
Short-term effects following stretch
Neurological conditions
No study measured a quality of life outcome during this time
period.
Non-neurological conditions
Three studies with a total of 111 participants investigated the
short-term effects on quality of life following stretch in people with
non-neurological conditions (Buchbinder 1993; Kolmus 2012;
Lee 2007). Two studies with a total of 97 participants provided
sufficient data (Lee 2007; Kolmus 2012). The participants in-
cluded people post radiation therapy and with burns. The SMD
was 0.3 (95% CI -0.1 to 0.7; I2 = 0%; P = 0.13) (see Analysis 3.1;
Summary of findings 2).The GRADE quality of evidence for this
result was moderate.
Long-term effects following stretch
Neurological conditions
No study measured a quality of life outcome during this time
period.
Non-neurological conditions
No study measured a quality of life outcome during this time
period.
Pain
Short-term effects following stretch
Neurological conditions
Nine studies with a total of 265 participants investigated the
short-term effects on pain following stretch in people with neu-
rological conditions (Ada 2005; Burge 2008; Crowe 2000; De
Jong 2006; Dean 2000; Gustafsson 2006; Horsley 2007; Lannin
2003a; Lannin 2007a). Five studies with a total of 174 participants
provided sufficient data (Crowe 2000; Gustafsson 2006; Horsley
2007; Lannin 2003a; Lannin 2007a). The participants included
people with stroke and spinal cord injury. The SMDwas 0.2 (95%
CI -0.1 to 0.5; I2 = 0%; P = 0.19) (see Analysis 4.1; Summary
of findings for the main comparison).The GRADE quality of ev-
idence for this result was low.
Non-neurological conditions
Nine studies with a total of 460 participants investigated the short-
term effects on pain following stretch in people with non-neuro-
logical conditions (Aoki 2009; Buchbinder 1993; Cox 2009; Fox
2000;Hussein 2015; Kemler 2012; Lee 2007;Moseley 2005; Paul
2014). Seven studies with a total of 422 participants provided suf-
ficient data (Aoki 2009; Fox 2000; Hussein 2015; Kemler 2012;
Lee 2007; Moseley 2005; Paul 2014). The participants included
frail elderly people and people with ankle fracture, post-radiation
therapy to the breast, arthritis, shoulder adhesive capsulitis/frozen
shoulder and Dupuytren’s contracture. The SMD was -0.2 (95%
CI -0.4 to 0.1; I2 = 44%; P = 0.22) (see Analysis 4.2; Summary
of findings 2). The GRADE quality of evidence for this result was
high.
Long-term effects following stretch
Neurological conditions
Four studies with a total of 132 participants investigated the long-
term effects on pain following stretch in people with neurolog-
ical conditions (Gustafsson 2006; Horsley 2007; Lannin 2003a;
Lannin 2007a). All studies provided sufficient data. The partici-
pants included people with stroke. The SMDwas 0 (95% CI -0.4
to 0.5; I2 = 38%; P = 0.90) (see Analysis 5.1).
Non-neurological conditions
Three studies with a total of 204 participants investigated the long-
term effects on pain following stretch in people with non-neuro-
logical conditions (Hussein 2015; Kemler 2012; Moseley 2005).
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Two studies with a total of 150 participants provided sufficient
data (Hussein 2015; Moseley 2005). Data were not pooled due to
clinical heterogeneity between studies. The participants included
people with shoulder adhesive capsulitis and ankle fracture. The
point estimates of effect of the two studies were -0.6 and 0 on a
10 cm visual analogue scale (see Analysis 5.2).
Activity limitations
Short-term effects following stretch
Neurological conditions
Twelve studies with a total of 321 participants investigated the
short-term effects on activity limitations following stretch in peo-
ple with neurological conditions (Ada 2005; Crowe 2000;De Jong
2006; DiPasquale-Lehnerz 1994; Gustafsson 2006; Hill 1994;
Horsley 2007; Hyde 2000; Lannin 2003a; Lannin 2007a; Law
1991; Rose 2010). Eight studies with a total of 247 participants
provided sufficient data (Ada 2005; De Jong 2006; Gustafsson
2006; Horsley 2007; Lannin 2003a; Lannin 2007a; Law 1991;
Rose 2010). There was substantial statistical heterogeneity be-
tween studies (I2 = 56%) and the SMD was 0.3 (95% CI -0.1 to
0.7). After exploring the reasons for this heterogeneity we decided
to exclude theDe Jong 2006 study because author correspondence
revealed that some of the participants received confounding in-
terventions including botulinum toxin injections, and additional
physiotherapy and occupational therapy. Therefore seven studies
with a total of 237 participants were included in the analyses (Ada
2005; Gustafsson 2006; Horsley 2007; Lannin 2003a; Lannin
2007a; Law 1991; Rose 2010). The participants included people
with stroke, cerebral palsy and Charcot-Marie-Tooth disease. The
SMD was 0.2 (95% CI -0.1 to 0.5; I2 = 37%; P = 0.25) (see
Analysis 6.1; Summary of findings for the main comparison). The
GRADE quality of evidence for this result was low.
Non-neurological conditions
Eight studieswith a total of 556participants investigated the short-
term effects on activity limitations following stretch in people with
non-neurological conditions (Aoki 2009; Collis 2013; Hussein
2015; Jerosch-Herold 2011; Jongs 2012; Kolmus 2012; Moseley
2005; Paul 2014). Six studies with a total of 416 participants pro-
vided sufficient data (Aoki 2009; Hussein 2015; Jerosch-Herold
2011; Jongs 2012; Kolmus 2012; Moseley 2005). There was sub-
stantial statistical heterogeneity between studies (I2 = 85%) and
the SMD was 0.2 (95% CI -0.3 to 0.7). The main reason for
this heterogeneity was the Hussein 2015 study. As indicated in
the short-term effects following stretch section, this study had
very large, implausible effects so we decided to omit it from the
analysis. Therefore five studies with a total of 356 participants
were included in the analyses (Aoki 2009; Jerosch-Herold 2011;
Jongs 2012; Kolmus 2012; Moseley 2005). The participants in-
cluded people with ankle fracture, arthritis, Dupuytren’s contrac-
ture, wrist fracture and burns. The SMD was 0.1 (95% CI -0.2 to
0.3; I2 = 25%; P = 0.49) (see Analysis 6.2; Summary of findings
2). The GRADE quality of evidence for this result was high.
Long-term effects following stretch
Neurological conditions
Six studies with a total of 191 participants investigated the long-
term effects on activity limitations following stretch in people with
neurological conditions (Gustafsson 2006; Horsley 2007; Lannin
2003a; Lannin 2007a; Law 1991; McNee 2007). All studies pro-
vided sufficient data. The participants included people with stroke
and cerebral palsy. The SMD was 0.2 (95% CI -0.1 to 0.6; I2 =
25%; P = 0.19) (see Analysis 7.1).
Non-neurological conditions
Four studies with a total of 328 participants investigated the long-
term effects on activity limitations following stretch in people
with non-neurological conditions (Hussein 2015; Jerosch-Herold
2011; Jongs 2012; Moseley 2005). There was substantial statisti-
cal heterogeneity between studies (I2 = 91%) and the SMD was
0.4 (95% CI -0.4 to 1.2). The main reason for this heterogeneity
was the Hussein 2015 study. As indicated in the short-term effects
following stretch section, this study had very large, implausible
effects so we decided to omit it from the analysis. Therefore three
studies with a total of 268 participants were included in the anal-
yses (Jerosch-Herold 2011; Jongs 2012; Moseley 2005). The par-
ticipants included people with ankle fracture, Dupuytren’s con-
tracture and wrist fracture. The SMD was -0.1 (95% CI -0.3 to
0.2; I2 = 0%; P = 0.49) (see Analysis 7.2).
Participation restrictions
Short-term effects following stretch
Neurological conditions
One study with a total of 58 participants investigated the short-
term effects on participation restrictions following stretch in peo-
ple with neurological conditions (Harvey 2006). This study did
not provide sufficient data.
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Non-neurological conditions
Two studies with a total of 129 participants investigated the short-
term effects on participation restrictions following stretch in peo-
plewith non-neurological conditions (Jongs 2012;Moseley 2005).
Both studies provided sufficient data. The participants included
people with ankle and wrist fracture. The SMD was -0.2 (95%
CI -0.6 to 0.1; I2 = 0%; P = 0.21) (see Analysis 8.1; Summary of
findings 2). The GRADE quality of evidence for this result was
low.
Long-term effects following stretch
Neurological conditions
No study measured a participation restriction outcome during this
time period.
Non-neurological conditions
Two studies with a total of 122 participants investigated the long-
term effects on participation restrictions following stretch in peo-
plewith non-neurological conditions (Jongs 2012;Moseley 2005).
Both studies provided sufficient data. The participants included
people with ankle and wrist fracture. The SMDwas -0.2 (95% CI
-0.6 to 0.3; I2 = 26%; P = 0.50) (see Analysis 9.1).
Spasticity
Short-term effects following stretch
Neurological conditions
Seven studies with a total of 159 participants investigated the
short-term effects on spasticity following stretch in people with
neurological conditions (Basaran 2012; Burge 2008; Copley 2013;
De Jong 2006; Hill 1994; Lai 2009; Lannin 2007a). Six studies
with a total of 144 participants provided sufficient data (Basaran
2012; Burge 2008; Copley 2013; De Jong 2006; Lai 2009; Lannin
2007a). The participants included people with stroke and acquired
brain injury. The SMD was 0.0 (95% CI -0.3 to 0.4; I2 = 0%; P
= 0.85) (see Analysis 10.1).
Non-neurological conditions
No study measured a spasticity outcome during this time period
as spasticity is not relevant to this group.
Long-term effects following stretch
Neurological conditions
Three studies with a total of 73 participants investigated the long-
term effects on spasticity following stretch in people with neuro-
logical conditions (Ackman 2005; Copley 2013; Lannin 2007a).
All studies provided sufficient data. The participants included peo-
ple with stroke, cerebral palsy and acquired brain injury. The SMD
was -0.3 (95% CI -0.8 to 0.1; I2 = 0%; P = 0.16) (see Analysis
11.1).
Non-neurological conditions
No study measured a spasticity outcome during this time period
as spasticity is not relevant to this group.
Adverse events
Neurological conditions
Five studies with a total of 145 participants provided statements
about adverse events (Ackman 2005; Horsley 2007; Fox 2000;
Rose 2010; Turton 2005). However, the data were not sufficiently
detailed or comparable to analyse quantitatively. The details of the
adverse events described in the five studies are:
• Ackman 2005 stated that there were no adverse events
directly related to the experimental intervention (plaster cast) but
three children from the experimental group withdrew from the
study because their parents felt they were tripping and falling
more than usual.
• Fox 2000 and Rose 2010 reported five adverse events,
including skin breakdown, mild bruising, and a blister on a toe.
These adverse events were thought to be due to the intervention
(application of plaster casts).
• Horsley 2007 reported one death in the control group. It is
very unlikely the death was caused by the intervention.
• Turton 2005 stated that three participants ceased the
intervention because of shoulder pain (n = 1) or wrist pain (n =
2). It is not clear if these adverse events were caused by the
intervention.
Non-neurological conditions
Nine studies with a total of 635 participants included statements
about adverse events (Horton 2002; Jerosch-Herold 2011; Jongs
2012; Kemler 2012; Kolmus 2012; Lee 2007; Paul 2014; Seeger
1987; Zenios 2002). Two studies (Kolmus 2012; Paul 2014)
explicitly stated that there were no adverse events. One study
(Jerosch-Herold 2011) indicated that some participants did not
comply with the experimental intervention because of discomfort,
22Stretch for the treatment and prevention of contractures (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
pain, sleep disturbance, a rash or stiffness but did not provide any
further details. The data from the remaining six studies were not
sufficiently detailed or comparable to analyse quantitatively. The
details of the adverse events described in the six studies are:
• Horton 2002 reported one adverse event in a control
participant (haematoma) and three adverse events in participants
receiving the intervention (one deep venous thrombosis, one
death and one requiring manipulation under anaesthesia).
• Jongs 2012 stated that some participants in the
intervention group experienced transient numbness (n = 10) or
pain (n = 1) due to the splint. It is not clear if adverse events were
monitored in the control participants.
• Kemler 2012 reported 14 adverse events in experimental
participants (haematoma = 5; flexion deficits = 8) and eight
adverse events in control participants (haematoma = 4; flexion
deficits = 4).
• Lee 2007 reported swelling in control (n = 4) and
intervention participants (n = 1).
• Seeger 1987 stated that four participants in the intervention
group dropped out because of exacerbation of Raynauds’
phenomenon due to the splint. It is not clear if adverse events
were monitored in the control participants.
• Zenios 2002 reported wound infections in control (n = 1)
and intervention participants (n = 10).
Subgroup analyses
The effects of different stretch dosages on joint
mobility (total stretch time)
Thirty seven studies with a total of 1519 participants measured
joint mobility in degrees and provided sufficient data to estimate
the effect of mean total stretch time on joint mobility (Ackman
2005; Ada 2005; Aoki 2009; Basaran 2012; Collis 2013; Copley
2013; Ben 2005; Bulstrode 1987; De Jong 2006; Dean 2000;
Fox 2000; Gustafsson 2006; Harvey 2000; Harvey 2003; Harvey
2006; Horsley 2007; Horton 2002; Hussein 2015; Jang 2015;
Jerosch-Herold 2011; John 2011; Jongs 2012; Kemler 2012;
Kolmus 2012; Lai 2009; Lannin 2003a; Lannin 2007a; Lee 2007;
McNee 2007;Moseley 1997;Moseley 2005; Paul 2014; Refshauge
2006; Seeger 1987; Steffen 1995; Turton 2005; Zenios 2002). As
mean time data were skewed, they were transformed by taking the
natural logarithm of time. We adjusted total stretch time for the
length of time between randomisation and measurement as well
as the length of time between the last stretch and measurement
using multiple meta-regression. The MDwas 0° for each log hour
increase in total stretch time (95%CI -1 to 1; I2 = 31%; P = 0.119)
(see Figure 6).
Figure 6. Bubble plot of meta-regression analysis: Joint mobility - effects of total stretch time on joint
mobility - all conditions (degrees)
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The effects of different stretch interventions on joint
mobility
Thirty seven studies with a total of 1530 participants measured
joint mobility in degrees and provided sufficient data to esti-
mate the effect of different stretch interventions on joint mobil-
ity (Ackman 2005; Ada 2005; Aoki 2009; Basaran 2012; Collis
2013; Copley 2013; Ben 2005; Bulstrode 1987; De Jong 2006;
Dean 2000; Fox 2000; Gustafsson 2006; Harvey 2000; Harvey
2003; Harvey 2006; Horsley 2007; Horton 2002; Hussein 2015;
Jang 2015; Jerosch-Herold 2011; John 2011; Jongs 2012; Kemler
2012; Kolmus 2012; Lai 2009; Lannin 2003a; Lannin 2007a; Lee
2007; McNee 2007; Moseley 1997; Moseley 2005; Paul 2014;
Refshauge 2006; Seeger 1987; Steffen 1995; Turton 2005; Zenios
2002). We examined the overall effect of administering stretch in
five different ways: serial casting; positioning; splinting; self-ad-
ministration; and other ways. The effect of stretch on joint mobil-
ity was not influenced by the way stretch was administered (test for
subgroup differences; P = 0.33) although these results need to be
interpreted with caution because some subgroups only included
two studies.
Three studies with a total of 57 participants investigated the effect
of serial casting on joint mobility (Ackman 2005; McNee 2007;
Moseley 2005). The MD of serial casting on joint mobility was
5° (95% CI -3 to 12; I2= 65%; P = 0.21) (see Analysis 12.1).
Seven studies with a total of 165 participants investigated the effect
of positioning on joint mobility (Ada 2005; De Jong 2006; Dean
2000; Fox 2000; Gustafsson 2006; Jang 2015; Turton 2005). The
MD of positioning on joint mobility was 3° (95% CI -3 to 8; I2
= 40%; P = 0.32) (see Analysis 12.1).
Eighteen studies with a total of 847 participants investigated
the effects of splinting on joint mobility (Basaran 2012; Collis
2013; Copley 2013; Harvey 2006; Horton 2002; Hussein 2015;
Jerosch-Herold 2011; John 2011; Jongs 2012; Kemler 2012;
Kolmus 2012; Lai 2009; Lannin 2003a; Lannin 2007a; Refshauge
2006; Seeger 1987; Steffen 1995; Zenios 2002). There was sub-
stantial statistical heterogeneity between studies (I2 = 97%). The
main reason for this heterogeneity was the Hussein 2015 study. As
indicated in the short-term effects following stretch section, this
study had very large, implausible effects so we decided to omit it
from the analysis. Therefore 17 studies with a total of 787 partic-
ipants were included in the analyses (Basaran 2012; Collis 2013;
Copley 2013; Harvey 2006; Horton 2002; Jerosch-Herold 2011;
John 2011; Jongs 2012; Kemler 2012; Kolmus 2012; Lai 2009;
Lannin 2003a; Lannin 2007a; Refshauge 2006; Seeger 1987;
Steffen 1995; Zenios 2002). The MD of splinting on joint mo-
bility was 0° (95% CI -1 to 2; I2 = 28%; P = 0.68) (see Analysis
12.1 and Figure 7).
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Figure 7. Forest plot of comparison: Joint mobility - subgroup analyses by type of stretch intervention -
neurological conditions (degrees)
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Two studies with a total of 75 participants investigated the ef-
fects of self-administered stretches on joint mobility (Aoki 2009;
Bulstrode 1987). The MD of self-administered stretches on joint
mobility was 3° (95% CI 0 to 6; I2 = 0%; P = 0.04) (see Analysis
12.1 and Figure 7).
Seven studies with a total of 386 participants investigated the
effects of other stretch interventions on joint mobility (Ben 2005;
Harvey 2000; Harvey 2003; Horsley 2007; Lee 2007; Moseley
2005; Paul 2014). TheMD of other stretch interventions on joint
mobility was 1° (95%CI -1 to 3; I2 = 48%; P = 0.41) (see Analysis
12.1 and Figure 7).
The effects of stretch on joint mobility in small joints
versus large joints
Thirty seven studies with a total of 1506 participants measured
joint mobility in degrees and provided sufficient data to esti-
mate the effects of stretch in small versus large joints (Ackman
2005; Ada 2005; Aoki 2009; Basaran 2012; Collis 2013; Copley
2013; Ben 2005; Bulstrode 1987; De Jong 2006; Dean 2000;
Fox 2000; Gustafsson 2006; Harvey 2000; Harvey 2003; Harvey
2006; Horsley 2007; Horton 2002; Hussein 2015; Jang 2015;
Jerosch-Herold 2011; John 2011; Jongs 2012; Kemler 2012;
Kolmus 2012; Lai 2009; Lannin 2003a; Lannin 2007a; Lee 2007;
McNee 2007;Moseley 1997;Moseley 2005; Paul 2014; Refshauge
2006; Seeger 1987; Steffen 1995; Turton 2005; Zenios 2002).
The effect of stretch on joint mobility was not influenced by the
size of the joint (test for subgroup differences; P = 0.42).
Twenty studies with a total of 822 participants investigated the
effects of stretch in small joints (Ackman 2005; Ben 2005;
Basaran 2012; Collis 2013; Copley 2013; Harvey 2000; Harvey
2006;Horsley 2007; Jerosch-Herold 2011; Lannin 2003a; Lannin
2007a; John 2011; Jongs 2012; Kemler 2012; McNee 2007;
Moseley 1997; Moseley 2005; Refshauge 2006; Seeger 1987;
Turton 2005). The MD of stretch in small joints was 1° (95% CI
0 to 3; I2 = 45%; P = 0.07) (see Analysis 12.2).
Seventeen studies with a total of 705 participants measured joint
mobility in degrees and provided sufficient data to estimate the
effects of stretch in large joints (Aoki 2009; Ada 2005; Bulstrode
1987; De Jong 2006; Dean 2000; Fox 2000; Gustafsson 2006;
Harvey 2003; Horton 2002; Hussein 2015; Jang 2015; Kolmus
2012; Lai 2009; Lee 2007; Paul 2014; Steffen 1995; Zenios 2002).
There was substantial statistical heterogeneity between studies (I2
= 97%). The main reason for this heterogeneity was the Hussein
2015 study. As indicated in the short-term effects following stretch
section, this study had very large, implausible effects so we decided
to omit it from the analysis. Therefore 16 studieswith a total of 645
participants were included in the analyses (Aoki 2009; Ada 2005;
Bulstrode 1987; De Jong 2006; Dean 2000; Fox 2000; Gustafsson
2006; Harvey 2003; Horton 2002; Jang 2015; Kolmus 2012; Lai
2009; Lee 2007; Paul 2014; Steffen 1995; Zenios 2002). TheMD
of splinting on joint mobility was 1° (95% CI -1 to 2; I2 = 36%;
P = 0.44) (see Analysis 12.2).
The effects of stretch on joint mobility when
influenced by participants’ perceptions of discomfort
Thirty-seven studies with a total of 1506 participants measured
joint mobility in degrees and provided sufficient data to estimate
the effects of stretch when measurements could be influenced by
participants’ perceptions of discomfort versus whenmeasurements
could not be influenced by participants’ perceptions of discom-
fort (Ackman 2005; Ada 2005; Aoki 2009; Basaran 2012; Collis
2013; Copley 2013; Ben 2005; Bulstrode 1987; De Jong 2006;
Dean 2000; Fox 2000; Gustafsson 2006; Harvey 2000; Harvey
2003; Harvey 2006; Horsley 2007; Horton 2002; Hussein 2015;
Jang 2015; Jerosch-Herold 2011; John 2011; Jongs 2012; Kemler
2012; Kolmus 2012; Lai 2009; Lannin 2003a; Lannin 2007a; Lee
2007; McNee 2007; Moseley 1997; Moseley 2005; Paul 2014;
Refshauge 2006; Seeger 1987; Steffen 1995; Turton 2005; Zenios
2002). The effect of stretch on joint mobility was not influenced
by participants’ perceptions of discomfort (test for subgroup dif-
ferences; P = 0.90).
Twenty-six studies with a total of 1069 participants used meth-
ods where joint mobility measurements could be influenced by
participants’ perceptions of discomfort (e.g. studies that measured
maximal passive or active joint range of motion) (Ackman 2005;
Ada 2005; Aoki 2009; Basaran 2012; Collis 2013; Copley 2013;
Bulstrode 1987; De Jong 2006; Dean 2000; Fox 2000; Gustafsson
2006; Horton 2002; Hussein 2015; Jang 2015; Jerosch-Herold
2011; John 2011; Jongs 2012; Kemler 2012; Kolmus 2012; Lai
2009; Lee 2007; McNee 2007; Paul 2014; Seeger 1987; Turton
2005; Zenios 2002). There was substantial statistical heterogene-
ity between studies (I2 = 95%) and the SMD was 7° (95% CI 1°
to 10°). The main reason for this heterogeneity was the Hussein
2015 study. As indicated in the short-term effects following stretch
section, this study had very large, implausible effects so we de-
cided to omit it from the analysis. Therefore 25 studies with a
total of 1009 participants were included in the analyses (Ackman
2005; Ada 2005; Aoki 2009; Basaran 2012; Collis 2013; Copley
2013; Bulstrode 1987; De Jong 2006; Dean 2000; Fox 2000;
Gustafsson 2006; Horton 2002; Jang 2015; Jerosch-Herold 2011;
John 2011; Jongs 2012; Kemler 2012; Kolmus 2012; Lai 2009;
Lee 2007; McNee 2007; Paul 2014; Seeger 1987; Turton 2005;
Zenios 2002). The MD of stretch on joint mobility when joint
mobility measurements could be influenced by participants’ per-
ceptions of discomfort was 1° (95% CI 0 to 3; I2 = 42%; P = 0.14)
(see Analysis 12.3).
Eleven studies with a total of 461 participants usedmethods where
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joint mobility measurements could not be influenced by partic-
ipants’ perceptions of discomfort (e.g. studies that standardised
passive joint torque when measuring joint mobility) (Ben 2005;
Harvey 2000; Harvey 2003; Harvey 2006; Horsley 2007; Lannin
2003a; Lannin 2007a; Moseley 1997; Moseley 2005; Refshauge
2006; Steffen 1995). The MD of stretch on joint mobility when
joint mobility measurements could not be influenced by partici-
pants’ perceptions of discomfort was 1° (95% CI 0 to 3; I2 = 46%;
P = 0.16).
The effects of stretch on joint mobility for the
treatment of contractures versus the prevention of
contractures
The distinction between stretch for the treatment and prevention
of contractures was often ambiguous.Many studies recruited amix
of participants (that is, some participants had existing contractures
whilst other participants were at risk of developing contractures).
Only four studies clearly investigated the effects of stretch for
the prevention of contractures (that is, participants did not have
contractures on entry to the study) (Ada 2005; Copley 2013;
Crowe 2000;Melegati 2003). However, only two studies provided
sufficient data (Ada 2005; Copley 2013), preventing the planned
subgroup analysis.
The effect of stretch on joint mobility when
measurements were taken within one day of the last
stretch
Studies did not always clearly state the time period between the last
stretch and the first post-intervention assessment of joint mobility.
This is important because measurements taken within 24 hours
of the last stretch may reflect the short-lived viscous effects of
stretch. Therefore, when not stated, we assumed that the first post-
intervention assessment of joint mobility was taken within 24
hours of the last stretch.
Twenty-eight studies with a total of 1128 participants measured
joint mobility in degrees and provided sufficient data to estimate
the effects of stretch when measurements were taken less than
one day after the last stretch intervention (Ada 2005; Aoki 2009;
Basaran 2012; Bulstrode 1987; Collis 2013; Copley 2013; Dean
2000; De Jong 2006; Fox 2000; Gustafsson 2006; Horton 2002;
Jang 2015; Jerosch-Herold 2011; John 2011; Jongs 2012; Kemler
2012; Kolmus 2012; Lai 2009; Lannin 2003a; Lannin 2007a; Lee
2007; Moseley 1997; Moseley 2005; Paul 2014; Refshauge 2006;
Rose 2010; Seeger 1987; Steffen 1995). TheMD was 1° (95% CI
0 to 2; I2 = 30; P = 0.02) (see Analysis 12.4).
Seven studies with a total of 245 participants measured joint mo-
bility in degrees and provided sufficient data to estimate the effects
of stretch when measurements were taken more than one day after
the last stretch intervention (Ben 2005; Fox 2000; Harvey 2000;
Harvey 2003; Harvey 2006; Horsley 2007; Turton 2005). The
MD was 1° (95% CI 0 to 2; I2 = 31%; P = 0.02) (see Analysis
12.4).
Sensitivity analyses
We conducted sensitivity analyses on the neurological and non-
neurological populations to examine the effects of randomisation
(adequate sequence generation versus inadequate sequence gener-
ation), allocation concealment (concealed versus non-concealed),
blinding of assessors (blinding versus no blinding) and complete-
ness of outcome data (complete outcome data available versus in-
complete outcome data available) on the primary outcome of joint
mobility (details below).
Short-term effects following stretch on joint mobility
Neurological conditions
Excluding studies that did not fulfil the risk of bias criteria (ad-
equate sequence generation, allocation concealment, blinding of
assessors and completeness of outcome data) had no effect on the
mean difference.We excluded between two and five studies (out of
a total of 18 studies) for each of the criteria. We have summarised
the results in Table 1 (Additional tables).
Non-neurological conditions
Excluding studies that did not fulfil the risk of bias criteria (ad-
equate sequence generation, allocation concealment, blinding of
assessors and completeness of outcome data) had no effect on the
mean difference.We excluded between four and eight studies (out
of a total of 16 studies) for each of the criteria. We have sum-
marised the results in Table 2 (Additional tables).
Long-term effects following stretch on joint mobility
Neurological conditions
Excluding studies that did not fulfil the risk of bias criteria (ad-
equate sequence generation, allocation concealment, blinding of
assessors and completeness of outcome data) had no effect on the
mean difference. We excluded between two and three studies (out
of a total of eight studies) for each of the criteria. We have sum-
marised the results Table 1 (Additional tables).
Non-neurological conditions
Excluding studies that did not fulfil the risk of bias criteria (ad-
equate sequence generation, allocation concealment, blinding of
assessors and completeness of outcome data) had no effect on the
mean difference. We excluded between no studies and two studies
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(out of a total of five studies) for each of the criteria. We have
summarised the results in Table 2 (Additional tables).
Small sample bias
To examine the possibility of small sample bias in the estimates of
the short-term effects of stretch on joint mobility for people with
neurological (see Figure 8) and non-neurological conditions (see
Figure 9), we generated two funnel plots. Both funnel plots indi-
cated evidence of small sample bias with the effect being greater in
the non-neurological conditions than the neurological conditions.
Figure 8. Funnel plot of comparison: 1 Joint mobility - short-term effects following stretch, outcome: 1.1
Neurological conditions (degrees)
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Figure 9. Funnel plot of comparison: 1 Joint mobility - short-term effects following stretch, outcome: 1.2
Non-neurological conditions
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Short- term effects of stretch for the treatment and prevention of contractures
Patient or population: people with non-neurological condit ions1
Settings: inpat ients and outpat ients
Intervention: short-term ef fects of stretch (< 1 week af ter the last stretch)
Outcomes Illustrative comparative risks* (95% CI) Relative % change
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments, summary
statistics and absolute
risk difference
Assumed risk Corresponding risk
Control Short- term effects of
stretch
Joint mobility
Range of motion
Scale f rom 0°-90°
(higher number ref lects
better outcome)
The mean joint mobil-
ity in the control groups
was 104°2
This translates to an ab-
solute mean increase
of 1° higher (0° to 2°
higher) compared with
control group on a 90°
scale3
865
(18 studies)
⊕⊕⊕⊕
high4,5
SMD = 0.2 higher (0.0
to 0.3 higher)
Absolute change = 1%
better (0% to 2% better)
Relat ive change = 1%
better (0% to 2% better)
The results rule out
a clinically important
treatment ef fect equiv-
alent to 5° and an abso-
lute change and relat ive
change of 5%
Quality of life
160-point Burn Spe-
cif ic Health Scale-Brief
quest ionnaire
(higher score ref lects
better outcome)
The mean quality of lif e
in the control group was
128 points on a 160-
point scale6
This translates to an ab-
solute mean increase
of 3 (-1 to 6) points
compared with control
group on a 160-point
scale7
97
(2 studies)
⊕⊕⊕©
moderate4,8,9
SMD = 0.3 higher (0.1
lower to 0.7 higher)
Absolute change = 2%
better (1% worse to 4%
better)
Relat ive change = 2%
better (1% worse to 5%
better)
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The results rule out
a clinically important
treatment ef fect equiv-
alent to 10 points and
an absolute change and
relat ive change of 5%
Pain
10-point VAS
(lower score ref lects
better outcome)
The mean pain in the
control group was 4
points on a 10-point
VAS10
This translates to an ab-
solute mean decrease
of 0.2 (-0.4 to 0.1)
points compared with
control group on an 10-
point scale11
422
(7 studies)
⊕⊕⊕⊕
high4,5
SMD 0.2 lower (0.4
lower to 0.1 higher)
Absolute change = 1%
better (3% better to 1%
worse)
Relat ive change = 2%
better (4% better to 1%
worse)
The results rule out
a clinically important
treatment ef fect equiv-
alent to 2 points and
an absolute change and
relat ive change of 5%
Activity limitations
100-point Disabilit ies
of the Arm, Shoul-
der and Hand quest ion-
naire (lower score re-
f lects better outcome)
The mean act ivity lim-
itat ion in the control
group was 7 points on
a 100-point upper limb
scale12
This translates to an ab-
solute mean increase of
1.2 (-2.2 to 4.5) points
compared with control
group on a 100-point
scale13
356
(5 studies)
⊕⊕⊕⊕
high4,5,8
SMD = 0.1 higher (0.2
lower to 0.3 higher)
Absolute change = 1%
better (2% worse to 4%
better)
Relat ive change= 8%
better (15% worse to
29% better)
Participation restric-
tions
100 mm return to usual
work act ivit ies VAS
(higher score ref lects
better outcome)
The mean part icipant
restrict ion in the control
group was 39 points on
a 100-point VAS for re-
turn to work act ivit ies14
This translates to an ab-
solute mean decrease
of 11 points (-30 to 6)
points compared with
control group on a 100-
point scale15
129
(2 studies)
⊕⊕©©
low16,17
SMD = 0.2 lower (0.6
lower to 0.1 higher)
Absolute change = 12%
worse (31%worse to 6%
better)
Relat ive change = 31%
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worse (79% worse to
17% better)
Adverse events Nine studies involving 635 part icipants reported
41 adverse events that may have been related to
the intervent ion. These included transient numb-
ness (n = 10), pain (n = 1), Raynauds’ phenomenon
(n = 4), venous thrombosis (n = 1), need for
manipulat ion under anaesthesia (n = 1), wound
infect ions (n = 10), haematoma (n = 5), f lexion
def icits (n= 8) and swelling (n = 1). These were
predominant ly f rom splints
Not est imable Not est imable Not est imable Not est imable
* The assumed risk (e.g. the mean control group risk across studies) is based on one representat ive study chosen on the basis of its size and suscept ibility to bias. The
corresponding risk (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: Conf idence interval; RR: Risk rat io; VAS: visual analogue scale
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1 All the studies included in this review and included in the ’Summary of Findings’ outcomes included people with the
following non-neurological condit ions: f rail elderly and people with ankle f racture, anklylosing spondylit is, oral submucous
f ibrosis, post-radiat ion therapy to the breast, post-radiat ion therapy to jaw, progressive systemic sclerosis, total knee
replacement, arthrit is, Dupuytren’s contractures, shoulder adhesive capsulit is/ f rozen shoulder, hallux lim itus, wrist f racture
and burns. An addit ional study included in this review but not included in the ’Summary of Findings’ outcomes included
people following anterior cruciate ligament reconstruct ion. The treatment ef fects were consistent across all types of non-
neurological condit ions.
2 Post data of the control group in Moseley 2005 (the corresponding data in Analysis 1.2 is not post data).
3 Calculat ions based on the control group baseline mean (SD) range of motion: 98.4 (5.5) points on a 90-degree range of
motion measure (f rom Moseley 2005).
4 The quality of evidence was not downgraded due to risk of bias even though at least some of the included trials had select ion,
performance, detect ion, attrit ion and report ing bias. These types of bias would tend to exaggerate treatment ef fect iveness.
Given this review did not demonstrate treatment ef fect iveness these forms of bias are probably not important.
5 The quality of the evidence was not downgraded due to indirectness because the results are based on studies involving
people with many dif ferent types of underlying condit ions (e.g. arthrit is, f rail elderly,ankle f ractures).32
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6 Post data of the control group in Kolmus 2012 (see Analysis 3.1).
7 Calculat ions based on the control group post mean (SD) quality of lif e: 123 (9) on the 160-point Burn Specif ic Health Scale
Brief (no study provided baseline mean (SD) data for quality of lif e) (f rom Kolmus 2012).
8 The quality of the evidence was not downgraded due to imprecision because the point est imate is reasonably precise if
expressed as relat ive % change and absolute risk dif f erence.
9 The quality of the evidence was downgraded due to indirectness because the results are based on only two studies involving
people with burns and post radiat ion therapy to the breast thereby lim it ing their generalisability.
10 Post data of the control group in Paul 2014 (see Analysis 4.1).
11 Calculat ions based on the control group baseline mean (SD) pain: 8.0 (0.8) on a 10-point pain scale (f rom Paul 2014).
12 Post data of the control group in Jerosch-Herold 2011 (see Analysis 6.2).
13 Calculat ions based on the control group baseline mean (SD) act ivity lim itat ion: 15.4 (13.2) on a 100-point scale (f rom
Jerosch-Herold 2011).
14 Post data of the control group in Moseley 2005 (see Analysis 8.1).
15 Calculat ions based on the control group baseline mean (SD) part icipat ion restrict ion: 39.0 (54.1) on a 100-point scale (f rom
Moseley 2005).
16 The quality of the evidence was downgraded due to indirectness because the results are based on only two studies involving
people with ankle and wrist f racture thereby lim it ing their generalisability.
17 The quality of the evidence was downgraded due to imprecision because the point est imates are imprecise if expressed as
relat ive % change or absolute risk dif f erence.
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D I S C U S S I O N
Summary of main results
The primary objective of this systematic review was to determine
whether stretch increases joint mobility in people with existing
contractures or those at risk of developing contractures. The results
provided high-quality evidence that stretch did not have a clini-
cally important short-term effect on joint mobility in people with
or without neurological conditions. Similarly, there was no evi-
dence of a long-term effect of stretch. These findings were robust
in most sensitivity and sub-group analyses. This systematic review
also provides moderate- and high-quality evidence that stretch did
not have clinically important short-term effects on quality of life
or pain, respectively, in people with non-neurological conditions.
The short- and long-term effects of stretch on quality of life and
pain in people with neurological conditions were uncertain. There
was little or no evidence about the short or long-term effects of
stretch on activity limitations or participation restrictions in peo-
ple with or without neurological conditions but there was initial
evidence to indicate that stretch did not have a short-term effect
on spasticity in people with neurological conditions (see Table 3
for a summary of the interpretation of all results). There was no
useable data to determine the possible adverse events of stretch for
people either with or without neurological conditions.
The studies in this review included a diverse group of people with
conditions such as spinal cord injury, acquired brain injury, stroke,
ankylosing spondylitis, oral submucous fibrosis, systemic sclero-
sis, ankle fracture and arthritis. The studies were categorised into
neurological and non-neurological conditions. We reasoned that
it was justified to pool data across these two populations because
(a) stretch is used in routine clinical practice in a similar man-
ner across a range of different conditions, and (b) there was rela-
tively little between-study heterogeneity of estimates of effect. We
separated neurological from non-neurological conditions to guard
against the possibility that involvement of the nervous system, and
specifically spasticity, influences the response of people to stretch.
The results of the sub-group analyses suggest that the response of
different groups of people to stretch is remarkably consistent with
little evidence that stretch has a differing effect on joint mobility
for people with different types of neurological (see subgroup anal-
yses in Analysis 1.1; Analysis 2.1) or non-neurological conditions
(see subgroup analyses in Analysis 1.2; Analysis 2.2). The only
exception was acquired brain injury which we discuss below.
The point estimates for the short- or long-term effects of stretch
on joint mobility in people with neurological conditions are very
small and precise (mean difference (MD) 2°; 95% confidence in-
terval (CI) 0 to 3; and MD 1°; 95% CI -1 to 3, respectively)
(see Summary of findings for the main comparison; Summary of
findings 2). The precision around both estimates indicates that
any possible treatment effect is not greater than 4°. Most would
not consider a treatment effect of less than 5° (Ben 2005; Harvey
2000; Harvey 2003; Harvey 2006; Lannin 2003a; Lannin 2007a;
Moseley 2005; Refshauge 2006) or even less than 10° (Dean 2000;
Gustafsson 2006;Horsley 2007; Lee 2007) as clinically important.
The inconsequential size of possible treatment effects are also ev-
ident when the results are expressed as absolute change (MD 1%;
95%CI 0 to 2; see Summary of findings for themain comparison).
The results are very similar for all sub-group analyses with the
exception of acquired brain injury. The point estimates for both
the short-term and long-term effects of stretch for people with
acquired brain injury are very imprecise failing to rule in or rule
out a clinically important treatment effect. However, the results
of these sub-group analyses need to be interpreted with caution
because the point estimate describing the long-term effect is only
based on one study (Copley 2013) of 10 people and this study is
highly susceptible to bias (see Figure 2). The point estimate for
the short-term effects is based on three studies, however one study
is vulnerable to bias (Copley 2013) and another study measured
joint mobility immediately after the removal of a plaster cast. The
measurement of joint mobility immediately after the removal of a
castmay only reflect viscous deformation andmay not indicate any
therapeutic effect on contracture management (Weppler 2010).
The point estimates describing the short- or long-term effects of
stretch on joint mobility in people with non-neurological condi-
tions are more difficult to interpret because not all studies mea-
sured joint mobility in degrees and consequently the results are
expressed as standardised mean differences (SMD). Nonetheless,
there is no indication of a short-term or long-term treatment ef-
fect (SMD 0.2; 95% CI 0 to 0.3; SMD -0.1; 95% CI -0.4 to 0.2,
respectively). This is also evident when the results are expressed as
absolute change. For example, themean (95%CI) absolute change
for the short-term effect of stretch is 1% (0 to 3; see Summary of
findings 2).
There is moderate-quality evidence to indicate that stretch has no
short-term effects on quality of life for people with non-neurolog-
ical conditions. No study has examined the long-term effects al-
though it is unlikely that there would be long-term effects if there
were no short-term effects. No study has examined the short- or
long-term effect of stretch on quality of life in people with neuro-
logical conditions.
A secondary purpose of this systematic review was to determine
the effect of stretch on pain. There is high-quality evidence to
suggest that stretch has no short-term effects on pain in people
with non-neurological conditions (SMD -0.2; 95%CI -0.4 to 0.1)
(see Summary of findings for the main comparison). The long-
term effects of stretch on pain in people with non-neurological
conditions and the short- and long-term effects of stretch on pain
in people with neurological conditions are less clear, failing to rule
in or rule out a possible therapeutic effect.
Stretch is sometimes administered to decrease spasticity in people
with neurological conditions. Spasticity is believed to contribute
to loss of joint mobility as well as directly interfere with attempts at
movement. However, spasticity is notoriously difficult to quantify
in clinical studies. Typically it is measured with the Ashworth
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or Tardieu scales (Bohannon 1987; Tardieu 1954). Only six and
three studies provided useable data to determine the short-term
and long-term effects of stretch on spasticity, respectively. These
studies failed to rule in or rule out a possible therapeutic effect
however none specifically included people with spasticity. We do
not know the effects of stretch from studies that restrict inclusion
to those with problematic spasticity.
The effects of stretch on activity limitations and participation re-
strictions have not been well investigated. In the few instances
where effects on these outcomes were evaluated, there was no clear
beneficial effect. This is not altogether surprising given the failure
of stretch to increase joint mobility or decrease pain. Without un-
derlying changes at the impairment level, it is difficult to envisage
a mechanism whereby stretch could have therapeutic effects on
activity limitations and participation restrictions.
The dosage of stretch administered in the included studies was
highly variable. We used meta-regression to explore the possibility
that total stretch time influences joint mobility. The results in-
dicated that increasing dosages of stretch did not influence joint
mobility (mean effect 0° for each log hour increase in total stretch
time; 95%CI -1 to 1).We also usedmeta-analysis to investigate the
relative effectiveness of different stretch interventions including se-
rial casting, positioning, splinting, self-administered stretches and
other stretches. The data do not support the hypothesis that any
particular intervention is superior to another. In addition, there
was no evidence that the effects of stretch differed between large
and small joints. However, the results of all these meta-analyses
and sub-group analyses need to be interpreted with some caution
because they are based on non-randomised between-study com-
parisons, rather than on randomised within-study comparisons,
so there is potential for serious confounding.
Overall completeness and applicability of
evidence
Most studies only investigated the use of stretch over relatively
short time periods of four to 12 weeks. No study investigated
the use of stretch over periods greater than seven months. The
effectiveness of stretch that is performed for periods longer than
sevenmonths remains unknown. It is conceivable that small effects
of stretch accumulate over many years. Studies conducted with
this time frame will be difficult to conduct and pose a logistic
challenge to future researchers, although we did identify one study
that is still being conducted that is examining the effect of orthoses
worn for one year in children with cerebral palsy (Characteristics
of ongoing studies).
Most of the included studies examined the added benefit of stretch
over and above the usual care provided to both experimental and
control groups. Usual care was rarely defined, but in most studies
probably involved comprehensive skin, nursing and in some in-
stances rehabilitation programmes. Stretch may have been admin-
istered as participants moved or were moved by others as part of
these programmes and as part of routine daily activities. Therefore,
while the results of this review indicate that stretch as typically
applied by physiotherapists does not produce lasting increases in
joint mobility, the effects or possible importance of stretch admin-
istered as part of usual nursing care has not been answered in this
review. For example, the results of this review do not shed light
on the assumed importance of appropriate positioning in bed for
people who are paralysed or unconscious. To answer this question,
clinical trials comparing nursing care that involves appropriate po-
sitioning in bed with nursing care that does not are required. How-
ever, these trials are not likely to be conducted because appropriate
positioning in bed is now considered standard care.
Quality of the evidence
The risk of bias in the 49 included studies was variable. Some of
the more serious risks of bias included the failure to use adequate
methods to generate the randomisation sequence (37% of stud-
ies), failure to conceal allocation (49% of studies), failure to blind
assessors to objective outcomes (27% of studies), and incomplete
outcome data (37% of studies). We included results from all stud-
ies in the main analyses regardless of quality. When studies at risk
of selection, detection or attrition bias were excluded in the sen-
sitivity analyses, there was no or little change in the estimates of
the effect of stretch (Table 1; Table 2). This suggests that the main
findings are robust.
There is some indication of small study bias (see Figure 8; Figure
9). That is, there is a disproportionate number of smaller stud-
ies with positive findings rather than negative findings. This is
more pronounced in studies involving people with non-neurolog-
ical conditions than people with neurological conditions. Small
study bias exaggerates treatment effects. Therefore, our results are
probably conservative. That is, the size of treatment effects may
be even lower than we have reported, particularly for people with
non-neurological conditions.
The GRADE methodology indicates that four of our findings are
based on high-quality evidence, namely the short-term effects of
stretch on joint mobility in neurological conditions, and the short-
term effects of stretch on joint mobility, pain and activity limi-
tations in non-neurological conditions (see Summary of findings
for the main comparison; Summary of findings 2). In contrast,
the quality of the evidence about the short-term effects of stretch
on pain and activity limitations in people with neurological con-
ditions is low. The evidence was downgraded for three reasons: (i)
some of the included studies had a high risk of bias (ii) the re-
sults were only based on studies involving people with stroke and
spinal cord injury (iii) the point estimates were imprecise when
expressed as a relative percent change (although they were precise
when expressed as an absolute change).
In people with non-neurological conditions, the quality of evi-
dence about the short-term effects of stretch on quality of life and
participation restrictions is moderate and low, respectively. The
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evidence of stretch on quality of life was downgraded because the
results are based on only two studies involving people with burns
and post-radiation therapy to the breast. Similarly, the evidence of
stretch on participation restrictions in people with non-neurolog-
ical conditions is low because the results are only based on stud-
ies involving people with ankle and wrist fracture and the point
estimates are imprecise if expressed as relative percent change or
absolute change.
Potential biases in the review process
A common source of bias in systematic reviews is the failure to
identify all relevant studies. We attempted to minimise this bias
by performing thorough database searches, including studies in
all languages, using forward citation tracking and reference list
searches of included studies and relevant systematic reviews, and
corresponding with authors of included studies. Despite these ef-
forts, bias may have been introduced from failing to identify un-
published studies. We did identify one unpublished study (Evans
1994) and a study which was only reported in a conference pro-
ceeding (Krumlinde-Sundholm 2011). We attempted to attain
the data from the authors of these two studies without success.
Nonetheless, the main findings are probably robust because re-
trieval bias generally tends to inflate estimates of effects (Dickersin
1993; Egger 1998) and most estimates of effect were small in this
review.
Bias may have been introduced by the exclusion of one of the
studies (Hussein 2015) from some analyses. This study included
people with shoulder adhesive capsulitis. This study was excluded
from some analyses because its results were so extreme that they
seemed highly implausible. For example, the authors reported a
mean between-group difference of 74° in shoulder abduction one
year after the end of a four-week intervention involving the appli-
cation of a splint for up to 1.5 hours per day. This is between 5
and 30 times greater than the results for any other study includ-
ing studies which only looked at the short-term effects of stretch.
There were other aspects of this study that raised concern. For
example, the authors claimed a 100% follow-up rate of 60 partici-
pants at one year post randomisation. This is possible but unusual.
Our attempts to contact the study authors for clarification were
unsuccessful. The potential source of bias in this study is not clear
although it is noted that the splint used in this study is very costly
and raises the question as to whether the study was sponsored by
a commercial company (no sponsorship or funding are declared
in any of the three papers that report the results of this study).
Bias in this systematic review may have been introduced because
four of the six authors of this systematic review have undertaken
randomised controlled trials on this topic. To address this issue
review authors did not extract data, assess risk of bias or assess
the quality of the evidence for studies in which they had been
involved. Instead, these tasks were performed by the other two
review authors.
Agreements and disagreements with other
studies or reviews
Anumber of systematic reviews have examined the effects of stretch
administered in varyingways on jointmobility (Autti-Ramo 2006;
Blackmore 2007; Bovend’Eerdt 2008; Hellweg 2008; Lannin
2003b; Lannin 2007b; Pin 2006; Singer 2001; Van Peppen 2004).
The conclusions vary, and not surprisingly, systematic reviews that
include non-randomised studies (Michlovitz 2004; Mortenson
2003; Teplicky 2002) tend to report more positive results than
systematic reviews that do not. Two recent systematic reviews used
meta-analysis to estimate the effects of stretch for improving joint
mobility after stroke and similar conditions (Borisova 2009; Tyson
2009). The authors concluded that stretch did not improve joint
mobility or upper limb function. These findings are in agreement
with the findings of our review.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The results of this systematic review are sufficiently robust to in-
dicate that stretch, as typically provided by physiotherapists, does
not produce clinically meaningful effects on severity of contrac-
tures in people with neurological or non-neurological conditions.
The effects of stretch, as typically provided as part of nursing care
for people who are paralysed or unconscious, is not known because
this review did not compare different types of nursing care. In ad-
dition, no study has examined the effects of stretch administered
for more than seven months. Therefore, it may be reasonable to
administer stretch to people with persistent neurological condi-
tions on a regular basis over the course of their lives in an effort to
treat and prevent contractures. However, it is not known if this is
effective.
Stretchmay have other therapeutic effects although this is unlikely
for the following reasons.
• There is high-quality evidence that stretch does not have
short-term effects on pain in people with non-neurological
conditions. It is therefore unlikely that stretch would have long-
term effects on pain. This is consistent with the two studies that
examined the long-term effects of stretch on pain; neither
demonstrated a long-term reduction in pain.
• The short- and long-term effects of stretch on pain in
neurological conditions are uncertain but stretch is unlikely to
reduce pain without accompanying effects on joint mobility and
spasticity.
• The effects of stretch on quality of life, activity limitations
and participation restrictions in people with and without
neurological conditions are uncertain, although there is
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moderate-quality evidence to indicate that stretch does not have
short-term effects on quality of life in people with non-
neurological conditions. While there is not strong evidence about
the effects of stretch on these outcomes, it is most unlikely that
stretch would have therapeutic effects on any of these outcomes
in the absence of an effect on joint mobility, pain or spasticity.
Implications for research
We do not recommend further studies looking at the short-term
effects of stretch on joint mobility in either people with neurologi-
cal or non-neurological conditions because the quality of evidence
indicating that stretch is ineffective is high and further studies are
unlikely to change these findings. While the quality of evidence
about the long-term effects is less rigorous, there is no theoretical
basis upon which to believe that stretchmay have long-term effects
on joint mobility in the absence of a short-term effect. There may
be worth in examining the effectiveness of stretch administered
with other interventions. For example, stretch administered with
motor training or botulinum toxin in people with neurological
conditions. There may also be worth in specifically looking at the
effectiveness of stretch for the prevention of contracture in those
at high risk of developing contracture (e.g. people with traumatic
brain injury).
Future research should be directed at clarifying the effects of stretch
performed for more than seven months. This research should only
be conducted in clinical populationswhere stretchmight routinely
be performed over long time periods (for example, people with
stroke, spinal cord injuries or cerebral palsy).
We do not recommend further studies to determine the effect of
stretch on pain in people with non-neurological conditions but it
may be worth clarifying the effect of stretch on pain in people with
neurological conditions if there is any theoretic reason to believe
that stretch may be therapeutic.
While there is potential for more research on the effect of stretch
on quality of life, activity limitations and participation restrictions
in people with and without neurological conditions, this area of
research may be futile in the absence of accompanying effects of
stretch on joint mobility.
Future researchers should strive to improve the quality and report-
ing of their studies. The use of concealed allocation and blinded
assessors is particularly important for reducing bias. The accuracy
of future meta-analyses could also be substantially improved if
researchers consistently reported between-group differences with
associated measures of variability for all outcomes and at all time
points of data collection. Future researchers should also clarify
whether their studies are directed at the treatment or prevention of
contractures. Clear reporting of these characteristics would enable
future meta-analysis to be conducted on this topic.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Ackman 2005
Methods Design: Randomised parallel-group study
Participants Health condition: Children with spastic cerebral palsy
Sample size: Experimental group: 13, Control group: 12, Other group: 14
Setting, Country: Outpatient clinics, USA
Joint of interest: Ankle
Inclusion criteria:
• Diagnosis of spastic hemiplegia or diplegia
• Between 3-10 years old
• Ambulate independently without assistive devices
• Ambulate in functional equinus (toe-toe or heel-toe pattern)
• Neutral ankle position with full knee extension
Exclusion criteria:
• Previous orthopaedic surgery to tendo-achilles or sub-talar joint
• No botulinum toxin injections in previous 6 months
• Hip or knee flexion contractures greater than 10°
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (range): Experimental group: 6 years (3-8), Control group: 6 years (3-9),
Other group: 6 years (3-9)
Gender: Experimental group: 54% female, Control group: 50% female, Other group:
57% female
Interventions Groups included in this review:
Experimental group: Botulinum toxin plus cast
Participants received botulinum toxin injections into gastrocnemius muscle followed by
cast for 3 weeks at baseline, 3 months and 6 months. Ankle-foot orthosis (AFO) worn
in between casting periods for 20-22 h/d
Total stretch time: 24 h x 7 d x 9 weeks = 1512 hours over a 6-month period
Control group: Botulinum toxin
Participants received botulinum toxin injections into gastrocnemius muscle at baseline,
3 months and 6 months. AFO worn for 20-22 h/d
Other group: Placebo plus cast
Participants received placebo injections into gastrocnemius muscle followed by cast for
3 weeks at baseline, 3 months and 6 months. AFO worn in between casting periods for
20-22 h/d
Total stretch time: 24 h x 7 d x 3 weeks = 504 hours over a 3-week period
Outcomes Outcomes included in this review:
• Passive ankle dorsiflexion with the knee extended (degrees)
• Triceps surae spasticity (Ashworth)
Other outcomes: Passive ankle dorsiflexion (knee flexed), active ankle dorsiflexion (knee
flexed), ankle dorsiflexion at initial contact during gait, peak ankle dorsiflexion during
stance, peak ankle dorsiflexion during swing, triceps surae spasticity (Tardieu), walking
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Ackman 2005 (Continued)
velocity, stride length, ankle plantarflexion strength, ankle dorsiflexion strength, ankle
power generation
Time points included in this review: Outcomes measured at 12 months
Other time points: Outcomes also measured at baseline, 3 months, 6 months and 7.5
months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...block design randomisation se-
quence”, p 621
Comment: Insufficient detail reported
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported. If
concealment was used, every third alloca-
tion could be determined due to the use of
a fixed blocked sequence
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...the children and parents were in-
structed not to discuss their treatment with
the evaluating clinician to ensure that the
clinician maintained blinding to the treat-
ment group”, p 6
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 5/39 (13%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias High risk Quote: “...leading to an early termination
of the study before obtaining the projected
number of children”, p 622
Comment: possible cause of bias intro-
duced by early termination of study
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Ada 2005
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 18, Control group: 18
Setting, Country: Inpatient rehabilitation units of 4 metropolitan hospitals, Australia
Joint of interest: Shoulder
Inclusion criteria:
• Experienced first stroke within the previous 20 days
• Had hemiplegia
• Between 50-80 years old
• At risk of developing contracture as a result of having little or no upper limb
function - defined as a score of 0-4 on item 6 of the MAS
Exclusion criteria:
• Already had a shoulder problem - defined as pain or loss of greater than 20° of
intact shoulder ROM in either external rotation or flexion
• Had cognitive problems that precluded them from participating in the
positioning programme
Existing contracture, at risk of contracture, or combination of both: Participants
were at risk of developing contracture
Mean age (SD): Experimental group: 70 years (7), Control group: 64 years (9)
Gender: Experimental group: 60% female, Control group: 56% female
Interventions Groups included in this review:
Experimental group: Shoulder positioning and routine care
Participants received 2 x 30-min sessions of shoulder positioning:
Position 1 - participants in supine, 45° shoulder abduction andmaximal external rotation
Position 2 - participants sitting with arm on table with shoulder flexed to 90° and elbow
bent at 90°
Participants also received up to 10 min shoulder exercises and routine upper-limb care
Total stretch time: 30 min x 5 days x 4 weeks = 10 h for each position over a 4-week
period
Control group: Routine care
Participants received up to 10 min shoulder exercises and routine upper-limb care
Other groups: Nil
Outcomes Outcomes included in this review:
• Maximum passive shoulder external rotation of the affected limb (degrees)
• Pain experienced during maximal external rotation (yes/no)
• Item 6 MAS (Limits 0-6; 0 = worse, 6 = better)
Other outcomes:Maximum passive shoulder flexion (affected limb), shoulder contrac-
ture in external rotation (as compared to intact limb), shoulder contracture in flexion
(as compared to intact limb), pain experienced during maximal flexion
Time points included in this review: Outcomes measured at discharge (or 4 weeks) -
whichever was the sooner
Other time points: Outcomes also measured at baseline
Notes
Risk of bias
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Ada 2005 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Comment: Insufficient detail reported in
paper. Author correspondence revealed that
the randomisation sequence was computer
generated
Allocation concealment (selection bias) Low risk Quote: “...centrally randomized into either
the experimental or the control group”, p
231
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...an assessor blinded to group al-
location carried out measurements”, p 231
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 5/36 (14%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
Aoki 2009
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with knee osteoarthritis
Sample size: Experimental group: 17 (33 knees), Control group: 19 (33 knees)
Setting, Country: Outpatient clinic of a large metropolitan hospital, Japan
Joint of interest: Knee
Inclusion criteria:
• Severe unilateral or bilateral knee osteoarthritis established using radiography
• Planning to undergo total knee arthroplasty
Exclusion criteria:
• Could not follow instructions
• Could not lie prone
• Self-reported severe cardiovascular disease, neurological disease, or lower limb
disorders other than knee osteoarthritis
Existing contracture, at risk of contracture, or combination of both: Participants
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Aoki 2009 (Continued)
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 72 years (5), Control group: 74 years (6)
Gender: Experimental group: 100% female, Control group: 100% female
Interventions Groups included in this review:
Experimental group : Home-based stretch
Participants self-administered two knee flexion stretches (sitting on the floor and prone)
Total stretch time1: 5 min x 7 d x 11.6 weeks = 6.7 h over a 3-month period
Control group : Maintain usual physical activity
Instructed to maintain their current level of physical activity
Other groups : Nil
Outcomes Outcomes included in this review:
• Knee ROM in supine (degrees)
• Gait speed (m/min)
• Pain during gait (VAS)
Other outcomes:
Knee ROM during gait
Time points included in this review: Outcomes measured at time of admission (end
of intervention)
Other time points: Outcomes also measured at baseline
Notes 1The mean duration of treatment (81 days) was used to estimate the total stretch time
for the Experimental group. Also assumed that participants performed 10 repetitions
each day, not 10 repetitions of each exercise (20 repetitions)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “…theywere randomly allocated to
stretching … and control groups”, p 114
Comment: Insufficient detail reported
Allocation concealment (selection bias) Unclear risk Quote: “…they were randomly allocated to
stretching … and control groups”, p 114
Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “S-ROM was measured by a phys-
iotherapist blinded to the participants”, p
115
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
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Aoki 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: Insufficient detail reported
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes stated
were reported
Other bias High risk Comment: More than one joint per partic-
ipant but authors have not adequately ac-
counted for this in the analysis
Basaran 2012
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 13, Control group: 13, Other group: 13
Setting, Country: Rehabilitation department in a university hospital, Turkey
Joint of interest: Wrist
Inclusion criteria:
• History of a single stroke
• Wrist Modified Ashworth Scale score ≥1+
Exclusion criteria:
• Cognitive impairment (determined by Mini-Mental State Examination)
• Behavioural disturbances
• Severe chronic disease likely to interfere with co-operation
• Cutaneous or joint pathologies in the upper limb preventing splinting
• Previous splinting of the upper limb within the last 8 weeks
• If taking antispasticity medication, dosage change in the last month
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 55 years (12) Control group: 60 years (10), Other
group: 52 years (11)
Gender: Experimental group: 46% female, Control group: 42% female, Other group:
38% female
Interventions Groups included in this review:
Experimental group : Volar splint and home-based exercise programme
Participants wore each night a custom-made static volar splint (thermoplastic resin with
plastazote on the inner surface) with the hand positioned beyond the angle of ’catch’
Participants also did home-based exercise programme (details below)
Total stretch time: 10 hx 7 d x 5 weeks = 350 h over a 1.25-month period
Control group : Home-based exercise programme only
Participants stretched the wrist and finger flexors plus practiced reaching and grasping an
object, 10 repetitions of each 3 x d. In addition they were instructed to use their hands
as much as possible during daily activities
Other group : Dorsal splint and home-based exercise programme
Custom-made static dorsal splint (thermoplastic resin with plastazote on the inner sur-
face) with the hand positioned beyond the angle of ’catch’ worn overnight
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Basaran 2012 (Continued)
Total stretch time: 8 h x 7 d x 5 weeks = 280 h over a 1.25-month period
Outcomes Outcomes included in this review:
• Passive wrist extension (degrees)
• Spasticity (Modified Ashworth Scale)
Other outcomes:
H latency of flexor carpi radialis, Hmax:Mmax ratio of flexor carpi radialis
Time points included in this review: Outcomes measured at 5 weeks (end of interven-
tion)
Other time points: Outcomes also measured at baseline
Notes Assumed participants wore the splint for 8 h per night when calculating total stretch
time
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “…subjects were randomly allo-
cated to control and experimental groups
by using a simple randomization process
(computer-generated randomnumbers) af-
ter baseline measurements”, p 330
Allocation concealment (selection bias) Low risk Quote: “An independent person was re-
sponsible for randomization and group as-
signment”, p 330
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
High risk Quote: “Measurements associated with
electroneuromyography (ENMG) were
blinded ...but the others were not”, p 331-
2
Comment: Range of motion and spasticity
measurements were not blinded
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 1/39 (3%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes stated
were reported
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Basaran 2012 (Continued)
Other bias Low risk Comment: Appears to be free of other bias
Ben 2005
Methods Design: Randomised within-subjects study
Participants Health condition: Adults with spinal cord injury
Sample size: Experimental group: 20 legs, Control group: 20 legs
Setting, Country: Inpatient rehabilitation unit, Australia
Joint of interest: Ankle
Inclusion criteria:
• Sustained a spinal cord injury within the past 12 months
• Commenced sitting out of bed
• Less than grade 2/5 strength in the lower limbs
Exclusion criteria:
• History of trauma to the pelvis or legs
• Unable to tolerate standing
• Likely to be discharged from hospital within 3 months
• Thought unlikely to co-operate
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 34 years (15), Control group: 34 years (15)
Gender: Experimental group: 20% female, Control group: 20% female
Interventions Groups included in this review:
Experimental group: Weight-bearing and stretch
Participants were stood on a tilt table with a 15° wedge on a high block placed under
the experimental foot
Total stretch time: 30 min x 3 d x 12 weeks = 18 h over a 12-week period
Control group: Non weight-bearing and non stretch
Participants were stood on a tilt table but with nothing placed underneath the control
foot
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive ankle dorsiflexion (torque controlled)
Other outcomes:Total proximal femur bone mineral density, total proximal femur bone
mineral density (% initial), total proximal femur bone mineral density (% loss of control)
Time points included in this review: Outcomes measured at 12 weeks (≥ 24 h after
last intervention)
Other time points: Outcomes also measured at baseline
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Ben 2005 (Continued)
Random sequence generation (selection
bias)
Low risk Quote: “...computer-generated random al-
location schedule”, p 253
Allocation concealment (selection bias) Low risk Quote: “...allocationswere placed in sealed,
opaque, sequentially numbered envelopes.
The envelopes were not opened until after
the initial tests had been performed”, p 253
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...measurements were taken...by
an independent ..”, p 253
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
Buchbinder 1993
Methods Design: Randomised parallel-group study
Participants Health condition: Adults post-radiation therapy for the jaw
Sample size: Experimental group: 9, Control group: 5, Other group: 7
Setting, Country: Oral and maxillofacial surgery clinic, USA
Joint of interest: Mandibular
Inclusion criteria:
• Decreased inter-incisal opening secondary to radiation therapy
• Maximum inter-incisal opening of ≤ 30 mm
Exclusion criteria:
• > 5 years since undergoing radiation therapy
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 51 years (14), Control group: 62 years (9), Other
group: 59 years (8)
Gender: Experimental group: 33% female, Control group: 40% female, Other group:
0% female
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Buchbinder 1993 (Continued)
Interventions Groups included in this review:
Experimental group: Therabite System plus unassisted exercise (Group 3)
Participants used the Therabite System to sustain a maximum comfortable stretch of the
jaw. Also performed 10 cycles/d of unassisted exercise - opening to maximal inter-incisal
distance, closing, then moving maximally to the left and right and protrusively
Total stretch time: 5 x 30 s x (6-10 sessions) x 7 d x 10 weeks = 17.5 h-29.2 h over a 10-
week period
Control group: Unassisted exercise (Group 1)
Participants performed 10 cycles/d of unassisted exercise - opening to maximal inter-
incisal distance, closing, then moving maximally to the left and right and protrusively
Other group: Stacked tongue depressors plus unassisted exercise (Group 2)
Participants used stacked tongue depressors to maximally open the mouth. Also per-
formed 10 cycles/d of unassisted exercise - opening to maximal inter-incisal distance,
closing, then moving maximally to the left and right and protrusively
Total stretch time: 5 x 30 s x (6-10 sessions) x 7 d x 10 weeks = 17.5 h-29.2 h over a 10-
week period
Outcomes Outcomes included in this review:
• Maximal incisal opening (mm)
• Pain rating (scale not reported)
• Subjective well-being (scale not reported)
Other outcomes: Subjective rating of ROM, lateral jaw movements, protrusive jaw
movements
Time points included in this review: Outcomes measured at 10 weeks (end of inter-
vention)
Other time points:Outcomes also measured at baseline, 2 weeks, 4 weeks, 6 weeks and
8 weeks
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...patients were randomly assigned
to one of three groups”, p 864
Comment: Insufficient detail reported
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Unclear risk Comment: Insufficient detail reported
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Buchbinder 1993 (Continued)
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No dropouts reported
Selective reporting (reporting bias) High risk Comment: Lateral and protrusive jaw
movements, pain, subjective ROM, and
subjective well-being all listed as outcomes
in the methods but no data reported
Other bias Low risk Comment: Appears free of other bias
Bulstrode 1987
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with ankylosing spondylitis
Sample size: Experimental group: 27, Control group: 12
Setting, Country: Inpatient hospital, UK
Joint of interest: Hip
Inclusion criteria:
• Typical radiological features of ankylosing spondylitis
• No previous hip surgery
Exclusion criteria: Nil reported
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: not reported, Control group: not reported
Gender: Not reported
Interventions Groups included in this review:
Experimental group: Stretch plus conventional care
Participants received cycles of 3 contract relax stretches to the hip muscles
Total stretch time: not reported
Control group: Conventional care
Participants received active exercises in gymnasium and hydrotherapy pool to increase
strength and joint mobility
Other groups: Nil
Outcomes Outcomes included in this review:
• Hip extension with knee in extension (degrees)
Other outcomes: Hip flexion, hip extension with knee in flexion, single leg abduction,
bimalleolar abduction, medial hip rotation, lateral hip rotation
Time points included in this review: Outcomes measured at 15 days (end of interven-
tion), 6 months following end of intervention
Other time points: Outcomes also measured at baseline
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Bulstrode 1987 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “were allocated at random ... in
blocks of nine to give two in the treatment
group for every one control”, p 40
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...measurements were recorded by
an independent assessor who did not know
to which group the patients had been allo-
cated”, p 40-1
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: No dropouts for 3-week data,
7/39 (18%) dropouts at 6 months No data
reported for 6 months
Selective reporting (reporting bias) High risk Comment: 6-month joint mobility data
were not reported
Other bias Low risk Comment: Appears free of other bias
Burge 2008
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 31, Control group: 16
Setting, Country: Inpatient rehabilitation unit, Switzerland
Joint of interest: Wrist
Inclusion criteria:
• Admitted for intensive rehabilitation
• No previous stroke
• Severe paresis of the upper limb - FMA upper-extremity motor score ≤ 45 points
• Sufficient comprehension to participate in trial as assessed by speech therapist
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Burge 2008 (Continued)
Exclusion criteria:
• Traumatic injuries
• Rheumatic co-morbidities
• Lesion of the peripheral nervous system
• Other lesions of the central nervous system
• Lymphoedema
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 68 years (12), Control group: 64 years (14)
Gender: Experimental group: 60% female, Control group: 67% female
Interventions Groups included in this review:
Experimental group: Orthosis plus conventional care
Participants were issued a thermoplastic customised wrist splint made following biome-
chanical principles. The wrist was maintained in a neutral position
Total stretch time: not reported
Control group: Conventional care
2 sessions of physical therapy/d, 1 session of occupational therapy/d, and, if indicated,
neuropsychologic and speech therapy
Other groups: Nil
Outcomes Outcomes included in this review:
• Wrist ROM (FMA sub-scale)
• Pain (VAS)
• Modified Ashworth scale
Other outcomes: FMA sub-scale for ROM of forearm, FMA sub-scale for ROM of
fingers, hand oedema, participant satisfaction with splint
Time points included in this review: Outcomes measured at 13 weeks (end of inter-
vention)
Other time points: Outcomes also measured at baseline
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...allocation schedule was com-
puter generated”, p 1858
Allocation concealment (selection bias) Low risk Quote: “concealed in opaque, consecu-
tively numbered sealed envelopes by a per-
son not otherwise involved in the study”, p
1858
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
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Burge 2008 (Continued)
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “independent blinded assessor
however, complete blinding of the asses-
sor to the group assignment proved to be
difficult in practice because some patients
would spontaneously comment on their
splint type”, p 1858
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 4/31 (13%) dropouts at 13
weeks
Selective reporting (reporting bias) High risk Comment: Insufficient detail reported to
include in meta-analysis
Other bias Low risk Comment: Appears free of other bias
Collis 2013
Methods Design: Randomised parallel-group study
Participants Health condition: Adults following surgical release for Dupuytren’s contracture
Sample size: Experimental group: 26, Control group: 30
Setting, Country: Hand therapy clinic, New Zealand
Joint of interest: Hand
Inclusion criteria:
• Surgical release of Dupuytren contracture (any surgery type)
• Attended their first postoperative hand therapy appointment within 14 d after
surgery
Exclusion criteria:
• K-wiring of the proximal interphalangeal joint during surgery
• Inability to comply with hand therapy
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 68 years (8), Control group: 67 years (9)
Gender: Experimental group: 15% female, Control group: 23% female
Interventions Groups included in this review:
Experimental group : Night extension orthosis plus hand therapy
Participants wore each night a thermoplastic orthosis that was custom-fabricated
(moulded on the dorsum of the hand holding the operated fingers in maximal comfort-
able extension without placing undue tension on the wound). The orthosis was adjusted
to apply greater extension force to the operated fingers if the therapist deemed this nec-
essary. Participants also received hand therapy (details below)
Total stretch time: 8 h x 7 d x 12 weeks = 672 h over a 3-month period
Control group : Hand therapy alone
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Participants received a standard hand therapy programme delivered by an occupational
therapist, physiotherapist or hand therapist, which could include active tendon gliding
ROM exercises, education, wound care, oedema management, scar management, graded
return to usual daily activities, passive stretch with or without heat to increase finger
extension and/or flexion, intermittent use of daytime finger-based dynamic proximal
interphalangeal joint extension orthoses, and grip strengthening
Other groups : Nil
Outcomes Outcomes included in this review:
• Active extension of the little finger (sum of metacarpophalangeal, proximal
interphalangeal and distal interphalangeal joints; degrees)
• Disabilities of the Arm, Shoulder and Hand Outcome Measure (DASH)
Other outcomes:
Active extension of each operated finger, active flexion of each operated finger, distal
palmar crease of each operated finger, grip strength of left and right hand
Time points included in this review: Outcomes measured at 3 months (end of inter-
vention)
Other time points:Outcomes also measured at before surgery, at the first postoperative
hand therapy visit and 6 weeks
Notes Assumed participants wore the splint for 8 h per night when calculating total stretch
time
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were randomly allo-
cated to 1 of 2 treatment groups ... This oc-
curred at the first postoperative hand ther-
apy appointment by the participant select-
ing a tag from an envelope with group al-
location concealed”, p 1286
Allocation concealment (selection bias) Low risk Quote: “Participants were randomly allo-
cated to 1 of 2 treatment groups ... This oc-
curred at the first postoperative hand ther-
apy appointment by the participant select-
ing a tag from an envelope [LH1] with
group allocation concealed”, p 1286
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Unclear risk Quote: “1 therapist took nearly all of the
measurements. When she was unavailable,
2 other therapists, trained by the first to
measure uniformly, filled in”, p 1287
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Comment: Insufficient detail reported
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 3/56 (5%) dropouts at 6 weeks
and 2/56 (4%) dropouts at 3 months
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias High risk Comment: Protocol allowed “rescue”. Also
a unit of analysis issue. Analysed joints
Copley 2013
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with acquired brain injury
Sample size: Experimental group: 6, Control group: 4
Setting, Country: Brain injury and geriatric assessment/rehabilitation units of a major
metropolitan hospital, Australia
Joint of interest: Wrist and fingers
Inclusion criteria:
• Aged 18-80 years
• At least 2 months since acquired brain injury
• Moderate stiffness in the wrist and/or hand flexor muscles of the affected upper
limb/s with a Modified Ashworth Scale rating of 1+ or 2
• Presence of spasticity in the wrist or finger flexor muscles as indicated by a muscle
reactivity rating of at least 2 on the Modified Tardieu Scale
• No soft tissue contracture in wrist or finger flexor muscles as indicated by the
Modified Tardieu Scale
Exclusion criteria:
• Cognitive or behavioural deficits that prevented the provision of informed consent
• Cognitive or behavioural deficits that prevented active participation in an upper
limb therapy programme
Existing contracture, at risk of contracture, or combination of both: Participants
were at risk of developing contracture
Mean age (SD): Experimental group: 40 years (16), Control group: 54 years (6)
Gender: Experimental group: 33% female, Control group: 50% female
Interventions Groups included in this review:
Experimental group : Splint and standard practice occupational therapy programme
Participants wore an individualised, thermoplastic resting mitt splint designed to ap-
proximate the standard resting position (20° wrist extension) but tailored to place each
participant’s hypertonic muscle groups on low load, prolonged stretch. The splint was
worn for 2-4 h during the day and overnight. Participants also received an occupational
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therapy programme (details below)
Total stretch time: 10 h x 90 d (3 months) = 900 h over a 3-month period
Control group : Standard practice occupational therapy programme only
Participants received a standard practice occupational therapy programme as typically
provided to people with upper limb hypertonicity (various combinations of movement
training, stretches and functional splinting)
Other groups : Nil
Outcomes Outcomes included in this review:
• Wrist extension with the fingers extended (degrees)
• Finger flexor spasticity (Modified Tardieu Scale)
Other outcomes:
Wrist extension with the fingers flexed, wrist flexor spasticity, wrist flexormuscle stiffness,
finger flexor muscle stiffness
Time points included in this review: Outcomes measured at 3 months (end of inter-
vention period) and 4 months
Other time points: Outcomes also measured at baseline, 1 month and 2 months
Notes Assumed participants wore the splint for 10 h per day when calculating total stretch time
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A random number table was gen-
erated by an independent researcher and
used to allocate participants to control (no-
splint) and experimental (splint) groups”,
p 888
Allocation concealment (selection bias) Unclear risk Quote: “A random number table was gen-
erated by an independent researcher and
used to allocate participants to control (no-
splint) and experimental (splint) groups”,
p 888
Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “Measures were completed by a
blinded assessor”, p 888
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
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Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 3/10 (30%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes stated
were reported
Other bias High risk Comment: 3 people were included in ITT
analysis but not clear how this was done
Cox 2009
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with oral submucous fibrosis
Sample size: Experimental group: 54, Control group: 23
Setting, Country: Hospital, Nepal
Joint of interest: Jaw/mouth
Inclusion criteria:
• Confirmed oral submucous fibrosis by biopsy
• Subjectively reduced oral opening
Exclusion criteria:
• Oral squamous cell carcinoma
• Severely restricted oral opening that required surgical treatment
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 36 years (15), Control group: 35 years (13), Other
group: 44 years (19)
Gender: Experimental group: 30% female, Control group: 30% female, Other group:
10% female
Interventions Groups included in this review:
Experimental group: Physiotherapy (stacked tongue depressors) plus conventional
care
Participants undertook jaw exercises 5 x d in which tongue spatulas were positioned
passively between anterior teeth, spatula number determined by comfortable maximal
oral opening. The jaws were opened 5 times in each session, and held in position with
the teeth resting on the spatulas for 1 min on each occasion. An additional spatula was
added every fifth day unless this caused pain in which case the additional spatula was
added on the tenth day. Participants also received conventional care
Total stretch time: 5 min x 5 sessions x 7 d x 17 weeks = 2975 min = 49.6 h over a 17-
week period
Control group: Conventional care
Participants were recommended to cease areca nut use, given dietary advice and received
conventional care
Other groups: Hyaluronidase and steroid injections plus conventional care
Participants received bi-weekly submucosal injections over 4 weeks of hyaluronidase
(1500 units) and hydrocortisone (100 mg)
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Outcomes Outcomes included in this review:
• Maximal inter-incisal opening (mm)
• Mucosal pain (absent, stimulated by eating, spontaneous, constant)
Other outcomes: Reported areca nut use, progressive involvement of oral mucosa
Time points included in this review: Outcomes measured at 4 months (end of inter-
vention)
Other time points: Outcomes also measured at baseline
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Random numbers were used for
assignation”, p 221
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Unclear risk Comment: Insufficient detail reported
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 26/54 (48%) dropouts at 4
months
Selective reporting (reporting bias) High risk Comment: Insufficient detail reported to
include in meta-analysis
Other bias High risk Quote: “patients unable to attend bi-
weekly injection were assigned for phys-
iotherapy with the next subject assigned
for injection”; “control and injection enrol-
ment ceased for ethical reasons when suf-
ficient control patients returned, and in-
jection was recognized as having poor out-
comes”, p 221
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Methods Design: Randomised parallel-group study
Participants Health condition: Adults with spinal cord injury
Sample size: Experimental group: 18, Control group: 21
Setting, Country: Acute hospital, Canada
Joint of interest: Shoulder
Inclusion criteria:
• Sustained traumatic spinal cord lesion at or above the C8 level
• Subjects with incomplete lesions were required to have some degree of motor
deficit
Exclusion criteria:
• Sustained fracture(s) scapula, clavicle or acromial head at the time of trauma
• Required shoulder immobilisation for any reason following their accident
Existing contracture, at risk of contracture, or combination of both: Participants
were at risk of developing contracture
Mean age (SD): Experimental group: 34 years (15), Control group: 44 years (19)
Gender: Experimental group: 11% female, Control group: 10% female
Interventions Groups included in this review:
Experimental group: Positioning plus conventional care (Group 2)
Participants received 2 sessions of shoulder positioning:
Position 1: participants in supine with their arms placed on padded supporting boards,
shoulders abducted to 90° and elbows extended for 30 min
Position 2: participants in supine with their shoulders positioned on pillows in 180°
flexion and lateral rotation for 15 min
If the positions were not tolerated, shorter durations were applied and slowly increased.
Participants also received full passive movements on their upper limbs (either passive,
active assisted, active or resisted), scapula stretches, modalities and medications as re-
quired for shoulder pain
Total stretch time: 45 min x 5 d x (2-16 weeks) = 7.5 h-60 h over a 2-16-week period
Control group: Conventional care (Group 1)
Participants received full passive movements on their upper limbs (either passive, active
assisted, active or resisted), scapula stretches, modalities and medications as required for
shoulder pain
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive shoulder abduction (right arm; degrees)
• Pain during preceding 24 h (right shoulder; VAS)
• Functional Independence Measure
Other outcomes: Passive shoulder abduction (left arm), passive shoulder flexion (right
arm), passive shoulder flexion (left arm), passive shoulder medial rotation (right arm),
passive shoulder medial rotation (left arm), passive shoulder lateral rotation (right arm)
, passive shoulder lateral rotation (left arm), pain during preceding 24 h (left shoulder),
hours sitting in chair
Time points included in this review: Outcomes measured at 2 weeks1
Other time points:Outcomes also measured at baseline, week 1, week 3, week 4, week
5, week 6, week 7, week 8, week 9, week 10, week 11 and week 12
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Notes 1The intervention was ceased early with some participants (from after week 2) while
others were treated up until week 12. We included outcomes from week 2 as all partici-
pants received at least 2 weeks of stretch
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...patients were randomly assigned
(using a random number generator...)”, p
268
Allocation concealment (selection bias) Low risk Quote: “…and a system of sealed en-
velopes”, p 268
Comment: Insufficient detail reported in
paper. Author correspondence revealed that
a system of sequentially-numbered, sealed,
opaque envelopes was used to conceal allo-
cation
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...data were collected by a single
therapist at each site who was blinded to
the treatment allocation of the patient”, p
269
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: Length of intervention was dif-
ferent for participants, determinedbywhen
theywere transferred to another facility. In-
sufficient detail reported to accurately de-
termine dropouts
Selective reporting (reporting bias) High risk Comment: Insufficient detail reported to
include in meta-analysis
Other bias High risk Quote: “...the trial was terminated with 39
subjects after 3 years of data collection”, p
272
Comment 1: possible cause of bias intro-
duced by early termination of study
Comment 2: No standard treatment pro-
tocol for participants as they were given
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varying amounts of treatment dependent
on length of stay
De Jong 2006
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 10, Control group: 9
Setting, Country: Rehabilitation unit, Netherlands
Joint of interest: Shoulder
Inclusion criteria:
• First ever stroke and maximum of 12 weeks post stroke
• Medial cerebral artery stroke
• No premorbid impairments of the affected arm
• No severe shoulder pain
• No use of anti-spasticity drugs
• No use of pain-reducing drugs except for paracetamol
• No planned date of discharge
• Able to give written informed consent
Exclusion criteria:
• Subjects with fair to good recovery of the arm (Brunnstrom stages 4, 5 or 6)
• Severe neglect (score of greater than 3 zeros on letter cancellation test)
• Severe loss of position sense (scores 2 and 3 on thumb finding test)
• Cognitive impairment (less than 23 on Mini-Mental State Examination)
• Able to prevent contracture by producing voluntary movement (FMA > 18 on the
shoulder/elbow/forearm sub-scales)
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 53 years (10.2)1, Control group: 52 years (8.8)1
Gender: Experimental group: 33% female1, Control group: 63% female1
Interventions Groups included in this review:
Experimental group: Positioning plus conventional care
Participant was positioned in supine with arm in maximal shoulder abduction, shoulder
external rotation, elbow extension and supination of the forearm that could be tolerated
without any pain. The arm was always supported by a pillow and, if necessary, held in
position with a sandbag. Participants also received conventional rehabilitation
Total stretch time: 30 min x 2 sessions x 5 d x (5-10 weeks) = 25 h-50 h over a 5-10-
week period
Control group: Conventional care
Participants received conventional rehabilitation
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive shoulder abduction (degrees)
• Pain (yes/no)
• Spasticity (Ashworth scale)
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• Arm motor performance (FMA)
Other outcomes: Passive shoulder flexion, passive shoulder external rotation, passive
elbow extension, passive forearm supination, Barthel Index
Time points included in this review: Outcomes measured at 10 weeks (end of inter-
vention).
Other time points: Outcomes also measured at baseline and 5 weeks
Notes 1Data obtained via correspondence with study author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote:“...an independent person carried
out the randomization procedure. The en-
velopes were shuffled and drawn blind-
folded”, p 658
Allocation concealment (selection bias) Low risk Quote: “...subjects were randomly assigned
to one of the two groups using opaque,
sealed envelopes...The envelopeswere shuf-
fled and drawn blindfolded”, p 658
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...the same two raters, unaware of
group allocation and not involved in the
treatment of subjects, carried out all the
measurements”, p 658
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 2/19 (11%) dropouts at 5-week
outcome assessment, 9/19 (47%) dropouts
at 10-week outcome assessment
Selective reporting (reporting bias) High risk Comment: Insufficient detail reported on
pain to include in meta-analysis
Other bias High risk Quote: “...after nearly two years the trial
had to be terminated because of set time
limits, leaving only 19 subjects who met all
inclusion criteria” p 663
Comment 1: Possible cause of bias intro-
duced by early termination of study
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Comment 2: Unclear whether the protocol
was for a 10-week or 5-week study
Dean 2000
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 14, Control group: 14
Setting, Country: Inpatient rehabilitation unit, Australia
Joint of interest: Shoulder
Inclusion criteria:
• Less than 10 weeks from the onset of stroke
• Score of less than 5 on the upper-arm function item of the MAS for stroke
• No pre-morbid shoulder pain
• No premorbid restriction of shoulder movement
• Passive range of shoulder abduction and flexion greater than 90°
• Able to comprehend and use a VAS for pain
Exclusion criteria:
• Subjects with a brainstem stroke
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 58 years (13), Control group: 58 years (11)
Gender: Experimental group: 50% female, Control group: 15% female
Interventions Groups included in this review:
Experimental group: Shoulder positioning plus conventional care
Participants received 3 x 20 min sessions of shoulder positioning:
Position 1: lying supine, shoulder inmaximum tolerable abduction and external rotation,
and elbow flexed
Position2: lying supine, shoulder abduction to 90°,maximum tolerable external rotation,
and elbow flexed
Position 3: sitting, shoulder forward flexed 90°, elbow extension, wrist extension, and a
cylinder in hand to provide a web space stretch
Participants also received active training of reaching and manipulation tasks
Total stretch time: 3 sessions x 20 min x 5 d x 6 weeks = 30 h over a 6-week period
Control group: Conventional care
Participants received active training of reaching and manipulation tasks. No formal
stretches were applied to the shoulder joint complex
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive shoulder external rotation (degrees)
• Pain at rest (VAS)
Other outcomes: Active shoulder abduction, pain on dressing
Time points included in this review: Outcomes measured at 6 weeks (end of interven-
tion)
Other time points: Outcomes also measured at baseline
71Stretch for the treatment and prevention of contractures (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Dean 2000 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote:“...random number tables to deter-
mine the subject’s group allocation”, p 36
Allocation concealment (selection bias) Low risk Quote: “...group allocation was completed
by a person independent of the recruitment
process...the recruiter telephoned another
person”, p 36
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists.
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...measurements were made by an
assessor who was blinded to the subject s
group allocation”, p 37
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 5/28 (18%) dropouts, with
four from experimental group
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
DiPasquale-Lehnerz 1994
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with spinal cord injury
Sample size: Experimental group: 7, Control group: 6
Setting, Country: Rehabilitation unit, USA
Joint of interest: Hand
Inclusion criteria:
• Not reported although study involved only people with C6 tetraplegia
Exclusion criteria: Nil reported
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
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Mean age (range): Experimental group: not reported, Control group: not reported,
both groups: 26 years (18-42)
Gender: Experimental group: not reported, Control group: not reported, both groups:
8% female
Interventions Groups included in this review:
Experimental group: Positional orthosis plus conventional rehabilitation
Participants were issued a short opponens or long opponens orthosis, depending on the
strength of their wrist extensors. Both orthoses maintained the distal transverse arch
and the thumb web space in 35° of CMC abduction, the metacarpophalangeal joint in
full extension, and the interphalangeal joint in slight flexion. Participants also received
conventional rehabilitation
Total stretch time: 8 h x 7 d x 12 weeks = 672 h over a 12-week period
Control group: Conventional rehabilitation
Participants received conventional rehabilitation
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive metacarpophalangeal (MCP) extension
• Jebsens hand test sub-item - simulated feeding (seconds)
Other outcomes:PassiveMCPflexion, passive proximal interphalangeal (PIP) extension,
passive PIP flexion, passive distal interphalangeal (DIP) extension, passive DIP flexion,
size of opening the hand when releasing, size of closing the hand with tenodesis, Jebsen
hand test - 6 other sub-items, thumb/finger opposition, palmar abduction, passive lateral
prehension grasp, wrist extensor strength
Time points included in this review: Outcomes measured at 12 weeks (end of inter-
vention)
Other time points: Outcomes also measured at baseline, 4 weeks and 8 weeks
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...subjects were randomly as-
signed”, p 140
Comment: Insufficient detail reported
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Unclear risk Comment: Insufficient detail reported
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Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 4/13 (31%) dropouts
Selective reporting (reporting bias) High risk Comment: Not all pre-stated outcomes
were reported
Other bias Low risk Comment: Appears free of other bias
Fox 2000
Methods Design: Randomised cross-over study
Participants Health condition: Elderly nursing-home residents
Sample size: Experimental group: 9, Control group: 9
Setting, Country: Chronic care hospital, Canada
Joint of interest: Knee
Inclusion criteria:
• No plans for discharge within 6 months
• Knee flexion contracture of 10° or greater in at least one leg
• Able to tolerate a bed positioning programme and ongoing assessments without
severe pain
Exclusion criteria:
• Behavioural problems that prevented adherence to the programme
• Receiving the medication baclofen at the time of recruitment
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (range): Experimental group: not reported, Control group: not reported,
both groups: 82 years (71-93)
Gender: Experimental group: not reported, Control group: not reported, both groups:
63% female
Interventions Groups included in this review:
Experimental group: Bed positioning programme (low-load prolonged knee stretch)
1
Participants were positioned in supine with their knee extended as much as possible. The
position was maintained using bed sheets secured under the mattress
Total stretch time: 40 min x 4 d x 8 weeks = 21.3 h over an 8-week period
Control group: No intervention 1
Participants received no intervention
Other groups : Nil
Outcomes Outcomes included in this review:
• Passive knee extension (degrees)
• Level of pain (rated by assessor)
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Other outcomes: Nil
Time points included in this review: Outcomes measuring combined effect after 8
weeks of stretch (both cross-over periods combined)
Other time points: Outcomes also measured at baseline, 1 week , 2 weeks, 3 weeks, 4
weeks, 5 weeks, 6 weeks, 7 weeks, 8 weeks (end of first cross-over period), 9 weeks, 10
weeks, 11 weeks, 12 weeks, 13 weeks, 14 weeks, 15 weeks and 16 weeks (end of second
cross-over period)
Notes 1Only includes details of the first period of the cross-over
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...randomly assigned to 2 groups by a
random numbers table”, p 365
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind participants
or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...a single rater blinded to the inter-
vention assessed the participants”, p 366
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind participants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 6/18 (33%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were re-
ported
Other bias High risk Comment: One participant’s group allocation
was changed to create even group numbers
Gustafsson 2006
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 17, Control group: 17
Setting, Country: Inpatient rehabilitation hospital, Australia
Joint of interest: Shoulder
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Inclusion criteria:
• Admitted for rehabilitation following first time stroke
• No previous history of neurological disease
• Pain in or injury to the affected shoulder
• At least 45° of passive abduction but less than full active flexion in the affected
shoulder
Exclusion criteria:
• Complex medical situation
• Not admitted for active rehabilitation
• More than 100 days from time of stroke to admission to rehabilitation
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 66 years (16), Control group: 67 years (14)
Gender: Experimental group: 41% female1, Control group: 40% female1
Interventions Groups included in this review:
Experimental group: Shoulder positioning plus conventional care
Participants received 2 x 20 min sessions of shoulder positioning:
Position 1: sitting with affected shoulder abducted to 90° and fully supported on the
surface of a table with the elbow extended and forearm in neutral
Position 2: lying in supine with affected shoulder abducted to 90° and in the maximal
amount of achievable external rotation, elbow flexed and forearm pronated
Participants also received an additional shoulder positioning programme for remainder
of days during the intervention period:
In sitting: arm positioned on a custom armrest in 10°-15° of shoulder abduction and
midway between shoulder external and internal rotation
In bed: a pillow was used to support the stroke-affected shoulder in a position midway
between external and internal rotation and not horizontally adducted
Participants also received 30 min upper limb therapy
Total stretch time: 24 h x 30 d2 = 720 h over a 30-d period
Control group: Conventional care
Participants received 30 min upper limb therapy. Participants also used locally fabricated
cushion supports for their stroke-affected upper limb when seated and in bed
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive shoulder external rotation (degrees)
• Hemiplegic shoulder pain at rest over previous 24 h (VAS)
• Functional independence (Modified Barthel Index)
Other outcomes:Hemiplegic shoulder pain during assessment (Ritchie Articular Index)
, hemiplegic shoulder pain with movement (VAS), MAS for stroke
Time points included in this review: Outcomes measured at discharge (end of inter-
vention) and 6 months following discharge
Other time points: Outcomes also measured at baseline
Notes 1Data obtained via correspondence with study author
2Length of intervention was calculated as an average of 30 days for the intervention and
control groups
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...referred to a random number ta-
ble to identify the predetermined, random
allocation”, p 279
Allocation concealment (selection bias) Low risk Quote: “...once consent was obtained, the
primary investigator referred to a random
number table to identify the predeter-
mined, random allocation of that partici-
pant to either the treatment or comparison
group”, p 279
Comment: Author correspondence re-
vealed that central allocation was used. The
person recruiting participants did not have
access to the random number table
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
High risk Quote: “...a blinded assessor completed the
measurement of the dependent variables at
admission and discharge from rehabilita-
tion”, p 279
Quote: “...follow-up assessments were
completed by the principal investigator”, p
163 in follow-up paper
Comment: Blinded assessor for discharge
outcomes. Non-blinded assessor for 6
month follow-up outcomes
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 2/17 (12%)dropouts in control
group, no dropouts in experimental group
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Unclear risk Comment: It was identified that 38 people
would be needed in the power analysis but
only 34 were recruited. Author correspon-
dence revealed that the study was stopped
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due to participant recruitment difficulties
Harvey 2000
Methods Design: Randomised within-subjects study
Participants Health condition: Adults with spinal cord injury
Sample size: Experimental group: 14 legs, Control group: 14 legs
Setting, Country: 2 spinal injury rehabilitation units, Australia
Joint of interest: Ankle
Inclusion criteria:
• Participating in a rehabilitation programme
• Sustained a spinal cord injury within the preceding year
• Have not more than grade 1 of 5 motor strength around both ankles
• Be willing to cease assisted-standing and all passive exercises and stretches to their
ankles for the duration of the study
Exclusion criteria:
• Pressure sores on their heels that prevented stretching or testing
• Considered unlikely to co-operate
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 36 years (16), Control group: 36 years (16)
Gender: Experimental group: 0% female, Control group: 0% female
Interventions Groups included in this review:
Experimental group: Stretch
Participants received a constant stretch on the experimental ankle into dorsiflexion with
the knee extended using a purpose-built device
Total stretch time: 30 minutes x (5 - 7 days) x 4 weeks = 10 hours to 14 hours over a 4-
week period
Control group: Non-stretch
Participants did not receive any type of manual therapy to either ankle nor did they stand
or walk
Other groups: Nil
Outcomes Outcomes included in this review:
• Ankle angle at 10 Nm torque with the knee extended (degrees)
Other outcomes: Ankle angle at 10 Nm torque with the knee flexed, ankle mobility
with knee extended (slope of torque/angle curve), ankle mobility with knee flexed (slope
of torque/angle curve), baseline ankle angle with knee extended, baseline ankle angle
with knee flexed
Time points included in this review: Outcomes measured at 4 weeks (end of interven-
tion)
Other time points: Outcomes also measured at baseline, 2 weeks and 5 weeks
Notes
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...a computer generated random
allocation schedule was determined before
the study by an investigator who was not
involved in patient recruitment or group
allocation”, p 1342
Allocation concealment (selection bias) Low risk Quote: “...allocationswere placed in sealed,
opaque, sequentially numbered envelopes
by an investigator who was not involved
in determining eligibility for the trial. The
envelopes were not opened until after the
initial tests had been performed”, p 1342
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...a blinded therapist was respon-
sible for all measurements”, p 1344
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
Harvey 2003
Methods Design: Randomised within-subjects study
Participants Health condition: Adults with spinal cord injury
Sample size: Experimental group: 16 legs , Control group: 16 legs
Setting, Country: 2 spinal injury rehabilitation units, Australia
Joint of interest: Hip
Inclusion criteria:
• Sustained a spinal cord injury within the past 12 months
• Commenced sitting out of bed following the initial injury
• Less than 110° passive hip flexion with the knee extended
Exclusion criteria:
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• More than grade 2/5 motor strength in the muscles around the hips and knees
• Unlikely to remain in the unit for 4 weeks
• History of trauma to the pelvis or upper leg
• Unable to tolerate stretch
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 33 years (15), Control group: 33 years (15)
Gender: Not reported
Interventions Groups included in this review:
Experimental group: Stretch
Participants received a stretch to the hamstring muscles with a 30 Nm torque using a
purpose-built device. Participants also performed normal activities of daily living
Total stretch time: 30 min x 5 d x 4 weeks = 10 h over a 4-week period
Control group: Non-stretch
Participants did not receive any stretches to the hamstring muscles
Participants performed normal activities of daily living
Other groups: Nil
Outcomes Outcomes included in this review:
• Hip flexion at 30 Nm torque (degrees)
Other outcomes: Nil
Time points included in this review: Outcomes measured at 4 weeks (end of interven-
tion)
Other time points: Outcomes also measured at baseline
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...a computer-generated random
allocation schedule was produced prior to
the study by one of the authors whowas not
otherwise involved in subject recruitment
or allocation”, p 178
Allocation concealment (selection bias) Low risk Quote: “...to ensure concealment, the same
person placed allocations in sealed, opaque,
sequentially-numbered envelopes. The en-
velopes were not opened until after the ini-
tial tests had been performed”, p 178
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
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Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...measurements were taken...by
an independent therapist who was blinded
to allocation”, p179
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
Harvey 2006
Methods Design: Randomised within-subjects and parallel-group study
Participants Health condition: Adults with spinal cord injury, stroke or traumatic brain injury
Sample size: Total: Experimental group: 30 thumbs, Control group: 30 thumbs
Spinal cord injury1: Experimental group: 19 thumbs, Control group: 20 thumbs
Stroke2: Experimental group: 7 thumbs, Control group: 7 thumbs
Traumatic brain injury3: Experimental group: 4 thumbs, Control group: 3 thumbs
Setting, Country: Community participants, Australia
Joint of interest: Thumb carpometacarpal
Inclusion criteria:
• Sustained a cervical spinal cord injury, traumatic brain injury or stroke that
affected one or both upper limbs
• Had a contracture of their thumb web-space as assessed by clinical examination
Exclusion criteria:
• Had a contracture deemed unlikely to respond to stretch
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (range): Unilateral participants: Experimental group: 58 years (49-67), Con-
trol group: 64 years (50-71)
Bilateral participants: Experimental group: 47 years (37-51), Control group: 47 years
(37-51)
Gender: Experimental group: 13% female, Control group: 30% female
Interventions Groups included in this review:
Experimental group: Thumb splint
Participants’ thumbs were stretched by splinting them into abduction. One of two splints
was used:
Splint 1: volar splint with a C-bar to position the thumb into palmar abduction
Splint 2: cone splint used where it was difficult to obtain a good stretch with the thumb
C-bar piece
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Splints were reviewed at week 1, week 4 and week 8 after baseline
Participants were also instructed to refrain from self-administering any other stretch
Total stretch time: 8 h x 7 d x 12 weeks = 672 h over a 12-week period
Control group: No splint
Participants received no intervention. Participants were instructed to refrain from self-
administering any stretch
Other groups: Nil
Outcomes Outcomes included in this review:
• Palmar abduction of the thumb carpometacarpal joint (degrees)
• The effect of the splinting regime on self selected goals (Canadian Outcome
Performance Measure)
Other outcomes:Questionnaire on participants’ attitudes towards the effectiveness and
convenience of the splinting regime
Time points included in this review: Outcomes measured at 12 weeks (end of inter-
vention)
Other time points: Outcomes also measured at baseline
Notes 1Spinal cord injury subgroup of Harvey 2006 study; 2Stroke subgroup of Harvey 2006
study; 3Traumatic brain injury subgroup of Harvey 2006 study; data obtained via cor-
respondence with study author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...an independent person used a
computer to generate the random alloca-
tion schedules”, p 252
Allocation concealment (selection bias) Low risk Quote: “...these were placed in opaque, se-
quentially numbered envelopes which were
sealed and kept off site”, p 252
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...the assessorswere blinded topar-
ticipant allocation and participants were
asked not to discuss any aspect of the trial
with the assessors in order to maintain
blinding”, p 252
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 1/60 (2%) dropouts
Selective reporting (reporting bias) Unclear risk Comment: Canadian Outcome Perfor-
mance Measure was discontinued
Other bias Low risk Comment: Appears free of other bias
Hill 1994
Methods Design: Randomised cross-over study
Participants Health condition: Adults with brain injury
Sample size: Experimental group: 81, Control group: 71
Setting, Country: Inpatient rehabilitation hospital, USA
Joint of interest: Elbow and wrist
Inclusion criteria:
• ≥ 8 years old
• Unilateral or bilateral hypertonicity
• Contractures in upper extremities that interfered with function
• ≤ 2 years since injury
• Able to follow simple instructions and participate in self-care skills
Exclusion criteria:
• Previously treated with casts
• Absent sensation in affected extremity
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (range): Experimental group: 25 years (9-44), Control group: 32 years (19-
48)
Gender: Not reported
Interventions Groups included in this review:
Experimental group: Serial casting followed by therapy (Group 1)
Participants wore rigid circular elbow or wrist casts. Casts were re-applied each 5-7 d,
with 4-6 casts applied in total. Limbs were positioned 5°-10° off maximal ROM
Total stretch time: 24 h x 7 d x 4.33 weeks = 728 h over a 4-week period
Control group: Therapy followed by serial casting (Group 2)
Participants received traditional treatments included passive and active movements, pro-
longed stretch, splinting, neurophysiological treatment techniques and relaxation tech-
niques
Other groups: Nil
Outcomes Outcomes included in this review:
• Unidirectional passive joint ROM (degrees)
• Joint angle at which stretch reflex elicited (degrees)
• Observation of performance of functional tasks
Other outcomes: Observation of rapid alternating movements
Time points included in this review:Outcomesmeasured at 1month (cross-over point)
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Other time points:Outcomes also measured at baseline, 2 months (end of intervention)
Notes 1Number of participants who were analysed by the study authors (i.e. these numbers do
not include dropouts). Study authors did not report the size of the group allocations at
baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “Subjects were alternately assigned”, p
220
Allocation concealment (selection bias) High risk Quote: “Subjects were alternately assigned”, p
220
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind participants
or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “The evaluations were performed by
an experienced occupational therapist who was
blind to the treatment each patient was receiv-
ing”, p 220
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind participants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 5/20 (25%) dropouts
Selective reporting (reporting bias) High risk Comment: Insufficient detail reported to in-
clude in meta-analysis
Other bias Low risk Comment: Appears free of other bias
Horsley 2007
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke or stroke-like brain injury
Sample size: Experimental group: 20, Control group: 20
Setting, Country: Inpatient rehabilitation hospital, Australia
Joint of interest: Wrist
Inclusion criteria:
• Stroke or stroke-like brain injury (i.e. subarachnoid haemorrhage resulting in
hemiplegia, not traumatic head injury or Parkinson’s disease)
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• 18 years of age or over
• Unable to actively extend the affected wrist past neutral
Exclusion criteria:
• Language, comprehension or reading problems which prevented informed consent
• Co-existing upper-limb conditions that directly affected movement
• Not able to participate in upper-limb rehabilitation
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 61 (21), Control group: 62 (17)
Gender: Experimental group: 70% female, Control group: 35% female
Interventions Groups included in this review:
Experimental group: Stretch plus usual care
Participants received a weight-bearing stretch of the arm in sitting, with the shoulder
positioned in external rotation, slight abduction and extension, elbow in extension,
forearm in supination andwrist and fingers inmaximumextension. If unable to do stretch
using this method, stretch performed manually or with a stretch board. Participants also
received usual upper limb care. No wrist or finger stretches were administered
Total stretch time: 30 min x 5 d x 4 weeks = 10 h over a 4-week period
Control group: Usual care
Participants received usual upper limb care.Nowrist or finger stretcheswere administered
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive wrist extension (degrees)
• Pain at rest at the time of testing (VAS)
• Upper limb activity (composite of 3 items of MAS)
Other outcomes: Nil
Time points included in this review: Outcomes measured at 4 weeks (end of interven-
tion) and 9 weeks (5 weeks after last intervention)
Other time points: Outcomes also measured at baseline and 5 weeks (1 week after last
intervention)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...computer-generated randomisa-
tion table”, p 240
Allocation concealment (selection bias) Low risk Quote: “...kept by a person who was re-
mote from the study site and independent
of recruitment, and group allocation was
revealed by phone call”, p 240
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Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...outcome measures were col-
lected by therapists...who were blind to
group allocation”, p 240
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 2/40 (5%) dropouts at 5 weeks,
3/40 (8%) dropouts at 9 weeks
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
Horton 2002
Methods Design: Randomised parallel-group study
Participants Health condition: Adults following total knee replacement
Sample size: Experimental group: 27, Control group: 28
Setting, Country: Acute hospital, UK
Joint of interest: Knee
Inclusion criteria:
• Osteoarthritis or rheumatoid arthritis
• Undergoing primary total knee replacement
Exclusion criteria:
• Previous surgery, other than arthroscopy
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 66 years (14), Control group: 69 years (10)
Gender: Experimental group: 59% female, Control group: 46% female
Interventions Groups included in this review:
Experimental group: Splint
Participants received a semi-rigid knee extension splint for the first 48 hours after total
knee replacement surgery. Participants also received usual care
Total stretch time: 24 h x 2 d = 48 h over 2 d
Control group: No splint
Participants received no splint after total knee replacement surgery
Participants received usual care.
Other groups: Nil
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Outcomes Outcomes included in this review:
• Knee fixed-flexion deformity (degrees)
Other outcomes: Knee extension lag, active knee flexion and length of hospital stay
Time points included in this review: Outcomes measured at 2 d (end of intervention)
and 3 months (~ 3 months after last intervention)
Other time points: Outcomes also measured at baseline and 1 week (5 days after last
intervention)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote:“...patients were randomly assigned to
two groups”, p 229
Comment: Insufficient detail reported
Allocation concealment (selection bias) Unclear risk Quote: “...randomisation was achieved by
the closed envelope technique at the time
of wound closure, blinding the surgeon to
the intended study group until this time”,
p 229
Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Unclear risk Quote: “...to ensure she would remain
blinded to the splint allocation, a second
person was trained to take the 48-h mea-
surements when the splints were still in
use”, p230
Comment: Second assessor not blinded to
splint allocation for outcomes measured at
2 d
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 2/55 (4%) dropouts at 3-
month follow-up
Selective reporting (reporting bias) High risk Comment: No data reported for 3-month
follow-up
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Other bias Unclear risk Comment: More participants were re-
cruited than original power calculations in-
dicated were necessary. No reason given
Hussein 2015
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with shoulder adhesive capsulitis
Sample size: Experimental group: 30, Control group: 30
Setting, Country: Outpatient facility, USA
Joint of interest: Shoulder
Inclusion criteria:
• 18 years of age or older
• globally limited glenohumoral translation
• loss of passive ROM (50% compared to the non-affected side)
• no radiographic findings on anteroposterior, axillary or scapular y-view shoulder
radiographs
Exclusion criteria:
• Bilateral shoulder involvement
• Previous shoulder surgeries
• Any neuromuscular disorders
• Diabetes mellitus
• Corticosteroid injection in the previous 6 months
• Prior trauma (dislocation, fracture, tendon rupture)
• Any intrinsic glenohumeral pathology (e.g. osteoarthritis)
• Complex regional pain syndrome
• Contraindications to treatment (joint fusion, severe osteoporosis, any signs or
symptoms of peripheral nerve compression)
• Pulmonary disease (active or latent pulmonary tuberculosis, chronic obstructive
pulmonary disease, interstitial lung disease or any pulmonary malignancy)
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 52 years (not reported), Control group: 51 years
(not reported)
Gender: Not reported
Interventions Experimental group : Static progressive stretch device plus traditional therapy
Particiapnts used a static progressive stretch device once daily for 30 min/session in week
1, twice daily for 30 min/session in weeks 2-3 and thrice daily for 30 min/session in
week 4 (readjusting the position of the stretch to tolerance every 5 min). Participants
also received traditional therapy (details below)
Total stretch time: (30 min x 7 d x 1 week) + (60 min x 7 d x 2 weeks) + (90 min x 7 d
x 1 week) = 28 h over a 1-month period
Control group : Traditional therapy
Participants received 3 physical therapy sessions per week for 4 weeks (hot pack followed
by manual therapy) with a home exercise programme (pulley, wand and pendulum
exercises performed 3 times daily with 10 repetitions each)
88Stretch for the treatment and prevention of contractures (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hussein 2015 (Continued)
Other groups : Nil
Outcomes Outcomes included in this review:
• Active shoulder abduction (degrees)
• Pain (VAS)
• Disabilities of the Arm, Shoulder and Hand Outcome Measure (DASH)
Other outcomes:
Passive shoulder abduction, passive shoulder external rotation, active shoulder external
rotation
Time points included in this review: Outcomesmeasured at 4 weeks (end intervention)
and 12 weeks
Other
Notes Nil
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Subjects were randomly assigned
by a computerized random number gener-
ator created by an independent biostatisti-
cian at an independent treatment center”,
p 140
Allocation concealment (selection bias) Unclear risk Quote: “Subjects were randomly assigned
by a computerized random number gener-
ator created by an independent biostatisti-
cian at an independent treatment center”,
p 140
Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “All clinical outcome measures
were assessed by an independent physi-
cal therapist who was blinded to subjects’
group allocation”, p 140
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 0/63 (0%) dropouts
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Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes stated
were reported
Other bias High risk Comment: The 100% follow-up rates at 2
years and the extremely large treatment ef-
fects were together highly improbable and
raised suspicions about the conduct of the
trial. In addition, the stretch devices used
in this study were extremely costly yet the
authors stated that they received no fund-
ing. It is not clear whether the company
provided the devices
Hyde 2000
Methods Design: Randomised parallel-group study
Participants Health condition: Children with Duchenne muscular dystrophy
Sample size: Experimental group: 15, Control group: 12
Setting; Country: 3 institutions; Norway, Sweden and Denmark
Joint of interest: Ankle
Inclusion criteria:
• Diagnosis of Duchenne muscular dystrophy
• Not less than 4 years of age
• Able to walk independently without the use of orthoses
Exclusion criteria:
• Taking medication that might influence muscle strength
• Previous lower limb surgery
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 7 years (2), Control group: 6 years (2)
Gender: Experimental group: 0% female, Control group: 0% female
Interventions Groups included in this review:
Experimental group: Night splint plus passive stretch
Participants received below-knee splints to be worn during the night
Participants also received passive stretches to the tendo-achilles, hip flexors, knee flexors
and iliotibial band. These stretches were performed 10 times per day
Total stretch time: not reported
Control group: Passive stretch
Participants received passive stretches to the tendo-achilles, hip flexors, knee flexors and
iliotibial band. These stretches were performed 10 times per day
Other groups: Nil
Outcomes Outcomes included in this review:
• Tendo-achilles contracture
• Motor ability scale
Other outcomes: Hip flexor contracture, time taken to run 10 m, Gowers manoeuvre
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(time taken to move from supine to standing), voluntary muscle strength
Time points included in this review: Outcomes measured at 32 months (assessment
12)
Other time points: Outcomes also measured at baseline (assessment 1), 1 month, 4
months (randomisation), 7 months, 10 months, 13 months, 17 months, 20 months, 23
months, 26 months and 29 months (assessment 11)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...randomization numbers from
standard statistical tables for random num-
bers”, p 258
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...the evaluators...were blinded to
the randomized treatment group allocation
and to the previous assessment”, p 258
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 16/27 (59%) dropouts over
length of study
Selective reporting (reporting bias) High risk Comment: Insufficient detail reported to
include in meta-analysis
Other bias Low risk Comment: Appears free of other bias
Jang 2015
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with recent (< 30 days) burns around the shoulder joint
Sample size: Experimental group: 11, Control group: 13
Setting, Country: Inpatient rehabilitation centre in a general hospital, South Korea
Joint of interest: Shoulder
Inclusion criteria:
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• burns around the shoulder joint
• the total burn surface area (TBSA) was > 10% and < 80%
• date of burning was < 30 days before the patient was included in the study
Exclusion criteria:
• septic condition that could limit their participation
• were planning to undergo skin graft surgery around the shoulder
• had a severe cognitive deficit that could prevent them from following instructions
• neurological impairment of the upper extremity that related to the shoulder burn
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 43.5 years (10.4), Control group: 48.3 years (6.
9)
Gender: Experimental group: 18% female, Control group: 23% female
Interventions Groups included in this review:
Experimental group : Shoulder splint and usual care
Participants wore a multi-axis shoulder abduction splint to keep the shoulder abducted
at 90° abduction after shoulder burn. Participants also received usual care (details below)
Total stretch time: 24 h x 7 d x 4 weeks = 672 h over a 1-month period
Control group: Usual care
Participants were prescribed an exercise programmewhich consisted of sessions of passive
and active mobilisation and stretching for 30 min twice a day
Other groups: Nil
Outcomes Outcomes included in this review:
• Active shoulder abduction (degrees)
Other outcomes: Active shoulder flexion, active shoulder external rotation
Time points included in this review: Outcomes were measured at 4 weeks (end of
intervention)
Other time points: Outcomes also measured at baselines, week 1, week 2 and week 3
Notes Participants exercised for 30 min twice daily, so the total splint wear time was 23 h/day
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...randomization procedure in-
volving a computer-generated random
number sequence…”, p 440
Allocation concealment (selection bias) Low risk Quote: “...sealed envelopes with random
numberswere used to allocate the patients”,
p 440
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
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Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...by assessors who were blinded to
whether the patient was being splinted”, p
441
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: Figure 1: 24/26 (8%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Unclear risk Comment: Insufficient detail provided
Jerosch-Herold 2011
Methods Design: Randomised parallel-group study
Participants Health condition: Adults following surgical release for Dupuytren’s contracture
Sample size: Experimental group: 77, Control group: 77
Setting, Country: 5 National Health Service Hospital Trusts, UK
Joint of interest: Hand
Inclusion criteria:
• Dupuytren’s contracture affecting one or more fingers of either hand
• Requiring surgical release by fasciectomy or dermofasciectomy
• Over 18 years of age
Exclusion criteria:
• Contracture affecting the thumb or first web space only
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 67 years (10), Control group: 68 years (9)
Gender: Experimental group: 21% female, Control group: 23% female
Interventions Groups included in this review:
Experimental group : Static night splint plus hand therapy
Particicpants wore a custom-made thermoplastic splint which accommodated the op-
erated rays of the hand with the metacarpophalangeal joints and/or proximal interpha-
langeal joints held in maximum extension without causing any tension to the wound.
The splint was remoulded intermittently to achieve a greater extension force. Participants
were instructed to wear the splint at night only. Participants also received hand therapy
(details below)
Total stretch time: 8 h x 182 d (6 months) = 1456 h over a 6-month period
Control group: Hand therapy
Participants receivedhand therapy aimed at reducing oedema, promotingwoundhealing,
maximising finger range of movement and facilitating full return to functional use of the
hand, including oedema control, exercises and advice. If a participant had a net loss of
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15 degrees or more at the proximal interphalangeal joint and/or a net loss of 20 degrees
or more at the metacarpal phalangeal joint of the operated fingers, they were then given
a splint
Other groups : Nil
Outcomes Outcomes included in this review:
• Active extension of the metacarpophalangeal, proximal interphalangeal and distal
interphalangeal joint of the operated fingers (degrees)
• Disabilities of Arm Shoulder and Hand Questionnaire (DASH; 1-100 points)
Other outcomes
Active flexion of themetacarpophalangeal, proximal interphalangeal and distal interpha-
langeal joints of the operated fingers, patient satisfaction with the outcome, recurrence
at 1 year
Time points included in this review: Outcomes measured at 6 months (end interven-
tion) and 12 months after surgery
Other time points: Outcomes also measured prior to surgery, and at 3 months after
surgery Patient satisfaction was assessed only at 6 and 12 months
Notes Assumed participants wore the splint for 8 h per night when calculating total stretch
time
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “Randomisation was stratified by
centre (five centres) and by surgical pro-
cedure (fasciectomy or dermofasciectomy)
in block lengths of 4. The allocation se-
quence was generated and administered in-
dependently through a central telephone
randomisation service”, p 4
Comment: Not clear how the randomisa-
tion sequence was generated
Allocation concealment (selection bias) Low risk Quote: “The allocation sequence was gen-
erated and administered independently
through a central telephone randomisation
service”, p 4
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
High risk Quote: “The primary outcome mea-
sure was patient-reported and participants
could not be blinded. Secondary outcomes
were collected by the research associates
who were also not blinded, although they
94Stretch for the treatment and prevention of contractures (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Jerosch-Herold 2011 (Continued)
were independent of the clinical staff deliv-
ering the interventions”, p 5
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 6/154 (3%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes stated
were reported. Abandoned the recurrence
at 1-year outcome
Other bias High risk Quote: “13 patients allocated to the no-
splint group (17%) went on to develop
a contracture of the PIPJ which exceeded
the agreed threshold andwere subsequently
given a splint as per protocol”, p 4
Comment: Crossover from control to ex-
perimental group, but analysis was by in-
tention-to-treat
John 2011
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with hallux limitus in the first metatarsophalangeal joint
following surgery
Sample size: Experimental group: 25, Control group: 25
Setting, Country: Outpatient clinics, USA
Joint of interest: Metatarsophalangeal joint of great toe
Inclusion criteria:
• Reduced flexibility in active ROM of extension in the great toe
• Pain that is worsened by walking and/or squatting
• Impaired gait pattern
Exclusion criteria:
• Metatarsal stress fracture
• Interdigital neuroma
• Sesamoid pathology
• Gout
• Metatarsalgia
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Not reported (Range: 29-69 years)
Gender: Experimental group: 44% female, Control group: 60% female
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Interventions Groups included in this review:
Experimental group :Dynamic splint and usual care
Participant wore a dynamic splint for first metatarsophalangeal joint of the great toe.
They also received usual care (details below)
Total stretch time: 3 h x 7 d x 8 weeks = 168 h over a 2-month period
Control group : Usual care
Participants were prescribed nonsteroidal anti-inflammatory drugs and orthotics. They
were also given instructions for home exercises
Other groups : Nil
Outcomes Outcomes included in this review:
• Active dorsiflexion at the first metatarsal joint of the hallux (great toe) (degrees)
Other outcomes: Nil
Time points included in this review: Outcomes measured at 8 weeks (end of interven-
tion)
Other time points: Outcomes also measured at baseline
Notes Nil
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: Insufficient detail reported
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Unclear risk Comment: Insufficient detail reported
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Two control patients withdrew
from the study because of excessive pain
that required additional treatment”, p 287
Selective reporting (reporting bias) Unclear risk Comment: Does not clearly state outcomes
and only reports on one outcome
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Other bias High risk Comment: Inadequate reporting to gauge
other possible sources of bias
Jongs 2012
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with contracture following distal radial fracture
Sample size: Experimental group: 19, Control group: 21
Setting, Country: Outpatient clinics, Australia
Joint of interest: Wrist
Inclusion criteria:
• Diagnosis of stable and united (or uniting) unilateral fracture
• Wrist contracture evident by a loss of passive extension compared to the
unaffected wrist
• Living in the Sydney metropolitan region
• Aged over 18 years
Exclusion criteria:
• Unlikely to co-operate
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (IQR): Experimental group: 66 years (56-72), Control group: 58 years (52-
65)
Gender: Experimental group: 79% female, Control group: 62% female
Interventions Groups included in this review:
Experimental group : Splint and routine care
Participantswore a dynamic splint during the daywhich stretched thewrist into extension
but allowed intermittent movement. They also received routine care (details below)
Total stretch time: 6 h x 7 d x 8 weeks = 336 h over a 2-month period
Control group : Routine care
Participants received exercises and advice for 8 weeks
Other groups : Nil
Outcomes Outcomes included in this review:
• Passive wrist extension (degrees)
• Pain and function (Patient Rated Hand Wrist Evaluation/100)
• Canadian Occupational Performance Measure for Performance (points)
Other outcomes: Active wrist extension, active wrist flexion, active radial deviation,
active ulnar deviation, Canadian Occupational Performance Measure for Satisfaction
Time points included in this review: Outcomes measured at 8 weeks (end of interven-
tion) and 12 weeks
Other time points: Outcomes also measured at baseline
Notes Nil
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “..a computerised blocked ran-
domisation sequence was generated prior
to the commencement of the trial by an in-
dependent offsite person”, p 174
Allocation concealment (selection bias) Low risk Quote: “Participants’ allocations were
placed in opaque sealed and sequentially
numbered envelopes that were held off-
site”, p 174
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “A blinded assessor performed as-
sessments at 8 weeks, ....an assessor not
blinded to group allocation performed as-
sessments at 12 weeks”, p 174
Comment: Only data from the 8-week as-
sessments were used in the meta-analyses
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 4/40 (10%) dropouts at 8
weeks and 8/40 (20%) dropouts at 12
weeks
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
Kemler 2012
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with Dupuytren’s disease
Sample size: Experimental group: 28, Control group: 26
Setting, Country: Outpatient clinics, Netherlands
Joint of interest: Proximal interphalangeal
Inclusion criteria:
• Dupuytren’s disease with a proximal interphalangeal joint flexion contracture of at
least 30°
• Underwent surgical release of a Dupuytren’s contracture
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Exclusion criteria:
• Below 18 years of age
• Undergone partial amputation or arthrodesis of a digit
• Insufficient knowledge of the Dutch language
Existing contracture, at risk of contracture, or combination of both: Participants
were at risk of developing contracture
Mean age (SD): Experimental group: 63 years (9), Control group: 64 years (11)
Gender: Experimental group: 18% female (n = 5), Control group: 12% female (n = 3)
Interventions Groups included in this review:
Experimental group : Hand splint and usual therapy
Participants wore a dorsal static extension splint postoperative. They also received usual
therapy (details below)
Total stretch time: (24 h x 28 d) + (8 h x 7 weeks x 7 d) = 672 h + 392 h = 1,064 h over
a 3-month period1
Control group : Usual therapy
Participants received a standardised programme of graded exercises designed to improve
the strength, mobility and function of the affected hand (30 min twice weekly; total
duration 3 months, starting 10 d after surgery)
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive extension of proximal interphalangeal joint (degrees)
• Pain (VAS)
Other outcomes: Global perceived effect, comfort of wearing splint
Time points included in this review: Outcomes measured at 6 weeks and 1 year
Other time points: Outcomes also measured at 3 months (but only at 1 site)
Notes 1Total stretch time calculations based on: participants were instructed to apply the splint
day and night during the first 4 weeks, but removed for exercises at least 5 times/d for
15 min. Then: participants gradually began to use their hands normally in the daytime
and the night splintage was continued
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Table of random numbers was
used to make the treatment assignments”,
p 734
Allocation concealment (selection bias) Unclear risk Quote: “The assignments were made by a
research assistant”, p 734
Comment: Not clear if the research assis-
tant had access to the allocation schedule
or was involved in making decisions about
inclusion
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Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “..concealed from the outcome as-
sessor”, p 734
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “After 1 year, all patients were avail-
able for follow-up”, p 735
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Unclear risk Comment: The 6-week and 3-month data
were only collected at one site (n = 36)
Kolmus 2012
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with an axillary burn (anterior chest involving the axillary
fold, anterior, lateral or posterior shoulder and the axillary region)
Sample size: Experimental group: 27, Control group: 25
Setting, Country: Burns unit of an acute hospital, Australia
Joint of interest: Shoulder
Inclusion criteria:
• Aged 18 years and over
• Axillary burn
Exclusion criteria:
• Not requiring surgical management
• Pre-existing shoulder pathology impacting on range and function
• Sustained an additional injury to the burned shoulder (fracture, muscle or
ligament tear)
• Greater than 50% total body surface area burn injury
• Admitted for chronic burn contracture release
Existing contracture, at risk of contracture, or combination of both: Participants
were at risk of developing contracture
Mean age (SD): Experimental group: 49 years (19), Control group: 44 years (18)
Gender: Experimental group: 30% female, Control group: 40% female
Interventions Groups included in this review:
Experimental group : Shoulder splint and usual care
Participants wore an Otto Bock Omo Immobil shoulder splint, holding the shoulder in
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90° abduction for 12 weeks. They also received usual care (details below)
Total stretch time: (24 h x 7 d x 6 weeks) + (8 h x 7 d x 6 weeks) = 1344 h over a 3-
month period1
Control group : Usual care
Participants received a daily exercise programme which included stretching, strengthen-
ing and functional retraining of the affected upper limb
Other groups: Nil
Outcomes Outcomes included in this review:
• Shoulder range of abduction (degrees,)
• Burn Specific Health Scale-Brief (points)
• Upper Extremity Functional Index scale (points)
Other outcomes: Shoulder range of flexion, the Grocery Shelving Task, length of stay
Time points included in this review: Outcomes measured at 12 weeks (end of inter-
vention)
Other time points: Outcomes also measured at baseline and 6 weeks
Notes 1 “… adherence with splint use was generally poor…” p 640 (no detailed adherence data
provided)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomisation was completed via
a computer generated program”, p 639
Allocation concealment (selection bias) Low risk Quote: “...allocation was concealed using
opaque envelopes”, p 639
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “Outcomes measured by an inde-
pendent data collector who was blinded to
group allocation”, p 639
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: Figure 1, Week 12: 40/52 =
77%
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
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Other bias Unclear risk Comment: Table 2 contains data on length
of stay that were not described as an out-
come in the text
Krumlinde-Sundholm 2011
Methods Design: Randomised cross-over study
Participants Health condition: Children with cerebral palsy (12 children had unilateral and 14
bilateral cerebral palsy)
Sample size: 37 children (cross-over)
Setting, Country: Hand clinic, Sweden
Joint of interest: Wrist and thumb
Inclusion criteria:
• Children with cerebral palsy already using splints
Exclusion criteria: Nil reported
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Both groups: 10 years (range 1-16)
Gender: Not reported
Interventions Groups included in this review:
Experimental group : Hand splint and usual care
Participants received a hand splint for 6 months.
Total stretch time: 8 h x 7 d x 26 weeks = 1456 h1
Control group : Usual care
Participants did not receive a hand splint
Other groups : Nil
Outcomes Outcomes included in this review:
• Passive wrist extension (degrees)
Other outcomes: Passive thumb abduction
Time points included in this review: Outcomes measured at 6 months (end of inter-
vention)
Other time points: Outcomes also measured at 3 months, 9 months and 12 months
Notes 1This assumes participants wore the splint each night for 8 h
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: Insufficient detail reported
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported.
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Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind participants
or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...blinded to group allocation”, p 26
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind participants
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “During the 12 month trial period 11
[of 37] dropped out leaving 26 children”, p 27
Comment: 11/47 (30%) dropout
Selective reporting (reporting bias) Unclear risk Comment: Insufficient detail reported
Other bias Unclear risk Comment: Only an abstract so difficult to as-
sess susceptibility to bias
Lai 2009
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 151 , Control group: 151
Setting, Country: Not reported, USA
Joint of interest: Elbow
Inclusion criteria:
• 18-75 years old
• Sustained stroke at least 6 months before entering study
• Modified Ashworth scale score of 2 or more during elbow extension
• ROM deficit of greater than 24% in elbow extension
Exclusion criteria:
• History of fracture to affected limb 3 months prior to enrolment
• Taking aminoglycosides
• Had botulinum toxin injections within the previous 4 months prior to enrolment
• Fixed, mechanical impingement blocking active ROM
• Previous phenol injections to the study limb
• Received serial casting of the study limb in the past 4 months
• Histories of other central neurological pathologies
• Had baclofen pump implants
• Pregnant, nursing, or may become pregnant
• Unable to attend the scheduled twice-weekly therapy appointments
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 49 years (4), Control group: 56 years (5)
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Gender: Experimental group: 53% female, Control group: 33% female
Interventions Groups included in this review:
Experimental group: Extension splint plus botulinum toxin and therapy
Participants wore an elbow extension dynasplint in addition to botulinum toxin and
therapy. Tension was increased 1 increment every 2 weeks, based on participant’s toler-
ance. The initial tension setting was #2 (16 kg/cm of torque), and the mean final tension
setting was #6 (58 kg/cm of torque). Participants also received botulinum toxin and
therapy (details below)
Total stretch time: (6-8 h) x 7 d x 14 weeks = 588 h to 784 h over a 14-week period
Control group: Botulinum toxin and therapy
All participants received botulinum toxin injections and occupational and manual ther-
apies. The botulinum toxin injections were injected into the biceps brachialis, and bra-
chioradialis muscles, and the occupational and manual therapies occurred weekly for 16
weeks. The occupational and manual therapy protocols included moist heat, education,
joint mobilisation, passive ROM, active ROM, proprio-neural facilitation and therapeu-
tic exercise
Other groups: Nil
Outcomes Outcomes included in this review:
• Maximal active ROM (elbow extension)
• Modified Ashworth scale (extension score)
Other outcomes: Nil
Time points included in this review: Outcomes measured at 14 weeks (end of inter-
vention)
Other time points: Outcomes also measured at baseline, 1 week
Notes 1Number of participants analysed by the study authors (i.e. these numbers do not include
dropouts). Authors did not report the size of the group allocations at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...selected with a randomized list”,
p 244
Comment: No information on allocation
concealment reported.
Allocation concealment (selection bias) Unclear risk Quote: “...selected with a randomized list”,
p 244
Comment: No information on allocation
concealment reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
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Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Unclear risk Quote: “Upon enrolment, all patients ...
measured by the same therapist before and
after the BTX injections”, p 243
Comment: Information about assessor
blinding was not stated
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 6/36 (17%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Unclear risk Quote: “This study was funded by Dynas-
plint Systems Inc.”, p 246
Comment: Unclear threat to bias
Lannin 2003a
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke or brain injury
Sample size: Experimental group: 17, Control group: 11
Setting, Country: Inpatient rehabilitation unit, Australia
Joint of interest: Wrist (long finger flexors)
Inclusion criteria:
• Single stroke or brain injury no more than 6 months prior
• Upper-limb hemiplegia
• Unable to actively extend the affected wrist
• 18-80 years old
Exclusion criteria:
• Language comprehension, perceptual, or cognitive deficits that would prevent
written, informed consent or participation in the programme
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 65 years (16), Control group: 68 years (7)
Gender: Experimental group: 53% female, Control group: 55% female
Interventions Groups included in this review:
Experimental group: Splint plus routine therapy
Participants wore a static, palmar resting mitt splint on a daily basis for a maximum of
12 h each night. Participants also received routine therapy (details below)
Total stretch time: 12 h x 7 d x 4 weeks = 336 h over a 4-week period
Control group: Routine therapy
Participants received routine therapy for individual motor training and upper-limb
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stretches 5 d/week. Upper limb stretches involved a seated weight-bearing stretch and a
seated upper limb stretch using an inflatable long-arm air splint
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive wrist extension (degrees)
• Upper limb pain (VAS)
• Upper limb activity (composite of 3 items of MAS)
Other outcomes: MAS - item 6, MAS - item 7, MAS - item 8
Time points included in this review: Outcomes measured at 4 weeks (end of interven-
tion)
Other time points: Outcomes also measured at baseline and 5 weeks (1 week after end
of intervention)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...a randomnumber table was used
to generate the random number sequence”,
p 298
Allocation concealment (selection bias) Low risk Quote: “...the investigator contacted an in-
dependent person to obtain group alloca-
tion for each subject. This ensured con-
cealed randomization”, p 298
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...both assessors were blinded to
allocation”, p 298
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 3/28 (10%) dropouts for 4-
week outcomes, 1/28 (4%) dropouts for 5-
week outcomes
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
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Other bias Low risk Comment: Appears free of other bias
Lannin 2007a
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 21, Control group: 21, Other group: 21
Setting, Country: 9 inpatient rehabilitation units, Australia
Joint of interest: Wrist (long finger flexors)
Inclusion criteria:
• Stroke within previous 8 weeks
• Aged 18 years or older
• No active wrist extension
• Sufficient cognitive and hearing function to be able to provide informed consent
and fully participate in the trial
• Resided in the greater Sydney metropolitan area
Exclusion criteria: Nil reported
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 69 years (12), Control group: 75 years (11), Other
group: 70 years (13)
Gender: Experimental group: 43% female, Control group: 57% female, Other group:
52% female
Interventions Groups included in this review:
Experimental group: Wrist extension splint and usual rehabilitation
Participants wore a custom-made, static, palmar mitt splint for up to 12 h overnight. The
wrist was positioned in a comfortable end-of-range extended position with the metacar-
pophalangeal and interphalangeal joints extended. Participants also received usual re-
habilitation, except that stretches of the wrist or long finger flexor muscles were not
performed during the study period. A maximum of 10 min of isolated wrist and finger
extension practice was permitted per day
Total stretch time: 12 h x 7 d x 4 weeks = 336 h over a 4-week period
Control group: No splint and usual rehabilitation
Participants did not wear a hand splint for the study period
Participants received usual rehabilitation, except that stretches of the wrist or long finger
flexor muscles were not performed during the study period. A maximum of 10 min of
isolated wrist and finger extension practice was permitted per day
Other group: Neutral wrist splint
Participants wore a custom-made, static, palmar mitt splint for up to 12 h overnight.
The wrist was positioned in 0-10° extension
Participants also received usual rehabilitation, except that stretches of the wrist or long
finger flexor muscles were not performed during the study period. A maximum of 10
min of isolated wrist and finger extension practice was permitted per day
Total stretch time: 12 h x 7 d x 4 weeks = 336 h over a 4-week period
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Outcomes Outcomes included in this review:
• Passive wrist extension (degrees)
• Pain (Disabilities of the Arm, Shoulder, and Hand Outcome Measure - pain
severity item)
• Spasticity angle (Tardieu scale)
• Disabilities of the Arm, Shoulder, and Hand Outcome Measure (DASH)
Other outcomes: Upper limb activity (composite of 3 items of MAS), Spasticity rating
(Tardieu)
Time points included in this review: Outcomes measured at 4 weeks (end of interven-
tion)
Other time points:Outcomes also measured at baseline and 6 weeks (2 weeks after end
of intervention)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...the allocation schedulewas com-
puter generated”, p 112
Allocation concealment (selection bias) Low risk Quote: “...concealed in opaque, consecu-
tively numbered envelopes by a person not
otherwise involved in the study”, p 112
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...measures were assessed...by an
independent assessor who was unaware of
which treatment the patient had received”,
p 112
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 1/63 (2%) dropouts at 4-week
assessment, 4/63 (6%) dropouts for pri-
mary outcome at 6-week assessment
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
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Law 1991
Methods Design: Randomised parallel-group study
Participants Health condition: Children with spastic cerebral palsy
Sample size: Experimental group: 191 , Control group: 181, Other group A: 171, Other
group B: 181, Entire sample: 792
Setting, Country: 3 treatment centres for disabled children, Canada
Joint of interest: Wrist (wrist flexors)
Inclusion criteria:
• Spastic cerebral palsy (hemiplegia or quadriplegia)
• Spasticity of wrist and hand
• Parent able to attend therapy
• Age 18 months to 8 years
Exclusion criteria:
• Skin sensitivity to casting material
• Fixed, permanent wrist contracture
• Upper-extremity surgery planned during intervention period
• Severe developmental disability
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Not reported
Gender: Experimental group: 68% female, Control group: 56% female, Other group
A: 59% female, Other group B: 61% female
Interventions Groups included in this review:
Experimental group: Cast plus intensive neurodevelopmental therapy (NDT)
Participants wore an upper extremity inhibitory short arm cast for a minimum of 4 h
per day. The cast immobilised the wrist in neutral to 10° extension. Participants also
received 45 min of NDT therapy twice weekly plus a home programme for 30 min/d
Total stretch time: 4 h x 7 d x 26 weeks = 728 h over a 26-week period
Control group: Intensive neurodevelopmental therapy (NDT)
Participants received 45 min of NDT therapy twice weekly plus a home programme for
30 min/d
Other group A: Regular neurodevelopmental therapy (NDT) plus cast
Participants wore an upper extremity inhibitory short arm cast for a minimum of 4 h/d.
The cast immobilised the wrist in neutral to 10 degrees extension
Participants also received NDT therapy for a minimum of once per month up to a
maximum of once per week. Participants performed a home programme for 15 min, 3
times per week
Total stretch time: 4 h x 7 days x 26 weeks = 728 h over a 26-week period
Other group B: Regular neurodevelopmental therapy (NDT)
Participants receivedNDT therapy for a minimum of once per month up to a maximum
of once per week. Participants performed a home programme for 15 min, 3 times per
week
Outcomes Outcomes included in this review:
• Wrist ROM (scale not reported)
• Peabody fine motor scale
Other outcomes: Quality of Upper Extremity Skills Test (QUEST)
Time points included in this review: Outcomes measured at 6 months (end of inter-
vention) and 9 months (3 months after end of intervention)
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Law 1991 (Continued)
Other time points: Outcomes also measured at baseline
Notes 1Number of participants who were analysed by the study authors (i.e. these numbers do
not include dropouts). Authors did not report the size of the group allocations at baseline
2 Number of participants who were randomised.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Comment: Insufficient detail reported
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...outcomes were assessed by an
evaluator, blind to the children’s status at
commencement”, p 381
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 7/79 (9%) dropouts
Selective reporting (reporting bias) High risk Comment: Insufficient detail reported to
include in meta-analysis
Other bias High risk Quote: “...one nine month assessment was
omitted because of consistently missed ap-
pointments”, p 382
Comment: Not analysed by intention-to-
treat
Lee 2007
Methods Design: Randomised parallel-group study
Participants Health condition: Adult women following radiotherapy for breast cancer
Sample size: Experimental group: 31, Control group: 30
Setting, Country: Outpatients department, Australia
Joint of interest: Shoulder
Inclusion criteria:
110Stretch for the treatment and prevention of contractures (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lee 2007 (Continued)
• Undergone breast cancer surgery
• Receiving radiotherapy to the breast, chest wall or supra-clavicular area
Exclusion criteria:
• Radiotherapy to the axilla
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 55 years (13), Control group: 53 years (12)
Gender: Experimental group: 100% female, Control group: 100% female
Interventions Groups included in this review:
Experimental group: Stretch plus usual care
Participants received an individualised pectoral muscle stretching programme consisting
of low-load, prolonged, passive stretches of pectoralis major and minor while in supine-
lying
Participants also followed an independent exercise programme outlined in a pamphlet
given to them after breast cancer surgery, which consisted of gentle shoulder ROM
exercises. Participants were seen by the physiotherapist on a weekly basis during their
radiotherapy for skin care, lymphoedema information and reviewing the above stretches
Total stretch time: 10 min x 2 muscles x 2 sessions x 7 d x 30.33 weeks = 141.5 h over a
30-week period
Control group: Usual care
Participants followed an independent exercise programme outlined in a pamphlet given
to them after breast cancer surgery. The exercise programme consisted of gentle shoulder
ROM exercises. Participants were also seen by the physiotherapist on a weekly basis
during their radiotherapy for skin care and lymphoedema information only
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive shoulder horizontal extension of the affected arm
• Pain after arm ROM measurement (VAS)
• European Organization for Research and Treatment of Cancer (EORTC) Quality
of Life Questionnaire (QLQ-C30)
Other outcomes: Passive shoulder horizontal extension ROM - unaffected, passive
shoulder forward flexion ROM - affected, passive shoulder forward flexion ROM - un-
affected, passive shoulder external rotation ROM - affected, passive shoulder external
rotation ROM - unaffected, active shoulder abduction ROM - affected, active shoulder
abduction ROM - unaffected, pain after armROMmeasurement - unaffected, European
Organization for Research and Treatment of Cancer (EORTC) Quality of Life Ques-
tionnaire (QLQ-C30), shoulder horizontal flexion strength - affected, shoulder horizon-
tal flexion strength - unaffected, shoulder forward flexion strength - affected, shoulder
forward flexion strength - unaffected, shoulder horizontal extension - affected, shoul-
der horizontal extension strength - unaffected, shoulder abduction strength - affected,
shoulder abduction strength - unaffected, Shoulder external rotation strength - affected,
shoulder external rotation strength - unaffected, arm swelling
Time points included in this review: Outcomes measured at 7 months (end of inter-
vention).
Other time points:Outcomes also measured at baseline and 6 weeks (end of radiother-
apy)
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Notes Pain and quality of life data were not reported in the publications and were therefore
obtained directly from the authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...participants were randomised to
either a control or stretch group using com-
puter-generated randomisation schedule”,
p 314
Allocation concealment (selection bias) Low risk Quote: “...allocation was concealed by the
use of numbered opaque envelopes”, p 314
Comment: Insufficient detail reported in
paper whether envelopes were sealed. Cor-
respondence with study author revealed
that envelopes were sealed prior to ran-
domisation
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...participants were measured by a
physiotherapist blinded to group allocation
at each of the three measurements..”
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 5/61 (8%) dropouts (Note:
Review authors treated self-reported out-
comes as dropouts)
Selective reporting (reporting bias) High risk Comment:No results reported for pain and
quality of life
Other bias High risk Comment: Changed protocol midway
through trial
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McNee 2007
Methods Design: Randomised cross-over study
Participants Health condition: Children with cerebral palsy
Sample size: Experimental group: 5, Control group: 4
Setting, Country: Outpatient clinic, UK
Joint of interest: Ankle
Inclusion criteria:
• Over the age of 5 years
• Mild fixed ankle plantarflexion contractures
• Clinical recommendation of serial casting to improve ankle dorsiflexion range
Exclusion criteria:
• Botulinum toxin injections in the past 6 months
• Previous surgery to the calf musculature
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 7 years (not reported), Control group: 7 years
(not reported)
Gender: Experimental group: 40% female, Control group: 75% female
Interventions Groups included in this review:
Experimental group: Cast 1
Participants had a short leg cast applied in prone with the knee flexed. Casts were re-
applied each week. Casts were not re-applied if there had been no improvement in ROM
or if a target ROM (10° dorsiflexion) had been achieved
Total stretch time: 24 h x 7 d x (3-4 weeks) = 504-672 h over a 3-4-week period
Control group: No cast 1
Participants did not receive a cast
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive ankle dorsiflexion with the knee extended (degrees)
• Normalcy index (NI) for walking
Other outcomes:Maximum passive ankle dorsiflexion with the knee flexed, maximum
ankle dorsiflexion in single-support, maximum ankle dorsiflexion in swing, minimum
knee flexion in stance, minimum hip flexion in stance, Gillette functional assessment
questionnaire, walking speed, cadence, stride length, time in single-support
Time points included in this review:Outcomes measured at 12 weeks (8-9 weeks after
end of intervention)
Other time points: Outcomes also measured at baseline and 5 weeks.
Notes 1Only includes details of the first period of the cross-over.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...participants in the study were allo-
cated to one of two groups”, p 465
Comment: Insufficient detail reported
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Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind participants
or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Unclear risk Comment: Insufficient detail reported
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind participants
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Comment: Insufficient detail reported
Selective reporting (reporting bias) Unclear risk Comment: Not clear how many kinematic
variables were measured
Other bias High risk Comment: Some participants had treatments
applied bilaterally. Not clear how bilateral data
were dealt with
Melegati 2003
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with primary anterior cruciate ligament reconstruction
Sample size: Experimental group: 18, Control group: 18
Setting, Country: Not reported, Italy
Joint of interest: Knee
Inclusion criteria:
• Complete and isolated ACL rupture
• Absence of previous surgical procedure in either knee
• More than 2 months since ACL rupture
• Over 15 years of age
Exclusion criteria: Nil reported
Existing contracture, at risk of contracture, or combination of both: Participants
were at risk of developing contracture
Mean age (SD): Experimental group: 28 years (3), Control group: 30 years (7)
Gender: Experimental group: 0% female, Control group: 0% female
Interventions Groups included in this review:
Experimental group: Knee extension brace
Participants wore a rehabilitation brace, locked in full extension, applied during the first
postoperative week. The brace was only unlocked during ROM exercises. Full extension
was maintained during gait and rest, including night-time
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Melegati 2003 (Continued)
Total stretch time: 23 h x 7 d = 161 h over a 1-week period
Control group: ROM brace (0 °-90 °)
Participants wore a rehabilitation brace locked from 0°-90°, applied from the day of
surgery to the seventh postoperative day.
In both groups, the brace was unlocked in the ROM 0°-120° during the second post-
operative week, and finally removed at the beginning of the third postoperative week.
The rehabilitation programme was started on the day after surgery. All the subjects
followed the same rigorous accelerated rehabilitation protocol
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive Knee extension (heel height difference; cm)
Other outcomes: KT1000 measurement of ACL laxity
Time points included in this review: Outcomes measured at 8 weeks post surgery (7
weeks after end of intervention)
Other time points: Outcomes also measured at baseline, 2 weeks, 4 weeks, 4 months
post surgery (KT1000 measurement only at this time point)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “...who were alternately distributed
into the groups after the operation”, p 323
Allocation concealment (selection bias) Unclear risk Comment: No information on allocation
concealment reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...the physician didn’t know to
which group the patients belonged”,
p 324
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: No dropouts reported
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
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Melegati 2003 (Continued)
Other bias Low risk Comment: Appears free of other bias
Moseley 1997
Methods Design: Randomised cross-over study
Participants Health condition: Adults with traumatic brain injury
Sample size: Experimental group: 5, Control group: 5
Setting, Country: Inpatient rehabilitation unit, Australia
Joint of interest: Ankle (plantarflexors)
Inclusion criteria:
• Restricted passive ankle dorsiflexion that prevented the heels from touching the
ground when standing with the hips extended
• No contra-indications to casting
• Ability to lie prone for plaster application
Exclusion criteria: Nil reported
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: not reported, Control group: not reported, both
groups: 29 years (11)
Gender: Experimental group: not reported, Control group: not reported, both groups:
11% female
Interventions Groups included in this review:
Experimental group: Cast 1
Participants had a short leg cast applied in prone with the knee flexed. Gastrocnemius
was stretched by placing knee in extension for prolonged periods of time. Participants
also received motor training aimed at improving the performance of everyday tasks
Total stretch time: 24 h x 7 d = 168 h over a 1-week period
Control group: No cast 1
Participants did not receive a cast and did not stretch. Participants receivedmotor training
aimed at improving the performance of everyday tasks
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive ankle dorsiflexion (degrees)
Other outcomes: Nil
Time points included in this review: Outcomes measured at 7 d (end of intervention)
.
Other time points: Outcomes also measured at baseline
Notes 1Only includes details of the first period of the cross-over
Risk of bias
Bias Authors’ judgement Support for judgement
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Moseley 1997 (Continued)
Random sequence generation (selection
bias)
Unclear risk Quote: “...the experimental and control con-
ditions occurred in random order”, p 243
Comment: Insufficient detail reported
Allocation concealment (selection bias) Unclear risk Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind participants
or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
High risk Quote: “...one potential threat to the validity
of the study was the use of a
non-blinded measurer”, p 246
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind participants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 1/10 (10%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were re-
ported
Other bias Low risk Comment: Appears free of other bias
Moseley 2005
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with ankle fracture
Sample size: Experimental group: 51, Control group: 50, Other group: 49
Setting, Country: Outpatient clinics, Australia
Joint of interest: Ankle
Inclusion criteria:
• Ankle fracture treated with cast immobilisation (with or without surgical fixation)
• Cast removed in preceding 5 days
• Approval received from orthopaedic specialist to weight-bear as tolerated or
partial weight-bear
• Reduced passive dorsiflexion (at least 5° less than the contralateral ankle)
• Completed skeletal growth
• No concurrent pathologies that affect the ability to perform everyday tasks or the
measurement procedures
Exclusion criteria: Not reported
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 47 years (15), Control group: 49 years (15), Other
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Moseley 2005 (Continued)
group: 43 yeas (15)
Gender: Experimental group: 53% female, Control group: 52% female, Other group:
53% female
Interventions Groups included in this review:
Experimental group: Long-duration stretch plus exercise
Participants performed long-duration stretches by standing with the affected foot on a
wedge with the back against a wall or, if weight bearing was not tolerated, in a sitting
position. The slope of the wedge and the amount of weight borne through the leg were
adjusted so that the participant felt a comfortable stretch in the ankle or calf muscles.
Both the slope and the weight were progressed throughout the course of treatment.
Participants also received ankle mobility and strengthening exercises, stepping exercises,
and exercises involving weight bearing and balancing on the affected leg. Participants
completed 30 repetitions of each exercise every day. Participants received gait training
and advice
Total stretch time: 30 min x 7 d x 4 weeks = 14 h over a 4-week period
Control group: Exercise
Participants received ankle mobility and strengthening exercises, stepping exercises, and
exercises involving weight bearing and balancing on the affected leg. Participants com-
pleted 30 repetitions of each exercise every day. Participants received gait training and
advice
Other group: Short-duration stretch plus exercise
Short duration stretches could be applied in a non-weight bearing position initially, with
progression to standing as tolerated
Participants also received ankle mobility and strengthening exercises, stepping exercises,
and exercises involving weight bearing and balancing on the affected leg. Participants
completed 30 repetitions of each exercise every day. Participants received gait training
and advice
Total stretch time: 6 min x 7 d x 4 weeks = 2.8 h over a 4-week period
Outcomes Outcomes included in this review:
• Ankle dorsiflexion angle at peak baseline torque with knee straight (degrees)
• Pain in standing with equal weight distribution (VAS)
• Perceived disability (Lower Extremity Functional Score)
• Return to work (VAS)
Other outcomes:Dorsiflexion angle at peak baseline torque with knee bent, peak ankle
dorsiflexion ROM with knee straight, peak ankle dorsiflexion ROM with knee bent,
measures of ankle stiffness with knee straight, measures of ankle stiffness with knee bent,
preload co-efficient with knee straight, preload co-efficient with knee bent, ankle torque
at the peak baseline dorsiflexion angle with knee straight, ankle torque at the peak baseline
dorsiflexion angle with knee bent, pain during stair descent, perceived adverse effects of
treatment, return to usual sport and leisure activities, speed when walking, step length
asymmetry, stepping rate when stair climbing, global perception of effect of treatment,
satisfaction with treatment, duration of PT treatment
Time points included in this review: Outcomes measured at 4 weeks (end of interven-
tion) and 3 months (2 months after end of intervention)
Other time points: Outcomes also measured at baseline
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...subjects were randomly allo-
cated into 1 of 3 groups… using a pro-
cedure that was stratified and blocked by
site”, p 1119
Comment: Insufficient detail reported.
Allocation concealment (selection bias) Low risk Quote: “...the randomization sequence was
concealed by using consecutively num-
bered, sealed, opaque envelopes”, p 1119
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...all measurements were made by
assessors who were blind to group alloca-
tion”, p 1112
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 11/150 (7%) dropouts at 4
week assessment, 16/150 (11%) dropouts
at 3 month assessment
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
Paul 2014
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with adhesive capsulitis (frozen shoulder)
Sample size: Experimental group: 50, Control group: 50
Setting, Country: Outpatient clinic, India
Joint of interest: Shoulder
Inclusion criteria:
• Restriction of shoulder movements
• Shoulder pain at night that often disturbed sleep
• Guarded shoulder movements
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• Difficulty in reaching behind the ear
• Reduced arm swing with walking
• Rounded shoulders and stooped posture
• Ability to complete questionnaires
Exclusion criteria:
• Recent joint infection or surgery (less than 6 months)
• History of shoulder subluxation, dislocation, or ligamentous injury
• Shoulder arthroplasty
• Shoulder impingement syndrome
• Trigger points in the upper trapezius
• Recent trauma
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 49 years (6), Control group: 53 years (7)
Gender: Experimental group: 36% female, Control group: 34% female
Interventions Groups included in this review:
Experimental group : Stretch with countertraction device and usual care
Participants received a shoulder stretch using an overhead device that provided aweighted
shoulder countertraction (3 kg distracted load). This was administered during shoulder
mobilisation. Participants also received usual care (details below)
Total stretch time: 10 min x 5 d x 2 weeks = 1.7 h over a 2-week period
Control group : Usual care
Participants received physiotherapy which consisted of heat prior to shoulder mobilisa-
tion, mobilisation to improve flexion & abduction range, and electrotherapy (ultrasound
or shortwave diathermy)
Other groups: Nil
Outcomes Outcomes included in this review:
• Shoulder flexion (degrees)
• Pain (VAS)
Other outcomes: shoulder abduction, shoulder function (Oxford Shoulder Score)
Time points included in this review: Outcomes measured at 2 weeks (end of interven-
tion)
Other time points: Outcomes also measured at baseline
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...computer generated”, p 2263
Allocation concealment (selection bias) Low risk Quote: “...based on a sealed-envelope sys-
tem”, p 2263
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Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “The outcomeswere recorded by an
independent outcome assessment trained
physiotherapist (DJ), whowas not involved
in the intervention procedures and also was
unaware of participants
allocated groups”, p 2265
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “The outcomes were measured and
calculated after the intervention period of
2 weeks and no participants dropped out
of the study”, p 2265
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Unclear risk Comment: Insufficient detail provided
Refshauge 2006
Methods Design: Randomised within-subjects cross-over study
Participants Health condition: Children and young adults with Charcot-Marie-Tooth disease
Sample size: Experimental group: 14 legs, Control group: 14 legs
Setting, Country: Outpatient clinic, Australia
Joint of interest: Ankle
Inclusion criteria:
• Charcot-Marie-Tooth disease Type 1A
• Restricted range of passive dorsiflexion in both ankles (≤ 15° dorsiflexion from
plantargrade)
Exclusion criteria:
• Previous surgery to either foot
• Previous recent ankle sprain or fracture of either leg
• Undergone any physiotherapy intervention or stretching programme within the
last 6 months
• Older than 30 years of age
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 15 years (8), Control group: 15 years (8)
Gender: Experimental group: 57% female, Control group: 57% female
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Refshauge 2006 (Continued)
Interventions Groups included in this review:
Experimental group: Night splint 1
Participants wore a pre-formed splint which was adjusted into dorsiflexion by the treating
physiotherapist until participants felt a stretch in their calf muscles which could be
tolerated during sleeping. The amount of dorsiflexion was increased if the stretch was
felt to be insufficient. Participants were instructed to wear the splint for the whole night.
Participants were also requested to avoid performing additional stretches or exercises that
deviated from their normal routine
Total stretch time: (4-9 h) x 7 d x 6 weeks = 168 h-78 h over a 6-week period
Control group: No splint 1
Participants were requested to avoid performing additional stretches or exercises that
deviated from their normal routine
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive ankle dorsiflexion
Other outcomes: Passive ankle eversion, isometric ankle dorsiflexion strength, isometric
ankle eversion strength, isometric ankle inversion strength
Time points included in this review:Outcomesmeasured at 6 weeks (end of 1st period)
Other time points: Outcomes also measured at baseline, 12 weeks (end of 2nd period)
and 26 weeks
Notes 1Only includes details of the first period of the cross-over
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...at the initial assessment, the
treating physiotherapist randomly selected
the leg to be splinted first by tossing a coin
after baseline measurements were com-
pleted”, p 194
Allocation concealment (selection bias) High risk Quote: “...at the initial assessment, the
treating physiotherapist randomly selected
the leg to be splinted first by tossing a coin
after baseline measurements were com-
pleted”, p 194
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...the same assessor, who was
blinded to group allocation, made all mea-
surements for each participant”, p 194
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Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 4/56 (7%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
Rose 2010
Methods Randomised parallel-group study
Participants Health condition: Children and young adults with Charcot-Marie-Tooth disease and
restricted ankle dorsiflexion range
Sample size: Experimental group: 15, Control group: 15
Setting, Country: Outpatient clinic, Australia
Joint of interest: Ankle
Inclusion criteria:
• 7-20 years
• Confirmed diagnosis of Charcot-Marie-Tooth
• Consistent clinical phenotype
• Confirmatory electrophysiological testing
• Restricted ROM in one or both ankles (< 25°)
Exclusion criteria:
• Ankle sprain or fracture in past 3 months
• Undergone foot or ankle surgery
• Enrolled in another trial
• Participated in a stretching programme in last 2 months
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 10 years (4), Control group: 11 years (3)
Gender: Experimental group: 60% female, Control group: 47% female
Interventions Groups included in this review:
Experimental group : Night cast for 4 weeks followed by stretches in standing for 4
weeks
Participants wore a fibreglass cast with the ankle positioned in dorsiflexion (knee not
included). The casts were bivalved and applied only at night for the first 4 weeks. The
casts were remade after 2 weeks. At 4 weeks, the stretches were administered in standing
using 2 types of stretches. Each stretch was held for 1 min and performed 3 times a day
Total stretch time: (6-10 h x 7 d x 4 weeks) + (1 min x 6 times per day x 7 d x 4 weeks)
= 170.8-282.2 h over an 8-week period
Control group : No intervention
Participants received no intervention.
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Other groups : Nil
Outcomes Outcomes included in this review:
1. Ankle dorsiflexion during a lunge test (degrees)
2. Speed of preferred walking (m/sec)
Other outcomes: Foot Posture Index (points), Patient Specific Functional Scale (points)
, standing up speed (stands/sec), speed of fast walking (m/sec), speed of ascending stairs
(stairs/sec), balance with feet together (sec), balance with feet toe to heel (sec), balance
in tandem stance (sec), number of falls (no.)
Time points included in this review: Outcomes measured at 8 weeks (end of interven-
tion).
Other time points: Outcomes also measured at baseline and 4 weeks.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “The randomisation sequence was com-
puter-generated...”, p 114
Allocation concealment (selection bias) Low risk Quote: “…telephoned the administrative assistant
to obtain the participant’s random allocation...” p
114
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind participants or
therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...assessor blinding...”, p 113
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind participants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: Table 2 - all outcomes at all end-points
Selective reporting (reporting bias) Low risk Comment: Table 2 - all outcomes at all end-points
Other bias Low risk Comment: Appears free of other bias
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Seeger 1987
Methods Design: Randomised within-subjects study
Participants Health condition: Adults with systemic sclerosis (scleroderma)
Sample size: Experimental group: 19 hands, Control group: 19 hands
Setting, Country: Outpatient clinic, USA
Joint of interest: Proximal interphalangeal
Inclusion criteria:
• Symmetrical and progressive systemic sclerosis
• Involvement of the hands with contractures of the interphalangeal joints
Exclusion criteria:
• Skin ulcers of the fingers or hands severe enough to interfere with splinting
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (range): Experimental group: 48 years (31-61)1 , Control group: 48 years (31-
61)1
Gender:Experimental group: 100%female1, Control group: 100%female1, both groups
including dropouts: 89% female
Interventions Groups included in this review:
Experimental group: Splint
Participants wore a dynamic splint on the experimental hand which provided a sustained
stretch into extension on the interphalangeal and metacarpophalangeal joints
Total stretch time: 8 h x 7 d x 8 weeks = 448 h over an 8-week period
Control group: No splint
Participants did not wear a splint on the control hand
Other groups: Nil
Outcomes Outcomes included in this review:
• Combined proximal interphalangeal (PIP) passive extension (degrees)
Other outcomes: Combined proximal interphalangeal active extension, index finger
proximal interphalangeal passive extension, index finger proximal interphalangeal ac-
tive extension, middle finger proximal interphalangeal passive extension, middle finger
proximal interphalangeal active extension, ring finger proximal interphalangeal passive
extension, ring finger proximal interphalangeal active extension, little finger proximal
interphalangeal passive extension, little finger proximal interphalangeal active extension
Time points included in this review: Outcomes measured at 2 months (end of inter-
vention)
Other time points: Outcomes also measured at baseline and 1 month
Notes 1 Excludes dropouts
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...random number table”, p 119
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Seeger 1987 (Continued)
Allocation concealment (selection bias) High risk Comment: Insufficient detail reported in
paper. Correspondence with study author
revealed that allocation was not concealed
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...measurements were done by the
same evaluatorwhowas blind to the study”,
p 119
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: “...2 were dropped for non-compli-
ance”, p 120
Comment: 12/19 (63%) dropouts for
PROM outcome
Selective reporting (reporting bias) High risk Comment: At least 8 ROM outcomes were
measured but only 2 were reported
Other bias Low risk Comment: Appears free of other bias
Sheehan 2006
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 6, Control group: 8
Setting, Country: Inpatient and outpatient rehabilitation centres, Australia
Joint of interest: Wrist (finger flexors)
Inclusion criteria:
• Stroke-related resistance of affected hand
• Not receiving other therapy for affected arm
• No history of fracture or other pre-existing condition that limited range of
movement of the affected hand
• No functional use of affected hand
• Clinically detectable spasticity (grade 2-3) in the affected hand as measured by the
modified Ashworth scale
• Ability to provide consent
• No comorbidities that could confound the findings
Exclusion criteria: Not reported
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 74 years (8.7)1, Control group: 70 years (7.5)1
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Sheehan 2006 (Continued)
Gender: Experimental group: 0% female, Control group: 17% female1
Interventions Groups included in this review:
Experimental group: Splint on 2nd week (Group 2)
Participants wore a thermoplastic resting splint during the 2nd week (i.e. participants
wore the splint from the 2nd week to the 7th week). Participants received no other upper
limb treatment interventions
Total stretch time: 8 h1 x 7 d x 1 week = 56 h over a 1-week period
Control group: No splint on 2nd week (Group 1)
Participants did not wear a thermoplastic resting splint during the 2nd week (i.e. par-
ticipants wore the splint from the 3rd week to the 7th week). Participants received no
other upper limb treatment interventions
Other groups : Nil
Outcomes Outcomes included in this review:
• Resistance at 20° extension (N)
Other outcomes: Resistance at 10° wrist extension, resistance at 0° wrist extension,
resistance at 10° wrist flexion, resistance at 20° wrist flexion, rate of change of resistance
Time points included in this review: Outcomes measured at 2 weeks (end of interven-
tion)
Other time points: Outcomes also measured at baseline and 7 weeks
Notes 1Data obtained from correspondence with study author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...random numbers table”, p 1033
Allocation concealment (selection bias) Low risk Quote: “...the slips of paper containing the
random numbers were replaced in a black
bag that was kept in a locked drawer in the
independent clinician’s desk...with vision
occluded, the independent clinician drew
a number from the bag and the participant
was allocated to the group”, p 1033
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “The researcher was not involved
in the random allocation of subjects and
was thus blinded to group allocation” (cor-
respondence with study author)
Comment: Insufficient detail reported in
paper. Correspondence with study author
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Sheehan 2006 (Continued)
revealed that assessors were blinded to
group allocation
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 2/14 (14%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias Low risk Comment: Appears free of other bias
Steffen 1995
Methods Design: Randomised within-subjects study
Participants Health condition: Elderly people with bilateral knee contractures
Sample size: Experimental group: 14, Control group: 14
Setting, Country: Nursing homes, USA
Joint of interest: Knee
Inclusion criteria:
• Nursing home residents with bilateral knee flexion contractures of ≥10°
Exclusion criteria: Not reported
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture
Mean age (SD): Experimental group: 86 years (7), Control group: 86 years (7)
Gender: Experimental group: 79% female, Control group: 79% female
Interventions Groups included in this review:
Experimental group: Knee splint (prolonged stretch) plus passive ROM exercises and
manually administered stretches
Participants wore a knee extension splint from the second month of the study through
to the seventh month (total = 6 months). The tension setting on the splint was initially
0 and progressed to 6 (62.2 kg-cm) between weeks 2 and 5 of the study. Participants also
received passive ROM and manually administered stretches (details below)
Total stretch time: 3 h x 5 d x 26 weeks = 390 h over a 26-week period
Control group: Passive ROM exercises and manually administered stretches
Each participant received passive ROM exercises and manually administered stretches to
both lower extremities twice aweek by on-site physiotherapists trained in the standardised
protocol
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive knee extension (degrees)
Other outcomes: Passive hip extension, passive ankle dorsiflexion, torque required to
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Steffen 1995 (Continued)
maintain maximum passive knee extension
Time points included in this review: Outcomes measured at 7 months (end of inter-
vention).
Other time points: Outcomes also measured at baseline, 2 weeks, 4 weeks, 2 months,
3 months, 4 months, 5 months and 6 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quote: “Use of the prolonged stretch was
alternately assigned to the right or left
knee”, p 889
Allocation concealment (selection bias) High risk Comment: Alternate assignment means al-
location was not concealed
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “The physiotherapists performing
the measurements were not aware of the
side of the experimental treatments”, p 888
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 10/28 (36%) dropouts re-
ported
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported
Other bias High risk Quote: “All the subjects in two of the nurs-
ing homes were checked for fit by the de-
signer of the splint, who also owns the com-
pany that makes the splint”, p 889
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Turton 2005
Methods Design: Randomised parallel-group study
Participants Health condition: Adults with stroke
Sample size: Experimental group: 14, Control group: 15
Setting, Country: Hospital inpatients, UK
Joint of interest: Wrist and shoulder
Inclusion criteria:
• Admitted to stroke ward
• Primary diagnosis of first unilateral stroke
• Within 4 weeks of onset
• Able to give informed consent
• Lost function in the affected arm and hand
Exclusion criteria:
• Arthritis or arm pain before the stroke
• Poor comprehension
• Confusion
• Dementia
• Medically unfit for the treatment
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 70 years (10)1, Control group: 66 years (14)1
Gender: Experimental group: 31% female2, Control group: 33% female2
Interventions Groups included in this review:
Experimental group: Stretch plus usual care
Participants received two 30-min sessions of positioning in each of these positions:
Position 1 - Wrist and finger stretch using a hinged board
Position 2 - Shoulder in abduction and some external rotation
Participants also received usual care (details below)
Total stretch time (maximum) = 2 wrist stretches x 30 min x 7 d x 12 weeks = 84 h3
Control group: Usual care
All participants received the standard arm care which did not include sustained stretches.
The affected arm was supported on a Bexhill arm support or pillow in sitting
Other groups: Nil
Outcomes Outcomes included in this review:
• Passive wrist extension of the affected arm (degrees)
Other outcomes: Passive wrist extension contracture (unaffected minus affected), pas-
sive shoulder external rotation - affected, passive shoulder external rotation contracture
(unaffected minus affected), active wrist extension ROM - affected, active shoulder ex-
ternal rotation ROM - affected
Time points included in this review: Outcomes measured at 12 weeks post-stroke4
Other time points: Outcomes also measured at 4 weeks post-stroke5 and 8 weeks4
Notes 1Mean age (SD) of participants at 4 weeks post stroke. Study authors did not measure
participants at point of randomisation
2Gender of participants at 4 weeks post stroke. Study authors did not measure partici-
pants at point of randomisation
3Total stretch time varied between participants because of varying recruitment timing
130Stretch for the treatment and prevention of contractures (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Turton 2005 (Continued)
and discharge timing. The intervention was also stopped if participants reached a certain
criteria for arm function or if they reached 12 weeks post-stroke
4Considerable variation in time since last stretch intervention ranging from less than 24
h to greater than 1 week
5At least 4 participants were already randomised prior to this first measure
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “...computer-generated sequence
for group allocation”, p 601
Allocation concealment (selection bias) Low risk Quote: “...group allocation was kept by a
personwhowas independent of the recruit-
ment process”, p 601
Comment: Off-site allocation
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Low risk Quote: “...readings were taken by the assis-
tant who was (when possible) kept blind to
the subject s allocation”, p 604
Comment: Insufficient detail reported in
paper. Correspondence with study author
revealed that blinding of assessors failed on
only 3 occasions
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
High risk Comment: 6/29 (21%) dropouts for 12
week assessment
Selective reporting (reporting bias) High risk Comment: No outcomes reported for ac-
tive ROM measures
Other bias High risk Comment: No standard treatment proto-
col. Experimental participants given vary-
ing amounts of treatment dependent on
length of stay or arm function
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Zenios 2002
Methods Design: Randomised parallel-group study
Participants Health condition: Adults following total knee replacement
Sample size: Experimental group: 42, Control group: 39
Setting, Country: Acute hospital, UK
Joint of interest: Knee
Inclusion criteria:
• Total knee replacement with patellar resurfacing
Exclusion criteria:
• One-stage bilateral knee replacement
• Unicondylar knee replacement
• Long term anticoagulant therapy
Existing contracture, at risk of contracture, or combination of both: Participants
had existing contracture and were at risk of developing contracture
Mean age (SD): Experimental group: 71 years (7), Control group: 71 years (8)
Gender: Experimental group: 69% female, Control group: 67% female
Interventions Groups included in this review:
Experimental group: Splint
Participants’ knees were splinted into extension using a cricket pad splint in the early
postoperative period. The splint was removed for the participants to do physiotherapy
exercises twice a day. Splints were removed when the participant could straight leg raise
Total stretch time: 23 h x 3 d = 69 h over a 3-day period
Control group: No splint
Participants had a wool and crepe bandage applied around their knee and were allowed
to fully mobilise from the first day. The bandage was removed at 48 hours post-op.
Participants in this group, in addition to the twice a day physiotherapy regime were
encouraged to actively flex the knee from the first postoperative day
Other groups: Nil
Outcomes Outcomes included in this review:
• Knee fixed flexion (passive knee extension ROM; degrees)
Other outcomes:Knee flexionROM, time to straight leg raise, wound drainage, amount
of analgesia required
Time points included in this review: Outcomes measured at 6 weeks (end of interven-
tion)
Other time points: Outcomes also measured at baseline and 5 days post-op1
Notes 1 Unclear whether the intervention was still continuing in some participants at the 5-
day outcome
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “...randomised into two groups”, p
225
Comment: Insufficient detail reported
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Zenios 2002 (Continued)
Allocation concealment (selection bias) Unclear risk Quote: “...using a sealed envelope tech-
nique”, p 225
Comment: Insufficient detail reported
Blinding (performance bias and detection
bias)
Therapists
High risk Comment: Not possible to blind partici-
pants or therapists
Blinding of outcome assessors (detection
bias) - objective outcomes
All outcomes
Unclear risk Quote: “...measurements were recorded by
an independent observer”, p 226
Comment: Insufficient detail reported
Blinding of outcome assessors (detection
bias) - self-reported outcomes
All outcomes
High risk Comment: Not possible to blind partici-
pants
Incomplete outcome data (attrition bias)
All outcomes
Low risk Comment: 2/81 (2%) dropouts
Selective reporting (reporting bias) Low risk Comment: All pre-stated outcomes were
reported. Details of secondary outcomes
are unclear
Other bias Low risk Comment: Appears free of other bias
FMA: Fugl-Meyer Assessment; ITT: intention-to-treat; MAS: Motor Assessment Scale; ROM: range of movement; VAS: Visual
Analogue Scale
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Adams 2008 Did not measure joint mobility
Al-Oraibi 2013 Stretch compared to serial casting. Unable to isolate the effects of stretch
Ayala 2010 Not a RCT.
Baker 2007 Correspondence with the study author revealed that participants received a confounding intervention.
Compared stretch to home exercises. Different home exercises were given to each group
Baker 2012 Participants were not at risk of contracture
Bek 2002 Stretch compared to two other stretch interventions. Unable to isolate the effects of stretch
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(Continued)
Bertoti 1986 Did not measure joint mobility
Bottos 2003 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Brar 1991 Did not measure joint mobility
Brouwer 2000 Not a RCT
Buckon 2001 Stretch compared to two other stretch interventions. Unable to isolate the effects of stretch
Budiman-Mak 1995 Not a stretch intervention
Bury 1995 Splint not applied for the purpose of maintaining or increasing joint mobility
Camin 2004 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Cantarero-Villanueva 2011 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Carda 2011 Stretch compared to two other stretch interventions. Unable to isolate the effects of stretch
Chadchavalpanichaya 2010 Stretch compared to two other stretch interventions. Unable to isolate the effects of stretch
Chow 2010 Stretch compared to two other stretch interventions. Unable to isolate the effects of stretch
Collis 2013a Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Conrad 1996 Not a stretch intervention
Corry 1998 Compared casting and botulinum toxin. No botulinum toxin given to casting group. Unable to isolate
the effects of stretch
Czaprowski 2013 Stretch compared to two other stretch interventions. Unable to isolate the effects of stretch
De Jong 2013 Stretch applied on one occasion only
Desloovere 2001 Compared different timings of same stretch before and after botulinum toxin. Unable to isolate effects
of stretch
Dinh 2011 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Duerden 2009 This study was registered and noted as a study in progress in the 2009 version of this Cochrane review.
However, according to the clinical trials registry, it never started and has since been withdrawn
Elliott 2011 Did not measure joint mobility
Farina 2008 Did not measure joint mobility
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(Continued)
Feland 2001 Participants were not at risk of contracture
Flett 1999 Compared casting to botulinum toxin. No botulinum toxin given to casting group. Unable to isolate
the effects of stretch
Flowers 1994 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Fogelman 2013 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Gajdosik 2005 Participants were not at risk of contracture
Gallon 2011 Participants were not at risk of contracture
Gaspar 2009 Not a RCT
Gbenedio Participants were not at risk of contracture
Gillmore 1995 Participants were not at risk of contracture
Glasgow 2003 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Gomes 2014 Stretch compared to massage. Unable to isolate the effects of stretch
Gonzalez-Rave 2012 Participants were not at risk of contracture
Gracies 2000 Splint applied on one occasion only
Hale 1995 Not a RCT
Harvey 2007 Not a stretch intervention
Hayek 2010 Not a RCT
Hermann 2013 Did not measure joint mobility
Hobbelen 2003 Not a stretch intervention
Hogan 2001 Orthosis applied on one occasion only
Jones 2002 Compared stretch to muscle strengthening. No muscle strengthening performed by stretch group.
Unable to isolate the effects of stretch
Jung 2011 Did not measure joint mobility
Kanellopoulos 2009 Not a RCT
Kappetijn 2014 Not a RCT
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(Continued)
Kerem 2001 Not a RCT
Kilbreath 2006 Compared resistance and stretching exercises to no exercises. Unable to isolate the effects of stretch
Kilgour 2008 Not a stretch intervention, involved primarily active exercises
Kilmartin 1994 Did not measure joint mobility
Kim 2013 Did not measure joint mobility
Lauridsen 2005 Not a stretch intervention
Law 1997 Compared intensive neurodevelopmental therapy plus casting to regular occupational therapy. Unable
to isolate the effects of casting
Li-Tsang 2002 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Light 1984 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Malcus 1992 Did not measure joint mobility
Maloney Backstrom 1995 Participants were not at risk of contracture
Marschall 1999 Participants were not at risk of contracture
McPherson 1985 Stretch compared to passive movements. Unable to isolate the effects of stretch
Mikkelsen 2003 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Miura 2005 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Montero Camara 2011 Stretch compared to another stretch intervention. Participants were not at risk of contracture
Morris 1991 Stretch applied on one occasion only
Moseley 2008 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Newman 2007 Compared different timings of the same stretch intervention. Unable to isolate the effects of stretch
Ott 1998 Participants were not at risk of contracture
Park 2010 Not a RCT
Pickenbrock 2015 Not a stretch intervention
Putt 2008 Participants were not at risk of contracture
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(Continued)
Reiter 1998 Compared botulinum toxin to botulinum toxin plus taping. Different botulinum toxin dosages and
injection sites were used between groups. Unable to isolate the effects of taping
Risberg 1999 Not a stretch intervention
Robinson 2008 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Rose 1987 Splint applied on one occasion only
Rose 2007 Not a RCT
Rydwik 2006 Not a stretch intervention
Santamato 2015 Stretch compared to another stretch intervention. Unable to isolate the effects of stretch
Thibaut 2015 Stretch applied on one occasion only
Vliet 2009 Not a RCT
Watt 2011 Participants were not at risk of contracture
Watt 2014 Not a RCT
Winters 2004 Participants were not at risk of contracture
RCT: randomised controlled trial
Characteristics of studies awaiting assessment [ordered by study ID]
Amirsalari 2011
Methods Published in Arabic - awaiting translation. Unable to determine if eligible
Participants Unable to determine
Interventions Unable to determine
Outcomes Unable to determine
Notes Unable to determine
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Dalvand 2012
Methods Published in Arabic - awaiting translation. Unable to determine if eligible
Participants Unable to determine
Interventions Unable to determine
Outcomes Unable to determine
Notes Unable to determine
Evans 1994
Methods Unable to attain full text. Unable to determine if eligible
Participants Unable to determine
Interventions Unable to determine
Outcomes Unable to determine
Notes Unable to determine
Javanshir 2010
Methods Published in Arabic - awaiting translation. Unable to determine if eligible
Participants Unable to determine
Interventions Unable to determine
Outcomes Unable to determine
Notes Unable to determine
Lagalla 1997
Methods Published in Italian - awaiting translation. Unable to determine if eligible
Participants Unable to determine
Interventions Unable to determine
Outcomes Unable to determine
Notes Unable to determine
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Tutunchi 2011
Methods
Participants
Interventions
Outcomes
Notes
Characteristics of ongoing studies [ordered by study ID]
ACTRN12613000690752
Trial name or title
Methods
Participants
Interventions
Outcomes
Starting date
Contact information
Notes
ACTRN12616000230459
Trial name or title
Methods
Participants
Interventions
Outcomes
Starting date
Contact information
Notes
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Maas 2012
Trial name or title Splint: the efficacy of orthotic management in rest to prevent equinus in children with cerebral palsy, a
randomised controlled trial
Methods RCT
Participants Children with cerebral palsy
Interventions Orthoses worn for 1 year to prevent a decrease in ROM in the ankle
Outcomes Ankle dorsiflexion
Starting date January 2010
Contact information Josina C Maas. Department of Rehabilitation Medicine and the EGMO + Institute for Health and Care
Research and Research Institute MOVE, VU University Medical Center, De Boelelaan 1117, 1081 HV
Amsterdam, The Netherlands, jc.maas@vumc.nl
Notes The published trial protocol indicates that the trial will be completed by December 2012. We contacted the
study authors in May 2016 to clarify status of the trial but have not had a response
NCT02638480
Trial name or title
Methods
Participants
Interventions
Outcomes
Starting date
Contact information
Notes
ROM: range of motion
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D A T A A N D A N A L Y S E S
Comparison 1. Joint mobility - short-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Neurological conditions 18 549 Mean Difference (IV, Random, 95% CI) 1.81 [0.45, 3.17]
1.1 Stroke 11 295 Mean Difference (IV, Random, 95% CI) 0.56 [-1.56, 2.68]
1.2 Charcot-Marie-Tooth
disease
2 82 Mean Difference (IV, Random, 95% CI) 2.27 [0.16, 4.38]
1.3 Acquired brain injury 3 35 Mean Difference (IV, Random, 95% CI) 8.48 [0.60, 16.36]
1.4 Spinal cord injury 4 137 Mean Difference (IV, Random, 95% CI) 1.42 [-0.54, 3.37]
2 Non-neurological conditions 18 865 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.00, 0.33]
2.1 Frail elderly 2 60 Std. Mean Difference (IV, Random, 95% CI) 0.23 [-0.28, 0.74]
2.2 Ankle fracture 1 93 Std. Mean Difference (IV, Random, 95% CI) -0.05 [-0.46, 0.35]
2.3 Anklylosing spondylitis 1 39 Std. Mean Difference (IV, Random, 95% CI) 0.63 [-0.07, 1.32]
2.4 Oral submucous fibrosis 1 24 Std. Mean Difference (IV, Random, 95% CI) 0.83 [-0.05, 1.72]
2.5 Post-radiation therapy to
breast
1 56 Std. Mean Difference (IV, Random, 95% CI) 0.05 [-0.47, 0.58]
2.6 Post-radiation therapy to
jaw
1 14 Std. Mean Difference (IV, Random, 95% CI) 1.54 [0.25, 2.82]
2.7 Progressive systemic
sclerosis
1 14 Std. Mean Difference (IV, Random, 95% CI) 0.78 [-0.32, 1.88]
2.8 Total knee replacement 1 55 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-0.72, 0.34]
2.9 Arthritis 1 36 Std. Mean Difference (IV, Random, 95% CI) 0.41 [-0.25, 1.07]
2.10 Dupuytren’s contractures 3 226 Std. Mean Difference (IV, Random, 95% CI) 0.09 [-0.27, 0.45]
2.11 Shoulder adhesive
capsulitis/frozen shoulder
1 100 Std. Mean Difference (IV, Random, 95% CI) -0.28 [-0.67, 0.11]
2.12 Hallux limitus 1 48 Std. Mean Difference (IV, Random, 95% CI) 0.43 [-0.14, 1.01]
2.13 Wrist fracture 1 36 Std. Mean Difference (IV, Random, 95% CI) 0.24 [-0.41, 0.90]
2.14 Burns 2 64 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.35, 0.63]
Comparison 2. Joint mobility - long-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Neurological conditions 8 211 Mean Difference (IV, Random, 95% CI) 0.73 [-1.37, 2.82]
1.1 Stroke 4 134 Mean Difference (IV, Random, 95% CI) -0.32 [-4.09, 3.44]
1.2 Cerebral palsy 2 39 Mean Difference (IV, Random, 95% CI) 1.37 [-2.05, 4.79]
1.3 Spinal cord injury 1 28 Mean Difference (IV, Random, 95% CI) 0.0 [-3.05, 3.05]
1.4 Acquired brain injury 1 10 Mean Difference (IV, Random, 95% CI) 10.42 [0.62, 20.22]
2 Non-neurological conditions 6 438 Std. Mean Difference (IV, Random, 95% CI) -0.10 [-0.36, 0.16]
2.1 ACL reconstruction 1 36 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.54, 0.77]
2.2 Ankle fracture 1 90 Std. Mean Difference (IV, Random, 95% CI) -0.20 [-0.62, 0.21]
2.3 Total knee replacement 1 79 Std. Mean Difference (IV, Random, 95% CI) -0.36 [-0.80, 0.09]
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2.4 Dupuytren’s contracture 2 201 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-0.47, 0.09]
2.5 Wrist fracture 1 32 Std. Mean Difference (IV, Random, 95% CI) 0.80 [0.07, 1.52]
Comparison 3. Quality of life - short-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non-neurological conditions 2 97 Std. Mean Difference (IV, Random, 95% CI) 0.31 [-0.09, 0.71]
1.1 Post-radiation therapy to
breast
1 57 Std. Mean Difference (IV, Random, 95% CI) 0.15 [-0.37, 0.67]
1.2 Burns 1 40 Std. Mean Difference (IV, Random, 95% CI) 0.55 [-0.08, 1.18]
Comparison 4. Pain - short-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Neurological conditions 5 174 Std. Mean Difference (IV, Random, 95% CI) 0.20 [-0.10, 0.50]
1.1 Stroke 4 135 Std. Mean Difference (IV, Random, 95% CI) 0.31 [-0.03, 0.66]
1.2 Spinal cord injury 1 39 Std. Mean Difference (IV, Random, 95% CI) -0.18 [-0.81, 0.45]
2 Non-neurological conditions 7 422 Std. Mean Difference (IV, Random, 95% CI) -0.17 [-0.43, 0.10]
2.1 Ankle fracture 1 93 Std. Mean Difference (IV, Random, 95% CI) 0.0 [-0.41, 0.41]
2.2 Frail elderly 1 24 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-1.10, 0.51]
2.3 Post-radiotherapy to
breast
1 55 Std. Mean Difference (IV, Random, 95% CI) -0.10 [-0.63, 0.43]
2.4 Arthritis 1 36 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-0.96, 0.35]
2.5 Shoulder adhesive
capsulitis/frozen shoulder
2 160 Std. Mean Difference (IV, Random, 95% CI) -0.20 [-1.17, 0.78]
2.6 Dupuytren’s contracture 1 54 Std. Mean Difference (IV, Random, 95% CI) -0.09 [-0.62, 0.44]
Comparison 5. Pain - long-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Neurological conditions 4 132 Std. Mean Difference (IV, Random, 95% CI) 0.03 [-0.41, 0.47]
1.1 Stroke 4 132 Std. Mean Difference (IV, Random, 95% CI) 0.03 [-0.41, 0.47]
2 Non-neurological conditions 2 Mean Difference (IV, Random, 95% CI) Totals not selected
2.1 Ankle fracture 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 Shoulder adhesive
capsulitis
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 6. Activity limitations - short-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Neurological conditions 7 237 Std. Mean Difference (IV, Random, 95% CI) 0.19 [-0.13, 0.52]
1.1 Stroke 5 170 Std. Mean Difference (IV, Random, 95% CI) 0.27 [-0.09, 0.63]
1.2 Cerebral palsy 1 37 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.21, 1.09]
1.3 Charcot-Marie-Tooth
disease
1 30 Std. Mean Difference (IV, Random, 95% CI) -0.49 [-1.21, 0.24]
2 Non-neurological conditions 5 356 Std. Mean Difference (IV, Random, 95% CI) 0.09 [-0.17, 0.34]
2.1 Ankle fracture 1 93 Std. Mean Difference (IV, Random, 95% CI) 0.10 [-0.30, 0.51]
2.2 Arthritis 1 36 Std. Mean Difference (IV, Random, 95% CI) 0.47 [-0.20, 1.13]
2.3 Dupuytren’s contracture 1 151 Std. Mean Difference (IV, Random, 95% CI) -0.07 [-0.39, 0.25]
2.4 Wrist fracture 1 36 Std. Mean Difference (IV, Random, 95% CI) -0.31 [-0.97, 0.35]
2.5 Burns 1 40 Std. Mean Difference (IV, Random, 95% CI) 0.51 [-0.12, 1.14]
Comparison 7. Activity limitations - long-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Neurological conditions 6 191 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.11, 0.56]
1.1 Stroke 4 136 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.29, 0.58]
1.2 Cerebral palsy 2 55 Std. Mean Difference (IV, Random, 95% CI) 0.41 [-0.17, 1.00]
2 Non-neurological conditions 3 268 Std. Mean Difference (IV, Random, 95% CI) -0.09 [-0.32, 0.15]
2.1 Ankle fracture 1 90 Std. Mean Difference (IV, Random, 95% CI) -0.07 [-0.48, 0.35]
2.2 Dupuytren’s contracture 1 146 Std. Mean Difference (IV, Random, 95% CI) -0.08 [-0.41, 0.24]
2.3 Wrist fracture 1 32 Std. Mean Difference (IV, Random, 95% CI) -0.16 [-0.86, 0.54]
Comparison 8. Participation restrictions - short-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non-neurological conditions 2 129 Std. Mean Difference (IV, Random, 95% CI) -0.22 [-0.57, 0.12]
1.1 Ankle fracture 1 93 Std. Mean Difference (IV, Random, 95% CI) -0.31 [-0.72, 0.10]
1.2 Wrist fracture 1 36 Std. Mean Difference (IV, Random, 95% CI) 0.0 [-0.65, 0.65]
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Comparison 9. Participation restrictions - long-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non-neurological conditions 2 122 Std. Mean Difference (IV, Random, 95% CI) -0.15 [-0.60, 0.29]
1.1 Ankle fracture 1 90 Std. Mean Difference (IV, Random, 95% CI) 0.0 [-0.41, 0.41]
1.2 Wrist fracture 1 32 Std. Mean Difference (IV, Random, 95% CI) -0.49 [-1.20, 0.22]
Comparison 10. Spasticity - short-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Neurological conditions 6 144 Std. Mean Difference (IV, Random, 95% CI) 0.03 [-0.30, 0.36]
1.1 Stroke 5 134 Std. Mean Difference (IV, Random, 95% CI) 0.05 [-0.29, 0.39]
1.2 Acquired brain injury 1 10 Std. Mean Difference (IV, Random, 95% CI) -0.27 [-1.55, 1.00]
Comparison 11. Spasticity - long-term effects following stretch
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Neurological conditions 3 73 Std. Mean Difference (IV, Random, 95% CI) -0.34 [-0.81, 0.13]
1.1 Stroke 1 42 Std. Mean Difference (IV, Random, 95% CI) -0.50 [-1.12, 0.11]
1.2 Cerebral palsy 1 21 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.73, 1.00]
1.3 Traumatic brain injury 1 10 Std. Mean Difference (IV, Random, 95% CI) -0.70 [-2.03, 0.62]
Comparison 12. Joint mobility - subgroup analyses
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Types of stretch intervention 36 1470 Mean Difference (IV, Random, 95% CI) 1.07 [0.03, 2.10]
1.1 Cast 3 57 Mean Difference (IV, Random, 95% CI) 4.59 [-2.60, 11.78]
1.2 Splint 17 787 Mean Difference (IV, Random, 95% CI) 0.27 [-1.02, 1.55]
1.3 Self-administered 2 75 Mean Difference (IV, Random, 95% CI) 3.07 [0.19, 5.94]
1.4 Positioning 7 165 Mean Difference (IV, Random, 95% CI) 2.80 [-2.73, 8.33]
1.5 Other sustained passive
stretch
7 386 Mean Difference (IV, Random, 95% CI) 0.77 [-1.07, 2.61]
2 Large versus small joints 36 1467 Mean Difference (IV, Random, 95% CI) 1.03 [-0.02, 2.09]
2.1 Large joints 16 645 Mean Difference (IV, Random, 95% CI) 0.57 [-0.89, 2.03]
2.2 Small joints 20 822 Mean Difference (IV, Random, 95% CI) 1.44 [-0.11, 3.00]
3 Influence of discomfort 36 1470 Mean Difference (IV, Random, 95% CI) 1.07 [0.01, 2.13]
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3.1 Measurements influenced
by discomfort
25 1009 Mean Difference (IV, Random, 95% CI) 1.19 [-0.41, 2.78]
3.2 Measurements not
influenced by discomfort
11 461 Mean Difference (IV, Random, 95% CI) 1.05 [-0.42, 2.52]
4 Joint mobility measured less
than one day versus more than
one day
34 1400 Mean Difference (IV, Fixed, 95% CI) 1.17 [0.50, 1.85]
4.1 Less than one day 28 1155 Mean Difference (IV, Fixed, 95% CI) 1.10 [0.20, 2.00]
4.2 More than one day 7 245 Mean Difference (IV, Fixed, 95% CI) 1.26 [0.24, 2.28]
Analysis 1.1. Comparison 1 Joint mobility - short-term effects following stretch, Outcome 1 Neurological
conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 1 Joint mobility - short-term effects following stretch
Outcome: 1 Neurological conditions
Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD)[degrees]N Mean(SD)[degrees]IV,Random,95% CI IV,Random,95% CI
1 Stroke
Ada 2005 15 -6.1 (11.2) 16 -17.9 (19.6) 1.4 % 11.80 [ 0.65, 22.95 ]
Basaran 2012 13 52.31 (19.11) 12 52.5 (19.48) 0.8 % -0.19 [ -15.34, 14.96 ]
De Jong 2006 4 76 (16.8) 6 61.67 (8) 0.6 % 14.33 [ -3.33, 31.99 ]
Dean 2000 10 -11 (15.60047) 13 -14 (17.78728) 0.9 % 3.00 [ -10.67, 16.67 ]
Gustafsson 2006 17 50.3 (15.7) 15 49 (24.1) 0.9 % 1.30 [ -13.00, 15.60 ]
Harvey 2006 0.857143 (2.478479) 7 7 1.86 (3.236694) 9.3 % -1.00 [ -4.02, 2.02 ]
Horsley 2007 20 3.8 (10.16472) 20 0 (10.16472) 3.7 % 3.80 [ -2.50, 10.10 ]
Lai 2009 23.66667 (28.27333) 15 15 14.4 (26.8775) 0.5 % 9.27 [ -10.47, 29.01 ]
Lannin 2003a 14 1 (6.614547) 11 0 (5.863169) 5.3 % 1.00 [ -3.90, 5.90 ]
Lannin 2007a 21 0 (6.034517) 21 1.3 (6.034517) 7.7 % -1.30 [ -4.95, 2.35 ]
Turton 2005 12 -15.5 (18.7) 11 -9.9 (13.9) 1.0 % -5.60 [ -18.99, 7.79 ]
Subtotal (95% CI) 148 147 31.9 % 0.56 [ -1.56, 2.68 ]
Heterogeneity: Tau2 = 1.13; Chi2 = 10.93, df = 10 (P = 0.36); I2 =9%
Test for overall effect: Z = 0.52 (P = 0.60)
2 Charcot-Marie-Tooth disease
Refshauge 2006 26 1 (6.44) 26 0 (6.44) 8.0 % 1.00 [ -2.50, 4.50 ]
Rose 2010 15 5 (3.7) 15 2 (3.7) 10.4 % 3.00 [ 0.35, 5.65 ]
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(. . . Continued)
Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD)[degrees]N Mean(SD)[degrees]IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 41 41 18.5 % 2.27 [ 0.16, 4.38 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.80, df = 1 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 2.11 (P = 0.035)
3 Acquired brain injury
Copley 2013 6 60.83 (10.57) 4 50 (5) 1.7 % 10.83 [ 1.06, 20.60 ]
Harvey 2006 4 3.25 (4.031129) 3 0.33 (2.081666) 5.8 % 2.92 [ -1.68, 7.52 ]
Moseley 1997 9 13.5 (11.88) 9 -1.9 (11.88) 1.4 % 15.40 [ 4.42, 26.38 ]
Subtotal (95% CI) 19 16 8.9 % 8.48 [ 0.60, 16.36 ]
Heterogeneity: Tau2 = 30.57; Chi2 = 5.46, df = 2 (P = 0.07); I2 =63%
Test for overall effect: Z = 2.11 (P = 0.035)
4 Spinal cord injury
Ben 2005 20 -0.85 (4.530888) 20 -4.9 (3.279121) 11.0 % 4.05 [ 1.60, 6.50 ]
Harvey 2000 14 0 (4.454695) 14 0 (4.454695) 8.5 % 0.0 [ -3.30, 3.30 ]
Harvey 2003 16 4 (5.050892) 16 3 (5.050892) 8.0 % 1.00 [ -2.50, 4.50 ]
Harvey 2006 1.777778 (2.837089) 18 19 1.42 (2.914832) 13.1 % 0.36 [ -1.50, 2.21 ]
Subtotal (95% CI) 68 69 40.7 % 1.42 [ -0.54, 3.37 ]
Heterogeneity: Tau2 = 2.09; Chi2 = 6.44, df = 3 (P = 0.09); I2 =53%
Test for overall effect: Z = 1.42 (P = 0.16)
Total (95% CI) 276 273 100.0 % 1.81 [ 0.45, 3.17 ]
Heterogeneity: Tau2 = 2.79; Chi2 = 30.34, df = 19 (P = 0.05); I2 =37%
Test for overall effect: Z = 2.61 (P = 0.0090)
Test for subgroup differences: Chi2 = 4.27, df = 3 (P = 0.23), I2 =30%
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Analysis 1.2. Comparison 1 Joint mobility - short-term effects following stretch, Outcome 2 Non-
neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 1 Joint mobility - short-term effects following stretch
Outcome: 2 Non-neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N
Mean(SD)[deg
or mm] N
Mean(SD)[deg
or mm] IV,Random,95% CI IV,Random,95% CI
1 Frail elderly
Fox 2000 12 1.64 (3.274401) 12 0 (3.274401) 3.5 % 0.48 [ -0.33, 1.30 ]
Steffen 1995 1.166667 (10.15324) 18 18 0.44 (11.1367) 5.0 % 0.07 [ -0.59, 0.72 ]
Subtotal (95% CI) 30 30 8.5 % 0.23 [ -0.28, 0.74 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.61, df = 1 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 0.88 (P = 0.38)
2 Ankle fracture
Moseley 2005 46 0 (5.383214) 47 0.3 (5.441412) 9.5 % -0.05 [ -0.46, 0.35 ]
Subtotal (95% CI) 46 47 9.5 % -0.05 [ -0.46, 0.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.26 (P = 0.79)
3 Anklylosing spondylitis
Bulstrode 1987 27 2.4 (4.4) 12 -0.4 (4.3) 4.5 % 0.63 [ -0.07, 1.32 ]
Subtotal (95% CI) 27 12 4.5 % 0.63 [ -0.07, 1.32 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.77 (P = 0.077)
4 Oral submucous fibrosis
Cox 2009 (1) 16 7.75 (8.858141) 8 1.38 (1.92261) 3.0 % 0.83 [ -0.05, 1.72 ]
Subtotal (95% CI) 16 8 3.0 % 0.83 [ -0.05, 1.72 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.84 (P = 0.066)
5 Post-radiation therapy to breast
Lee 2007 29 28.4 (9.2) 27 27.9 (9.3) 6.9 % 0.05 [ -0.47, 0.58 ]
Subtotal (95% CI) 29 27 6.9 % 0.05 [ -0.47, 0.58 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.20 (P = 0.84)
6 Post-radiation therapy to jaw
Buchbinder 1993 (2) 13.55556 (6.635343) 9 5 4.4 (2.302173) 1.6 % 1.54 [ 0.25, 2.82 ]
Subtotal (95% CI) 9 5 1.6 % 1.54 [ 0.25, 2.82 ]
Heterogeneity: not applicable
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(. . . Continued)
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N
Mean(SD)[deg
or mm] N
Mean(SD)[deg
or mm] IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 2.35 (P = 0.019)
7 Progressive systemic sclerosis
Seeger 1987 16.14286 (25.58273) 7 7 -0.71 (12.73727) 2.1 % 0.78 [ -0.32, 1.88 ]
Subtotal (95% CI) 7 7 2.1 % 0.78 [ -0.32, 1.88 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.39 (P = 0.16)
8 Total knee replacement
Horton 2002 27 -3.8 (4.9) 28 -2.9 (4.4) 6.8 % -0.19 [ -0.72, 0.34 ]
Subtotal (95% CI) 27 28 6.8 % -0.19 [ -0.72, 0.34 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.71 (P = 0.48)
9 Arthritis
Aoki 2009 17 117.6 (20.2) 19 109.1 (20.4) 4.9 % 0.41 [ -0.25, 1.07 ]
Subtotal (95% CI) 17 19 4.9 % 0.41 [ -0.25, 1.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.21 (P = 0.23)
10 Dupuytren’s contractures
Collis 2013 20 38 (38) 20 33 (34) 5.4 % 0.14 [ -0.48, 0.76 ]
Jerosch-Herold 2011 74 -31 (23.3) 76 -28.4 (21.1) 12.0 % -0.12 [ -0.44, 0.20 ]
Kemler 2012 18 26 (14) 18 17 (19) 4.9 % 0.53 [ -0.14, 1.19 ]
Subtotal (95% CI) 112 114 22.3 % 0.09 [ -0.27, 0.45 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 3.06, df = 2 (P = 0.22); I2 =35%
Test for overall effect: Z = 0.48 (P = 0.63)
11 Shoulder adhesive capsulitis/frozen shoulder
Paul 2014 50 161.9 (13) 50 165.3 (10.99) 9.8 % -0.28 [ -0.67, 0.11 ]
Subtotal (95% CI) 50 50 9.8 % -0.28 [ -0.67, 0.11 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.39 (P = 0.16)
12 Hallux limitus
John 2011 25 44 (15) 23 35 (25) 6.1 % 0.43 [ -0.14, 1.01 ]
Subtotal (95% CI) 25 23 6.1 % 0.43 [ -0.14, 1.01 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.48 (P = 0.14)
13 Wrist fracture
Jongs 2012 17 9 (13) 19 6 (11) 5.0 % 0.24 [ -0.41, 0.90 ]
Subtotal (95% CI) 17 19 5.0 % 0.24 [ -0.41, 0.90 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.47)
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(. . . Continued)
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N
Mean(SD)[deg
or mm] N
Mean(SD)[deg
or mm] IV,Random,95% CI IV,Random,95% CI
14 Burns
Jang 2015 11 94.8 (22) 13 87 (18.4) 3.5 % 0.37 [ -0.44, 1.19 ]
Kolmus 2012 19 151.5 (7.77) 21 151.5 (7.77) 5.4 % 0.0 [ -0.62, 0.62 ]
Subtotal (95% CI) 30 34 9.0 % 0.14 [ -0.35, 0.63 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.52, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.55 (P = 0.58)
Total (95% CI) 442 423 100.0 % 0.16 [ 0.00, 0.33 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 23.49, df = 17 (P = 0.13); I2 =28%
Test for overall effect: Z = 1.92 (P = 0.055)
Test for subgroup differences: Chi2 = 18.86, df = 13 (P = 0.13), I2 =31%
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Analysis 2.1. Comparison 2 Joint mobility - long-term effects following stretch, Outcome 1 Neurological
conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 2 Joint mobility - long-term effects following stretch
Outcome: 1 Neurological conditions
Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD)[degrees] N Mean(SD)[degrees] IV,Random,95% CI IV,Random,95% CI
1 Stroke
Gustafsson 2006 16 33.8 (24.1) 14 48.9 (27.1) 1.3 % -15.10 [ -33.57, 3.37 ]
Horsley 2007 18 3.5 (12.47481) 19 0 (12.81665) 6.1 % 3.50 [ -4.65, 11.65 ]
Lannin 2003a 16 0 (7.504182) 11 2 (6.222139) 13.3 % -2.00 [ -7.20, 3.20 ]
Lannin 2007a 20 0.8 (6.857155) 20 0 (6.857155) 18.3 % 0.80 [ -3.45, 5.05 ]
Subtotal (95% CI) 70 64 39.0 % -0.32 [ -4.09, 3.44 ]
Heterogeneity: Tau2 = 3.70; Chi2 = 3.97, df = 3 (P = 0.27); I2 =24%
Test for overall effect: Z = 0.17 (P = 0.87)
2 Cerebral palsy
Ackman 2005 12 10 (7) 9 9 (11) 6.0 % 1.00 [ -7.21, 9.21 ]
McNee 2007 9 -1 (4.071821) 9 -2.45 (4.071821) 21.9 % 1.45 [ -2.31, 5.21 ]
Subtotal (95% CI) 21 18 27.9 % 1.37 [ -2.05, 4.79 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
3 Spinal cord injury
Harvey 2000 14 0 (4.117218) 14 0 (4.117218) 28.9 % 0.0 [ -3.05, 3.05 ]
Subtotal (95% CI) 14 14 28.9 % 0.0 [ -3.05, 3.05 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
4 Acquired brain injury
Copley 2013 6 56.67 (10.27) 4 46.25 (5.44) 4.3 % 10.42 [ 0.62, 20.22 ]
Subtotal (95% CI) 6 4 4.3 % 10.42 [ 0.62, 20.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.08 (P = 0.037)
Total (95% CI) 111 100 100.0 % 0.73 [ -1.37, 2.82 ]
Heterogeneity: Tau2 = 1.53; Chi2 = 8.44, df = 7 (P = 0.30); I2 =17%
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Chi2 = 4.41, df = 3 (P = 0.22), I2 =32%
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Analysis 2.2. Comparison 2 Joint mobility - long-term effects following stretch, Outcome 2 Non-
neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 2 Joint mobility - long-term effects following stretch
Outcome: 2 Non-neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N
Mean(SD)[deg
or cm] N
Mean(SD)[deg
or cm] IV,Random,95% CI IV,Random,95% CI
1 ACL reconstruction
Melegati 2003 (1) 18 -0.1 (13.9) 18 -1.6 (11.3) 11.4 % 0.12 [ -0.54, 0.77 ]
Subtotal (95% CI) 18 18 11.4 % 0.12 [ -0.54, 0.77 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.73)
2 Ankle fracture
Moseley 2005 44 0 (6.222139) 46 1.3 (6.36198) 20.1 % -0.20 [ -0.62, 0.21 ]
Subtotal (95% CI) 44 46 20.1 % -0.20 [ -0.62, 0.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
3 Total knee replacement
Zenios 2002 41 -1.7 (3.6) 38 -0.6 (2.3) 18.7 % -0.36 [ -0.80, 0.09 ]
Subtotal (95% CI) 41 38 18.7 % -0.36 [ -0.80, 0.09 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.58 (P = 0.12)
4 Dupuytren’s contracture
Jerosch-Herold 2011 72 -32.9 (27.4) 75 -29.6 (23.3) 25.2 % -0.13 [ -0.45, 0.19 ]
Kemler 2012 28 21 (22) 26 29 (21) 14.9 % -0.37 [ -0.90, 0.17 ]
Subtotal (95% CI) 100 101 40.0 % -0.19 [ -0.47, 0.09 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.55, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 1.36 (P = 0.17)
5 Wrist fracture
Jongs 2012 14 10 (8) 18 3 (9) 9.7 % 0.80 [ 0.07, 1.52 ]
Subtotal (95% CI) 14 18 9.7 % 0.80 [ 0.07, 1.52 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.14 (P = 0.032)
Total (95% CI) 217 221 100.0 % -0.10 [ -0.36, 0.16 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 8.60, df = 5 (P = 0.13); I2 =42%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Chi2 = 8.06, df = 4 (P = 0.09), I2 =50%
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Analysis 3.1. Comparison 3 Quality of life - short-term effects following stretch, Outcome 1 Non-
neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 3 Quality of life - short-term effects following stretch
Outcome: 1 Non-neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD)[points] N Mean(SD)[points] IV,Random,95% CI IV,Random,95% CI
1 Post-radiation therapy to breast
Lee 2007 28 -77.07 (16.551) 29 -79.55 (17.16) 59.7 % 0.15 [ -0.37, 0.67 ]
Subtotal (95% CI) 28 29 59.7 % 0.15 [ -0.37, 0.67 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
2 Burns
Kolmus 2012 19 132.06 (7.1) 21 128 (7.32) 40.3 % 0.55 [ -0.08, 1.18 ]
Subtotal (95% CI) 19 21 40.3 % 0.55 [ -0.08, 1.18 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.71 (P = 0.088)
Total (95% CI) 47 50 100.0 % 0.31 [ -0.09, 0.71 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.94, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 1.51 (P = 0.13)
Test for subgroup differences: Chi2 = 0.94, df = 1 (P = 0.33), I2 =0.0%
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Analysis 4.1. Comparison 4 Pain - short-term effects following stretch, Outcome 1 Neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 4 Pain - short-term effects following stretch
Outcome: 1 Neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Stroke
Gustafsson 2006 16 4 (7.9) 14 1.6 (3.3) 17.2 % 0.38 [ -0.35, 1.10 ]
Horsley 2007 20 0.2 (1.855465) 18 0 (1.760249) 22.2 % 0.11 [ -0.53, 0.75 ]
Lannin 2003a 14 0.2 (3.374769) 11 0 (2.991413) 14.5 % 0.06 [ -0.73, 0.85 ]
Lannin 2007a 21 7.5 (11.9037) 21 0 (11.9037) 23.4 % 0.62 [ 0.00, 1.24 ]
Subtotal (95% CI) 71 64 77.3 % 0.31 [ -0.03, 0.66 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.75, df = 3 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 1.80 (P = 0.072)
2 Spinal cord injury
Crowe 2000 18 1.7 (2.3) 21 2.1 (2) 22.7 % -0.18 [ -0.81, 0.45 ]
Subtotal (95% CI) 18 21 22.7 % -0.18 [ -0.81, 0.45 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
Total (95% CI) 89 85 100.0 % 0.20 [ -0.10, 0.50 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.59, df = 4 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 1.31 (P = 0.19)
Test for subgroup differences: Chi2 = 1.84, df = 1 (P = 0.18), I2 =46%
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Analysis 4.2. Comparison 4 Pain - short-term effects following stretch, Outcome 2 Non-neurological
conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 4 Pain - short-term effects following stretch
Outcome: 2 Non-neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Ankle fracture
Moseley 2005 (1) 46 0 (0E-7) 47 0 (7.2) 18.7 % 0.0 [ -0.41, 0.41 ]
Subtotal (95% CI) 46 47 18.7 % 0.0 [ -0.41, 0.41 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 Frail elderly
Fox 2000 12 0 (0.743614) 12 0.23 (0.743614) 8.2 % -0.30 [ -1.10, 0.51 ]
Subtotal (95% CI) 12 12 8.2 % -0.30 [ -1.10, 0.51 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.73 (P = 0.47)
3 Post-radiotherapy to breast
Lee 2007 29 0.7931 (1.7192) 26 1 (2.19089) 14.3 % -0.10 [ -0.63, 0.43 ]
Subtotal (95% CI) 29 26 14.3 % -0.10 [ -0.63, 0.43 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.70)
4 Arthritis
Aoki 2009 17 43.5 (21.33) 19 49.5 (17.3) 10.9 % -0.30 [ -0.96, 0.35 ]
Subtotal (95% CI) 17 19 10.9 % -0.30 [ -0.96, 0.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.90 (P = 0.37)
5 Shoulder adhesive capsulitis/frozen shoulder
Hussein 2015 30 1.1 (0.92) 30 0.83 (0.79) 14.9 % 0.31 [ -0.20, 0.82 ]
Paul 2014 50 3.48 (0.71) 50 3.98 (0.74) 18.8 % -0.68 [ -1.09, -0.28 ]
Subtotal (95% CI) 80 80 33.8 % -0.20 [ -1.17, 0.78 ]
Heterogeneity: Tau2 = 0.44; Chi2 = 9.00, df = 1 (P = 0.003); I2 =89%
Test for overall effect: Z = 0.40 (P = 0.69)
6 Dupuytren’s contracture
Kemler 2012 28 1.9 (2) 26 2.1 (2.4) 14.2 % -0.09 [ -0.62, 0.44 ]
Subtotal (95% CI) 28 26 14.2 % -0.09 [ -0.62, 0.44 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.33 (P = 0.74)
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(. . . Continued)
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 212 210 100.0 % -0.17 [ -0.43, 0.10 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 10.72, df = 6 (P = 0.10); I2 =44%
Test for overall effect: Z = 1.24 (P = 0.22)
Test for subgroup differences: Chi2 = 0.86, df = 5 (P = 0.97), I2 =0.0%
-2 -1 0 1 2
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(1) Actual value of experimental SD for Moseley 2005 was zero. The value 0.00000001 was added so that meta-analysis could be conducted
Analysis 5.1. Comparison 5 Pain - long-term effects following stretch, Outcome 1 Neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 5 Pain - long-term effects following stretch
Outcome: 1 Neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Stroke
Gustafsson 2006 15 5 (8.78) 13 0.3 (0.63) 22.0 % 0.71 [ -0.06, 1.48 ]
Horsley 2007 18 0.2 (2.67864) 17 0 (2.60317) 26.6 % 0.07 [ -0.59, 0.74 ]
Lannin 2003a 16 0 (4.90658) 11 1 (4.068322) 22.0 % -0.21 [ -0.98, 0.56 ]
Lannin 2007a 21 0 (15.95427) 21 5.6 (15.95427) 29.3 % -0.34 [ -0.95, 0.27 ]
Total (95% CI) 70 62 100.0 % 0.03 [ -0.41, 0.47 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 4.80, df = 3 (P = 0.19); I2 =38%
Test for overall effect: Z = 0.12 (P = 0.90)
Test for subgroup differences: Not applicable
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Analysis 5.2. Comparison 5 Pain - long-term effects following stretch, Outcome 2 Non-neurological
conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 5 Pain - long-term effects following stretch
Outcome: 2 Non-neurological conditions
Study or subgroup Stretch Control
Mean
Difference
Mean
Difference
N Mean(SD)[mm] N Mean(SD)[mm] IV,Random,95% CI IV,Random,95% CI
1 Ankle fracture
Moseley 2005 44 0 (0E-7) 46 0 (0E-7) 0.0 [ 0.00, 0.00 ]
2 Shoulder adhesive capsulitis
Hussein 2015 30 0.8 (0.92) 30 1.47 (0.78) -0.67 [ -1.10, -0.24 ]
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Analysis 6.1. Comparison 6 Activity limitations - short-term effects following stretch, Outcome 1
Neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 6 Activity limitations - short-term effects following stretch
Outcome: 1 Neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Stroke
Ada 2005 15 1 (1.6) 16 0 (0.8) 13.1 % 0.78 [ 0.04, 1.51 ]
Gustafsson 2006 17 71 (28.4) 15 79.3 (27.3) 14.0 % -0.29 [ -0.99, 0.41 ]
Horsley 2007 20 1.7 (3.388241) 20 0 (3.388241) 15.9 % 0.49 [ -0.14, 1.12 ]
Lannin 2003a 14 0 (3.50976) 11 0.1 (3.111069) 11.9 % -0.03 [ -0.82, 0.76 ]
Lannin 2007a 21 0 (9.919754) 21 -3.4 (9.919754) 16.5 % 0.34 [ -0.27, 0.95 ]
Subtotal (95% CI) 87 83 71.5 % 0.27 [ -0.09, 0.63 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 5.38, df = 4 (P = 0.25); I2 =26%
Test for overall effect: Z = 1.49 (P = 0.14)
2 Cerebral palsy
Law 1991 19 35.4 (13.9) 18 28.1 (18.4) 15.2 % 0.44 [ -0.21, 1.09 ]
Subtotal (95% CI) 19 18 15.2 % 0.44 [ -0.21, 1.09 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.32 (P = 0.19)
3 Charcot-Marie-Tooth disease
Rose 2010 15 -0.06 (0.12) 15 0 (0.12) 13.3 % -0.49 [ -1.21, 0.24 ]
Subtotal (95% CI) 15 15 13.3 % -0.49 [ -1.21, 0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.31 (P = 0.19)
Total (95% CI) 121 116 100.0 % 0.19 [ -0.13, 0.52 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 9.54, df = 6 (P = 0.15); I2 =37%
Test for overall effect: Z = 1.16 (P = 0.25)
Test for subgroup differences: Chi2 = 4.08, df = 2 (P = 0.13), I2 =51%
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Analysis 6.2. Comparison 6 Activity limitations - short-term effects following stretch, Outcome 2 Non-
neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 6 Activity limitations - short-term effects following stretch
Outcome: 2 Non-neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD)[points] N Mean(SD)[points] IV,Random,95% CI IV,Random,95% CI
1 Ankle fracture
Moseley 2005 46 1.3 (12.47927) 47 0 (12.61418) 26.2 % 0.10 [ -0.30, 0.51 ]
Subtotal (95% CI) 46 47 26.2 % 0.10 [ -0.30, 0.51 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
2 Arthritis
Aoki 2009 17 36.9 (8.2) 19 32.1 (11.4) 12.4 % 0.47 [ -0.20, 1.13 ]
Subtotal (95% CI) 17 19 12.4 % 0.47 [ -0.20, 1.13 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.38 (P = 0.17)
3 Dupuytren’s contracture
Jerosch-Herold 2011 75 -7.9 (11.4) 76 -7.1 (10.7) 35.4 % -0.07 [ -0.39, 0.25 ]
Subtotal (95% CI) 75 76 35.4 % -0.07 [ -0.39, 0.25 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
4 Wrist fracture
Jongs 2012 17 -21 (14) 19 -16 (17) 12.5 % -0.31 [ -0.97, 0.35 ]
Subtotal (95% CI) 17 19 12.5 % -0.31 [ -0.97, 0.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.93 (P = 0.35)
5 Burns
Kolmus 2012 19 59.22 (5.97) 21 56.24 (5.53) 13.4 % 0.51 [ -0.12, 1.14 ]
Subtotal (95% CI) 19 21 13.4 % 0.51 [ -0.12, 1.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.58 (P = 0.11)
Total (95% CI) 174 182 100.0 % 0.09 [ -0.17, 0.34 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 5.31, df = 4 (P = 0.26); I2 =25%
Test for overall effect: Z = 0.68 (P = 0.49)
Test for subgroup differences: Chi2 = 5.31, df = 4 (P = 0.26), I2 =25%
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Analysis 7.1. Comparison 7 Activity limitations - long-term effects following stretch, Outcome 1
Neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 7 Activity limitations - long-term effects following stretch
Outcome: 1 Neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Stroke
Gustafsson 2006 16 81.6 (28.3) 14 91.8 (11.5) 16.1 % -0.45 [ -1.18, 0.28 ]
Horsley 2007 18 2.3 (4.591954) 19 0 (4.717784) 18.8 % 0.48 [ -0.17, 1.14 ]
Lannin 2003a 16 0 (3.60778) 11 0.2 (2.991413) 14.8 % -0.06 [ -0.83, 0.71 ]
Lannin 2007a 21 0 (10.49841) 21 -4.9 (10.49841) 20.7 % 0.46 [ -0.16, 1.07 ]
Subtotal (95% CI) 71 65 70.5 % 0.14 [ -0.29, 0.58 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 4.83, df = 3 (P = 0.18); I2 =38%
Test for overall effect: Z = 0.64 (P = 0.52)
2 Cerebral palsy
Law 1991 19 38.1 (12.3) 18 27.8 (18.8) 18.5 % 0.64 [ -0.02, 1.30 ]
McNee 2007 9 -7.55 (335.6137) 9 -13.5 (335.6137) 11.0 % 0.02 [ -0.91, 0.94 ]
Subtotal (95% CI) 28 27 29.5 % 0.41 [ -0.17, 1.00 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 1.15, df = 1 (P = 0.28); I2 =13%
Test for overall effect: Z = 1.39 (P = 0.16)
Total (95% CI) 99 92 100.0 % 0.22 [ -0.11, 0.56 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 6.64, df = 5 (P = 0.25); I2 =25%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Chi2 = 0.53, df = 1 (P = 0.46), I2 =0.0%
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Analysis 7.2. Comparison 7 Activity limitations - long-term effects following stretch, Outcome 2 Non-
neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 7 Activity limitations - long-term effects following stretch
Outcome: 2 Non-neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD)[points] N Mean(SD)[points] IV,Random,95% CI IV,Random,95% CI
1 Ankle fracture
Moseley 2005 44 0 (13.52119) 46 0.9 (13.82507) 33.7 % -0.07 [ -0.48, 0.35 ]
Subtotal (95% CI) 44 46 33.7 % -0.07 [ -0.48, 0.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.76)
2 Dupuytren’s contracture
Jerosch-Herold 2011 71 -7 (14.6) 75 -6 (9.2) 54.6 % -0.08 [ -0.41, 0.24 ]
Subtotal (95% CI) 71 75 54.6 % -0.08 [ -0.41, 0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
3 Wrist fracture
Jongs 2012 14 -24 (17) 18 -21 (20) 11.8 % -0.16 [ -0.86, 0.54 ]
Subtotal (95% CI) 14 18 11.8 % -0.16 [ -0.86, 0.54 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.44 (P = 0.66)
Total (95% CI) 129 139 100.0 % -0.09 [ -0.32, 0.15 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.05, df = 2 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Chi2 = 0.05, df = 2 (P = 0.98), I2 =0.0%
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Analysis 8.1. Comparison 8 Participation restrictions - short-term effects following stretch, Outcome 1
Non-neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 8 Participation restrictions - short-term effects following stretch
Outcome: 1 Non-neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD)[mm] N Mean(SD)[mm] IV,Random,95% CI IV,Random,95% CI
1 Ankle fracture
Moseley 2005 46 86 (22.4) 47 95 (33.6) 71.9 % -0.31 [ -0.72, 0.10 ]
Subtotal (95% CI) 46 47 71.9 % -0.31 [ -0.72, 0.10 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.14)
2 Wrist fracture
Jongs 2012 17 3 (2) 19 3 (2) 28.1 % 0.0 [ -0.65, 0.65 ]
Subtotal (95% CI) 17 19 28.1 % 0.0 [ -0.65, 0.65 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Total (95% CI) 63 66 100.0 % -0.22 [ -0.57, 0.12 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.63, df = 1 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 1.27 (P = 0.21)
Test for subgroup differences: Chi2 = 0.63, df = 1 (P = 0.43), I2 =0.0%
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Analysis 9.1. Comparison 9 Participation restrictions - long-term effects following stretch, Outcome 1 Non-
neurological conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 9 Participation restrictions - long-term effects following stretch
Outcome: 1 Non-neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD)[mm] N Mean(SD)[mm] IV,Random,95% CI IV,Random,95% CI
1 Ankle fracture
Moseley 2005 44 100 (9.6) 46 100 (5.6) 68.3 % 0.0 [ -0.41, 0.41 ]
Subtotal (95% CI) 44 46 68.3 % 0.0 [ -0.41, 0.41 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 Wrist fracture
Jongs 2012 14 3 (2) 18 4 (2) 31.7 % -0.49 [ -1.20, 0.22 ]
Subtotal (95% CI) 14 18 31.7 % -0.49 [ -1.20, 0.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.35 (P = 0.18)
Total (95% CI) 58 64 100.0 % -0.15 [ -0.60, 0.29 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 1.35, df = 1 (P = 0.24); I2 =26%
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Chi2 = 1.35, df = 1 (P = 0.24), I2 =26%
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Analysis 10.1. Comparison 10 Spasticity - short-term effects following stretch, Outcome 1 Neurological
conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 10 Spasticity - short-term effects following stretch
Outcome: 1 Neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Stroke
Basaran 2012 13 2.38 (0.77) 12 2.42 (0.9) 17.5 % -0.05 [ -0.83, 0.74 ]
Burge 2008 14 0 (0.8) 13 0 (1.2) 18.9 % 0.0 [ -0.75, 0.75 ]
De Jong 2006 4 2 (0.6) 6 1.5 (1.6) 6.6 % 0.34 [ -0.94, 1.62 ]
Lai 2009 -0.46667 (1.187234) 15 15 -0.33 (0.723747) 21.0 % -0.13 [ -0.85, 0.58 ]
Lannin 2007a 21 1.3 (5.869188) 21 0 (5.869188) 29.3 % 0.22 [ -0.39, 0.82 ]
Subtotal (95% CI) 67 67 93.4 % 0.05 [ -0.29, 0.39 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.82, df = 4 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.31 (P = 0.76)
2 Acquired brain injury
Copley 2013 6 1.83 (0.37) 4 2 (0.79) 6.6 % -0.27 [ -1.55, 1.00 ]
Subtotal (95% CI) 6 4 6.6 % -0.27 [ -1.55, 1.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.68)
Total (95% CI) 73 71 100.0 % 0.03 [ -0.30, 0.36 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.05, df = 5 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.19 (P = 0.85)
Test for subgroup differences: Chi2 = 0.23, df = 1 (P = 0.63), I2 =0.0%
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Analysis 11.1. Comparison 11 Spasticity - long-term effects following stretch, Outcome 1 Neurological
conditions.
Review: Stretch for the treatment and prevention of contractures
Comparison: 11 Spasticity - long-term effects following stretch
Outcome: 1 Neurological conditions
Study or subgroup Stretch Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Stroke
Lannin 2007a 21 0 (4.877212) 21 2.5 (4.877212) 58.1 % -0.50 [ -1.12, 0.11 ]
Subtotal (95% CI) 21 21 58.1 % -0.50 [ -1.12, 0.11 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.60 (P = 0.11)
2 Cerebral palsy
Ackman 2005 12 2.5 (0.5) 9 2.4 (0.9) 29.4 % 0.14 [ -0.73, 1.00 ]
Subtotal (95% CI) 12 9 29.4 % 0.14 [ -0.73, 1.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.76)
3 Traumatic brain injury
Copley 2013 6 1.75 (0.25) 4 2.13 (0.73) 12.5 % -0.70 [ -2.03, 0.62 ]
Subtotal (95% CI) 6 4 12.5 % -0.70 [ -2.03, 0.62 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.04 (P = 0.30)
Total (95% CI) 39 34 100.0 % -0.34 [ -0.81, 0.13 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.73, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.42 (P = 0.16)
Test for subgroup differences: Chi2 = 1.73, df = 2 (P = 0.42), I2 =0.0%
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Analysis 12.1. Comparison 12 Joint mobility - subgroup analyses, Outcome 1 Types of stretch intervention.
Review: Stretch for the treatment and prevention of contractures
Comparison: 12 Joint mobility - subgroup analyses
Outcome: 1 Types of stretch intervention
Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Cast
Ackman 2005 12 10 (7) 9 9 (11) 1.4 % 1.00 [ -7.21, 9.21 ]
McNee 2007 9 -1 (4.071821) 9 -2.45 (4.071821) 4.3 % 1.45 [ -2.31, 5.21 ]
Moseley 1997 9 13.5 (11.87939) 9 -1.9 (11.87939) 0.8 % 15.40 [ 4.42, 26.38 ]
Subtotal (95% CI) 30 27 6.5 % 4.59 [ -2.60, 11.78 ]
Heterogeneity: Tau2 = 25.89; Chi2 = 5.73, df = 2 (P = 0.06); I2 =65%
Test for overall effect: Z = 1.25 (P = 0.21)
2 Splint
Basaran 2012 13 52.31 (19.11) 12 52.5 (19.48) 0.4 % -0.19 [ -15.34, 14.96 ]
Collis 2013 20 38 (38) 20 33 (34) 0.2 % 5.00 [ -17.35, 27.35 ]
Copley 2013 6 56.67 (10.27) 4 46.25 (5.44) 1.0 % 10.42 [ 0.62, 20.22 ]
Harvey 2006 1.758621 (2.914273) 29 29 1.41 (2.914273) 8.3 % 0.34 [ -1.16, 1.84 ]
Horton 2002 27 -3.8 (4.9) 28 -2.9 (4.4) 6.4 % -0.90 [ -3.36, 1.56 ]
Jerosch-Herold 2011 72 -32.9 (27.4) 75 -29.6 (23.3) 1.4 % -3.30 [ -11.54, 4.94 ]
John 2011 25 44 (15) 23 35 (25) 0.7 % 9.00 [ -2.79, 20.79 ]
Jongs 2012 14 10 (8) 18 3 (9) 2.4 % 7.00 [ 1.10, 12.90 ]
Kemler 2012 28 21 (22) 26 29 (21) 0.8 % -8.00 [ -19.47, 3.47 ]
Kolmus 2012 19 151.5 (7.77) 21 151.5 (7.77) 3.2 % 0.0 [ -4.82, 4.82 ]
Lai 2009 23.66667 (28.27333) 15 15 14.4 (26.8775) 0.3 % 9.27 [ -10.47, 29.01 ]
Lannin 2003a 16 0 (7.504182) 11 2 (6.222139) 2.8 % -2.00 [ -7.20, 3.20 ]
Lannin 2007a 20 0.8 (6.857155) 20 0 (6.857155) 3.7 % 0.80 [ -3.45, 5.05 ]
Refshauge 2006 26 1 (6.438649) 26 0 (6.438649) 4.7 % 1.00 [ -2.50, 4.50 ]
Seeger 1987 16.14286 (25.58273) 7 7 -0.71 (12.73727) 0.2 % 16.86 [ -4.31, 38.03 ]
Steffen 1995 1.166667 (10.15324) 18 18 0.44 (11.1367) 1.8 % 0.72 [ -6.24, 7.68 ]
Zenios 2002 41 -1.7 (3.6) 38 -0.6 (2.3) 8.7 % -1.10 [ -2.42, 0.22 ]
Subtotal (95% CI) 396 391 47.0 % 0.27 [ -1.02, 1.55 ]
Heterogeneity: Tau2 = 1.45; Chi2 = 22.25, df = 16 (P = 0.14); I2 =28%
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(. . . Continued)
Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 0.41 (P = 0.68)
3 Self-administered
Aoki 2009 17 117.6 (20.2) 19 109.1 (20.4) 0.6 % 8.50 [ -4.78, 21.78 ]
Bulstrode 1987 27 2.4 (4.4) 12 -0.4 (4.3) 5.6 % 2.80 [ -0.15, 5.75 ]
Subtotal (95% CI) 44 31 6.1 % 3.07 [ 0.19, 5.94 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.67, df = 1 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 2.09 (P = 0.037)
4 Positioning
Ada 2005 15 -6.1 (11.2) 16 -17.9 (19.6) 0.8 % 11.80 [ 0.65, 22.95 ]
De Jong 2006 4 76 (16.8) 6 61.67 (8) 0.3 % 14.33 [ -3.33, 31.99 ]
Dean 2000 10 -11 (15.60047) 13 -14 (17.78728) 0.5 % 3.00 [ -10.67, 16.67 ]
Fox 2000 12 1.64 (3.274401) 12 0 (3.274401) 6.1 % 1.64 [ -0.98, 4.26 ]
Gustafsson 2006 16 33.8 (24.1) 14 48.9 (27.1) 0.3 % -15.10 [ -33.57, 3.37 ]
Jang 2015 11 94.8 (22) 13 87 (18.4) 0.4 % 7.80 [ -8.60, 24.20 ]
Turton 2005 12 -15.5 (18.7) 11 -9.9 (13.9) 0.6 % -5.60 [ -18.99, 7.79 ]
Subtotal (95% CI) 80 85 9.1 % 2.80 [ -2.73, 8.33 ]
Heterogeneity: Tau2 = 19.75; Chi2 = 9.94, df = 6 (P = 0.13); I2 =40%
Test for overall effect: Z = 0.99 (P = 0.32)
5 Other sustained passive stretch
Ben 2005 20 -0.85 (4.530888) 20 -4.9 (3.279121) 6.5 % 4.05 [ 1.60, 6.50 ]
Harvey 2000 14 0 (4.117218) 14 0 (4.117218) 5.4 % 0.0 [ -3.05, 3.05 ]
Harvey 2003 16 4 (5.050892) 16 3 (5.050892) 4.7 % 1.00 [ -2.50, 4.50 ]
Horsley 2007 18 3.5 (12.47481) 19 0 (12.81665) 1.4 % 3.50 [ -4.65, 11.65 ]
Lee 2007 29 28.4 (9.2) 27 27.9 (9.3) 3.1 % 0.50 [ -4.35, 5.35 ]
Moseley 2005 46 0 (5.383214) 47 0.3 (5.441412) 6.9 % -0.30 [ -2.50, 1.90 ]
Paul 2014 50 161.9 (13) 50 165.3 (10.99) 3.3 % -3.40 [ -8.12, 1.32 ]
Subtotal (95% CI) 193 193 31.3 % 0.77 [ -1.07, 2.61 ]
Heterogeneity: Tau2 = 2.69; Chi2 = 11.43, df = 6 (P = 0.08); I2 =48%
Test for overall effect: Z = 0.82 (P = 0.41)
Total (95% CI) 743 727 100.0 % 1.07 [ 0.03, 2.10 ]
Heterogeneity: Tau2 = 2.75; Chi2 = 59.08, df = 35 (P = 0.01); I2 =41%
Test for overall effect: Z = 2.02 (P = 0.043)
Test for subgroup differences: Chi2 = 4.59, df = 4 (P = 0.33), I2 =13%
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Analysis 12.2. Comparison 12 Joint mobility - subgroup analyses, Outcome 2 Large versus small joints.
Review: Stretch for the treatment and prevention of contractures
Comparison: 12 Joint mobility - subgroup analyses
Outcome: 2 Large versus small joints
Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Large joints
Ada 2005 15 -6.1 (11.2) 16 -17.9 (19.6) 0.8 % 11.80 [ 0.65, 22.95 ]
Aoki 2009 17 117.6 (20.2) 19 109.1 (20.4) 0.6 % 8.50 [ -4.78, 21.78 ]
Bulstrode 1987 27 2.4 (4.4) 12 -0.4 (4.3) 5.6 % 2.80 [ -0.15, 5.75 ]
De Jong 2006 4 76 (16.8) 6 61.67 (8) 0.3 % 14.33 [ -3.33, 31.99 ]
Dean 2000 10 -11 (15.60047) 13 -14 (17.78728) 0.6 % 3.00 [ -10.67, 16.67 ]
Fox 2000 12 1.64 (3.274401) 12 0 (3.274401) 6.1 % 1.64 [ -0.98, 4.26 ]
Gustafsson 2006 16 33.8 (24.1) 14 48.9 (27.1) 0.3 % -15.10 [ -33.57, 3.37 ]
Harvey 2003 16 4 (5.050892) 16 3 (5.050892) 4.7 % 1.00 [ -2.50, 4.50 ]
Horton 2002 27 -3.8 (4.9) 28 -2.9 (4.4) 6.4 % -0.90 [ -3.36, 1.56 ]
Jang 2015 11 94.8 (22) 13 87 (18.4) 0.4 % 7.80 [ -8.60, 24.20 ]
Kolmus 2012 19 151.5 (7.77) 21 151.5 (7.77) 3.2 % 0.0 [ -4.82, 4.82 ]
Lai 2009 23.6666667 (28.27333) 15 15 14.4 (26.8775) 0.3 % 9.27 [ -10.47, 29.01 ]
Lee 2007 29 28.4 (9.2) 27 27.9 (9.3) 3.2 % 0.50 [ -4.35, 5.35 ]
Paul 2014 50 161.9 (13) 50 165.3 (10.99) 3.3 % -3.40 [ -8.12, 1.32 ]
Steffen 1995 1.1666667 (10.15324) 18 18 0.44 (11.1367) 1.9 % 0.72 [ -6.24, 7.68 ]
Zenios 2002 41 -1.7 (3.6) 38 -0.6 (2.3) 8.5 % -1.10 [ -2.42, 0.22 ]
Subtotal (95% CI) 327 318 46.3 % 0.57 [ -0.89, 2.03 ]
Heterogeneity: Tau2 = 2.32; Chi2 = 23.41, df = 15 (P = 0.08); I2 =36%
Test for overall effect: Z = 0.77 (P = 0.44)
2 Small joints
Ackman 2005 12 10 (7) 9 9 (11) 1.4 % 1.00 [ -7.21, 9.21 ]
Basaran 2012 13 52.31 (19.11) 12 52.5 (19.48) 0.5 % -0.19 [ -15.34, 14.96 ]
Ben 2005 20 -0.85 (4.530888) 20 -4.9 (3.279121) 6.4 % 4.05 [ 1.60, 6.50 ]
Collis 2013 20 38 (38) 20 33 (34) 0.2 % 5.00 [ -17.35, 27.35 ]
Copley 2013 6 56.67 (10.27) 4 46.25 (5.44) 1.0 % 10.42 [ 0.62, 20.22 ]
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Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Harvey 2000 14 0 (4.117218) 14 0 (4.117218) 5.4 % 0.0 [ -3.05, 3.05 ]
Harvey 2006 1.7586207 (2.914273) 29 29 1.41 (2.914273) 8.2 % 0.34 [ -1.16, 1.84 ]
Horsley 2007 18 3.5 (12.47481) 19 0 (12.81665) 1.4 % 3.50 [ -4.65, 11.65 ]
Jerosch-Herold 2011 72 -32.9 (27.4) 75 -29.6 (23.3) 1.4 % -3.30 [ -11.54, 4.94 ]
John 2011 25 44 (15) 23 35 (25) 0.7 % 9.00 [ -2.79, 20.79 ]
Jongs 2012 14 10 (8) 18 3 (9) 2.4 % 7.00 [ 1.10, 12.90 ]
Kemler 2012 28 21 (22) 26 29 (21) 0.8 % -8.00 [ -19.47, 3.47 ]
Lannin 2003a 16 0 (7.504182) 11 2 (6.222139) 2.9 % -2.00 [ -7.20, 3.20 ]
Lannin 2007a 20 0.8 (6.857155) 20 0 (6.857155) 3.8 % 0.80 [ -3.45, 5.05 ]
McNee 2007 9 -1 (4.071821) 9 -2.45 (4.071821) 4.4 % 1.45 [ -2.31, 5.21 ]
Moseley 1997 9 13.5 (11.87939) 9 -1.9 (11.87939) 0.9 % 15.40 [ 4.42, 26.38 ]
Moseley 2005 44 0 (6.222139) 46 1.3 (6.36198) 6.2 % -1.30 [ -3.90, 1.30 ]
Refshauge 2006 26 1 (6.438649) 26 0 (6.438649) 4.7 % 1.00 [ -2.50, 4.50 ]
Seeger 1987 16.1428571 (25.58273) 7 7 -0.71 (12.73727) 0.2 % 16.86 [ -4.31, 38.03 ]
Turton 2005 12 -15.5 (18.7) 11 -9.9 (13.9) 0.6 % -5.60 [ -18.99, 7.79 ]
Subtotal (95% CI) 414 408 53.7 % 1.44 [ -0.11, 3.00 ]
Heterogeneity: Tau2 = 3.97; Chi2 = 34.35, df = 19 (P = 0.02); I2 =45%
Test for overall effect: Z = 1.82 (P = 0.069)
Total (95% CI) 741 726 100.0 % 1.03 [ -0.02, 2.09 ]
Heterogeneity: Tau2 = 2.98; Chi2 = 60.42, df = 35 (P = 0.005); I2 =42%
Test for overall effect: Z = 1.91 (P = 0.056)
Test for subgroup differences: Chi2 = 0.64, df = 1 (P = 0.42), I2 =0.0%
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Analysis 12.3. Comparison 12 Joint mobility - subgroup analyses, Outcome 3 Influence of discomfort.
Review: Stretch for the treatment and prevention of contractures
Comparison: 12 Joint mobility - subgroup analyses
Outcome: 3 Influence of discomfort
Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Measurements influenced by discomfort
Ackman 2005 12 10 (7) 9 9 (11) 1.4 % 1.00 [ -7.21, 9.21 ]
Ada 2005 15 -6.1 (11.2) 16 -17.9 (19.6) 0.8 % 11.80 [ 0.65, 22.95 ]
Aoki 2009 17 117.6 (20.2) 19 109.1 (20.4) 0.6 % 8.50 [ -4.78, 21.78 ]
Basaran 2012 13 52.31 (19.11) 12 52.5 (19.48) 0.5 % -0.19 [ -15.34, 14.96 ]
Bulstrode 1987 27 2.4 (4.4) 12 -0.4 (4.3) 5.5 % 2.80 [ -0.15, 5.75 ]
Collis 2013 20 38 (38) 20 33 (34) 0.2 % 5.00 [ -17.35, 27.35 ]
Copley 2013 6 56.67 (10.27) 4 46.25 (5.44) 1.1 % 10.42 [ 0.62, 20.22 ]
De Jong 2006 4 76 (16.8) 6 61.67 (8) 0.3 % 14.33 [ -3.33, 31.99 ]
Dean 2000 10 -11 (15.60047) 13 -14 (17.78728) 0.6 % 3.00 [ -10.67, 16.67 ]
Fox 2000 12 1.64 (3.274401) 12 0 (3.274401) 6.1 % 1.64 [ -0.98, 4.26 ]
Gustafsson 2006 16 33.8 (24.1) 14 48.9 (27.1) 0.3 % -15.10 [ -33.57, 3.37 ]
Horton 2002 27 -3.8 (4.9) 28 -2.9 (4.4) 6.4 % -0.90 [ -3.36, 1.56 ]
Jang 2015 11 94.8 (22) 13 87 (18.4) 0.4 % 7.80 [ -8.60, 24.20 ]
Jerosch-Herold 2011 72 -32.9 (27.4) 75 -29.6 (23.3) 1.4 % -3.30 [ -11.54, 4.94 ]
John 2011 25 44 (15) 23 35 (25) 0.8 % 9.00 [ -2.79, 20.79 ]
Jongs 2012 14 10 (8) 18 3 (9) 2.4 % 7.00 [ 1.10, 12.90 ]
Kemler 2012 28 21 (22) 26 29 (21) 0.8 % -8.00 [ -19.47, 3.47 ]
Kolmus 2012 19 151.5 (7.77) 21 151.5 (7.77) 3.2 % 0.0 [ -4.82, 4.82 ]
Lai 2009 23.6666667 (28.27333) 15 15 14.4 (26.8775) 0.3 % 9.27 [ -10.47, 29.01 ]
Lee 2007 29 28.4 (9.2) 27 27.9 (9.3) 3.2 % 0.50 [ -4.35, 5.35 ]
McNee 2007 9 -1 (4.071821) 9 -2.45 (4.071821) 4.4 % 1.45 [ -2.31, 5.21 ]
Paul 2014 50 161.9 (13) 50 165.3 (10.99) 3.3 % -3.40 [ -8.12, 1.32 ]
Seeger 1987 16.1428571 (25.58273) 7 7 -0.71 (12.73727) 0.2 % 16.86 [ -4.31, 38.03 ]
Turton 2005 12 -15.5 (18.7) 11 -9.9 (13.9) 0.6 % -5.60 [ -18.99, 7.79 ]
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Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Zenios 2002 41 -1.7 (3.6) 38 -0.6 (2.3) 8.4 % -1.10 [ -2.42, 0.22 ]
Subtotal (95% CI) 511 498 53.3 % 1.19 [ -0.41, 2.78 ]
Heterogeneity: Tau2 = 4.38; Chi2 = 41.25, df = 24 (P = 0.02); I2 =42%
Test for overall effect: Z = 1.46 (P = 0.14)
2 Measurements not influenced by discomfort
Ben 2005 20 -0.85 (4.530888) 20 -4.9 (3.279121) 6.4 % 4.05 [ 1.60, 6.50 ]
Harvey 2000 14 0 (4.454695) 14 0 (4.454695) 5.0 % 0.0 [ -3.30, 3.30 ]
Harvey 2003 16 4 (5.050892) 16 3 (5.050892) 4.7 % 1.00 [ -2.50, 4.50 ]
Harvey 2006 1.7586207 (2.914273) 29 29 1.41 (2.914273) 8.1 % 0.34 [ -1.16, 1.84 ]
Horsley 2007 20 3.8 (10.16472) 20 0 (10.16472) 2.2 % 3.80 [ -2.50, 10.10 ]
Lannin 2003a 16 0 (7.504182) 11 2 (6.222139) 2.9 % -2.00 [ -7.20, 3.20 ]
Lannin 2007a 20 0.8 (6.857155) 20 0 (6.857155) 3.8 % 0.80 [ -3.45, 5.05 ]
Moseley 1997 9 13.5 (11.87939) 9 -1.9 (11.87939) 0.9 % 15.40 [ 4.42, 26.38 ]
Moseley 2005 44 0 (6.222139) 46 1.3 (6.36198) 6.1 % -1.30 [ -3.90, 1.30 ]
Refshauge 2006 26 1 (6.438649) 26 0 (6.438649) 4.7 % 1.00 [ -2.50, 4.50 ]
Steffen 1995 1.1666667 (10.15324) 18 18 0.44 (11.1367) 1.9 % 0.72 [ -6.24, 7.68 ]
Subtotal (95% CI) 232 229 46.7 % 1.05 [ -0.42, 2.52 ]
Heterogeneity: Tau2 = 2.43; Chi2 = 18.63, df = 10 (P = 0.05); I2 =46%
Test for overall effect: Z = 1.40 (P = 0.16)
Total (95% CI) 743 727 100.0 % 1.07 [ 0.01, 2.13 ]
Heterogeneity: Tau2 = 3.05; Chi2 = 60.94, df = 35 (P = 0.004); I2 =43%
Test for overall effect: Z = 1.97 (P = 0.049)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.90), I2 =0.0%
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Analysis 12.4. Comparison 12 Joint mobility - subgroup analyses, Outcome 4 Joint mobility measured less
than one day versus more than one day.
Review: Stretch for the treatment and prevention of contractures
Comparison: 12 Joint mobility - subgroup analyses
Outcome: 4 Joint mobility measured less than one day versus more than one day
Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Less than one day
Ada 2005 15 -6.1 (11.2) 16 -17.9 (19.6) 0.4 % 11.80 [ 0.65, 22.95 ]
Aoki 2009 17 117.6 (20.2) 19 109.1 (20.4) 0.3 % 8.50 [ -4.78, 21.78 ]
Basaran 2012 13 52.31 (19.11) 12 52.5 (19.48) 0.2 % -0.19 [ -15.34, 14.96 ]
Bulstrode 1987 27 2.4 (4.4) 12 -0.4 (4.3) 5.2 % 2.80 [ -0.15, 5.75 ]
Collis 2013 20 38 (38) 20 33 (34) 0.1 % 5.00 [ -17.35, 27.35 ]
Copley 2013 6 60.83 (10.57) 4 50 (5) 0.5 % 10.83 [ 1.06, 20.60 ]
De Jong 2006 4 76 (16.8) 6 61.67 (8) 0.1 % 14.33 [ -3.33, 31.99 ]
Dean 2000 10 -11 (15.60047) 13 -14 (17.78728) 0.2 % 3.00 [ -10.67, 16.67 ]
Fox 2000 12 1.64 (3.274401) 12 0 (3.274401) 6.6 % 1.64 [ -0.98, 4.26 ]
Gustafsson 2006 17 50.3 (15.7) 15 49 (24.1) 0.2 % 1.30 [ -13.00, 15.60 ]
Horton 2002 27 -3.8 (4.9) 28 -2.9 (4.4) 7.5 % -0.90 [ -3.36, 1.56 ]
Jang 2015 11 94.8 (22) 13 87 (18.4) 0.2 % 7.80 [ -8.60, 24.20 ]
Jerosch-Herold 2011 74 -31 (23.3) 76 -28.4 (21.1) 0.9 % -2.60 [ -9.72, 4.52 ]
John 2011 25 44 (15) 23 35 (25) 0.3 % 9.00 [ -2.79, 20.79 ]
Jongs 2012 17 8 (13) 19 6 (11) 0.7 % 2.00 [ -5.92, 9.92 ]
Kemler 2012 18 26 (14) 18 17 (19) 0.4 % 9.00 [ -1.90, 19.90 ]
Kolmus 2012 19 151.5 (7.77) 21 151.5 (7.77) 2.0 % 0.0 [ -4.82, 4.82 ]
Lai 2009 23.66667 (28.27333) 15 15 14.4 (26.8775) 0.1 % 9.27 [ -10.47, 29.01 ]
Lannin 2003a 14 1 (6.614547) 11 0 (5.863169) 1.9 % 1.00 [ -3.90, 5.90 ]
Lannin 2007a 21 0 (6.034517) 21 1.3 (6.034517) 3.4 % -1.30 [ -4.95, 2.35 ]
Lee 2007 29 28.4 (9.2) 27 27.9 (9.3) 1.9 % 0.50 [ -4.35, 5.35 ]
Moseley 1997 9 13.5 (11.87939) 9 -1.9 (11.87939) 0.4 % 15.40 [ 4.42, 26.38 ]
Moseley 2005 46 0 (5.383214) 47 0.3 (5.441412) 9.4 % -0.30 [ -2.50, 1.90 ]
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Study or subgroup Stretch Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Paul 2014 50 161.9 (13) 50 165.3 (10.99) 2.0 % -3.40 [ -8.12, 1.32 ]
Refshauge 2006 26 1 (6.438649) 26 0 (6.438649) 3.7 % 1.00 [ -2.50, 4.50 ]
Rose 2010 15 5 (3.702811) 15 2 (3.702811) 6.5 % 3.00 [ 0.35, 5.65 ]
Seeger 1987 16.14286 (25.58273) 7 7 -0.71 (12.73727) 0.1 % 16.86 [ -4.31, 38.03 ]
Steffen 1995 1.166667 (10.15324) 18 18 0.44 (11.1367) 0.9 % 0.72 [ -6.24, 7.68 ]
Subtotal (95% CI) 582 573 56.3 % 1.10 [ 0.20, 2.00 ]
Heterogeneity: Chi2 = 38.62, df = 27 (P = 0.07); I2 =30%
Test for overall effect: Z = 2.40 (P = 0.016)
2 More than one day
Ben 2005 20 -0.85 (4.530888) 20 -4.9 (3.279121) 7.6 % 4.05 [ 1.60, 6.50 ]
Fox 2000 12 1.64 (3.274401) 12 0 (3.274401) 6.6 % 1.64 [ -0.98, 4.26 ]
Harvey 2000 14 0 (4.454695) 14 0 (4.454695) 4.2 % 0.0 [ -3.30, 3.30 ]
Harvey 2003 16 4 (5.050892) 16 3 (5.050892) 3.7 % 1.00 [ -2.50, 4.50 ]
Harvey 2006 1.758621 (2.914273) 29 29 1.41 (2.914273) 20.2 % 0.34 [ -1.16, 1.84 ]
Horsley 2007 20 3.8 (10.16472) 20 0 (10.16472) 1.1 % 3.80 [ -2.50, 10.10 ]
Turton 2005 12 -15.5 (18.7) 11 -9.9 (13.9) 0.3 % -5.60 [ -18.99, 7.79 ]
Subtotal (95% CI) 123 122 43.7 % 1.26 [ 0.24, 2.28 ]
Heterogeneity: Chi2 = 8.70, df = 6 (P = 0.19); I2 =31%
Test for overall effect: Z = 2.42 (P = 0.015)
Total (95% CI) 705 695 100.0 % 1.17 [ 0.50, 1.85 ]
Heterogeneity: Chi2 = 47.38, df = 34 (P = 0.06); I2 =28%
Test for overall effect: Z = 3.40 (P = 0.00067)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.82), I2 =0.0%
-20 -10 0 10 20
Favours stretch Favours control
A D D I T I O N A L T A B L E S
Table 1. Sensitivity analyses: joint mobility - neurological conditions
Joint mobility -
neurological con-
ditions
Pooled results Randomi-
sation (studies with
adequate sequence
generation)
Allocation (studies
with concealed al-
location)
Assessors (studies
with blinded asses-
sors)
Dropout
rate (studies with≤
15% dropouts)
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Table 1. Sensitivity analyses: joint mobility - neurological conditions (Continued)
Short-term effects
following stretch
2 ° (0 to 3)
n = 18
2 ° (0 to 3)
n = 16
1 ° (0 to 3)
n = 15
2 ° (0 to 3)
n = 14
2 ° (0 to 3)
n = 13
Long-term effects
following stretch
1 ° (-1 to 3)
n = 8
1 ° (-3 to 4)
n = 6
0 ° (-2 to 2)
n = 5
1 ° (-2 to 3)
n = 6
0 ° (-2 to 2)
n = 6
Results are presented in degrees; mean (95% CI).
n = number of studies included in analysis
Table 2. Sensitivity analyses: joint mobility - non-neurological conditions
Joint mobility
- non-neurological
conditions
Pooled results Randomi-
sation (studieswith
adequate sequence
generation)
Allocation (studies
with concealed al-
location)
Assessors (studies
with blinded asses-
sors)
Dropout
rate (studies with≤
15% dropouts)
Short-term effects
following stretch
1° (-1 to 2)
n = 16
1° (-1 to 3)
n = 9
-1° (-2 to 1)
n = 8
1° (-1 to 3)
n = 12
0° (-2 to 1)
n = 10
Long-term effects
following stretch
-1° (-3 to 2)
n = 5
0° (-6 to 7)
n = 3
1° (-5 to 7)
n = 3
0° (-7 to 7)
n = 3
-1° (-3 to 2)
n = 5
Results are presented in degrees; mean (95%CI). Studies in which data were no expressed in degrees were excluded from all analyses
(Buchbinder 1993, Cox 2009 and Melegati 2003).
n = number of studies included in analysis.
Table 3. Interpretation of results
Neurological conditions Non-neurological conditions
Short-term Long-term Short-term Long-term
Joint ROM Ineffective1 - HIGH
(95% CI; 0 to 3°)
Ineffective1
(95% CI; -1 to 3°)
Ineffective1 - HIGH
(95% CI; 0 to 0.3 SD)
Ineffective1
(95%CI; -0.4 to 0.2 SD)
QOL Not measured Not measured Ineffective2 - MOD
(95%CI; -0.1 to 0.7 SD)
Not measured
Pain* Uncertain - LOW
(95%CI; -0.1 to 0.5 SD)
Uncertain
(95%CI; -0.4 to 0.5 SD)
Ineffective3 - HIGH
(95%CI; -0.4 to 0.1 SD)
Uncertain
No meta-analysis per-
formed4
Spasticity* Uncertain
(95%CI; -0.3 to 0.3 SD)
Uncertain
(95%CI; -0.8 to 0.1 SD)
Not relevant for peo-
ple with non-neurologi-
cal conditions
Not relevant or peo-
ple with non-neurologi-
cal conditions
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Table 3. Interpretation of results (Continued)
Activity limitations Uncertain - LOW
(95%CI; -0.1 to 0.5 SD)
Uncertain
(95%CI; -0.1 to 0.6 SD)
Uncertain - HIGH
(95%CI; -0.2 to 0.3 SD)
Uncertain
(95%CI; -0.3 to 0.2 SD)
Participation restrictions Not measured Not measured Uncertain - LOW
(95%CI; -0.1 to 0.7 SD)
Uncertain
95%CI; (-0.6 to 0.3 SD)
* Negative value favours stretch
Ineffective = the results rule out a clinically important treatment effect.
The quality of the evidence for the short-term effects was rated using GRADE and is indicated by high, moderate (mod) or low.
GRADE was not used to rate the quality of evidence for the long-term effects.
1 The results rule out a clinically important treatment effect of 5°. Results expressed as SMD were back converted to degrees (see
Summary of findings for the main comparison).
2 The results rule out a clinically important treatment effect equivalent to 10 points on a 160-point scale, and an absolute change and
relative change of 5% (see Summary of findings 2).
3 The results rule out a clinically important treatment effect equivalent to 2 points on a 10-point pain scale, and an absolute change
and relative change of 5% (see Summary of findings 2).
4 A meta-analysis was not performed on the two studies because of clinical heterogeneity between studies (see Results).
A P P E N D I C E S
Appendix 1. Cochrane CENTRAL search strategy
#1 MeSH descriptor Contracture explode all trees
#2 contracture*
#3 MeSH descriptor Muscle Spasticity explode tree 1
#4 MeSH descriptor Muscle Hypertonia explode all trees
#5 MeSH descriptor Muscle Rigidity explode tree 1
#6 (spasticity or rigid*)
#7 MeSH descriptor Elasticity explode all trees
#8 elastic*
#9 stiff*
#10 extensib*
#11 flexib*
#12 MeSH descriptor Range of Motion, Articular explode all trees
#13 (range* NEAR/3 (motion* or movement or joint*))
#14 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13)
#15 MeSH descriptor Muscle Stretching Exercises explode all trees
#16 stretch*
#17 MeSH descriptor Splints, this term only
#18 splint*
#19 cast*
#20 positioning
#21 MeSH descriptor Orthotic Devices explode all trees
#22 orthotic*
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#23 orthos*
#24 MeSH descriptor Exercise Therapy explode tree 1
#25 thermoplastic*
#26 bracing
#27 brace*
#28 MeSH descriptor Yoga, this term only
#29 yoga
#30 (#15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR
#29)
#31 (#14 AND #30)
Appendix 2. MEDLINE search strategy
1. exp Contracture/
2. contracture$.tw.
3. Muscle Spasticity/
4. Muscle Rigidity/
5. (spasticity or rigid$).tw.
6. exp Elasticity/
7. elastic$.tw.
8. stiff$.tw.
9. extensib$.tw.
10. flexibil$.tw.
11. exp “Range of Motion, Articular”/
12. (range$ adj3 (motion$ or movement or joint$)).tw.
13. or/1-12
14. Muscle Stretching Exercises/
15. stretch$.tw.
16. Splints/
17. splint$.tw.
18. cast$.tw.
19. positioning.tw.
20. exp Orthotic Devices/
21. orthotic$.tw.
22. orthos$.tw.
23. Exercise Therapy/
24. thermoplastic$.tw.
25. bracing.tw.
26. brace$.tw.
27. Yoga/
28. yoga.tw.
29. or/14-28
30. 13 and 29
31. randomized controlled trial.pt.
32. controlled clinical trial.pt.
33. randomized.ab.
34. placebo.ab.
35. drug therapy.fs.
36. randomly.ab.
37. trial.ab.
38. groups.ab.
39. or/31-38
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40. humans.sh.
41. 39 and 40
42. 41 and 30
Appendix 3. Embase search strategy
1. exp Contracture/
2. contracture$.tw.
3. exp Muscle Hypertonia/
4. (spasticity or rigid$).tw.
5. Muscle Length/
6. exp elasticity/
7. elastic$.tw.
8. stiff$.tw.
9. extensib$.tw.
10. flexibil$.tw.
11. exp “joint characteristics and functions”/
12. “range of motion”/
13. (range$ adj3 (motion$ or movement or joint$)).tw.
14. or/1-13
15. muscle stretching/
16. stretch$.tw.
17. splint/
18. splint$.tw.
19. plaster cast/
20. cast$.tw.
21. positioning.tw.
22. orthotics/
23. orthotic$.tw.
24. orthos$.tw.
25. thermoplastic$.tw.
26. bracing$.tw.
27. brace/
28. brace$.tw.
29. yoga/
30. yoga.tw.
31. or/15-30
32. 14 and 31
33. Randomized Controlled Trial/
34. Single Blind Procedure/
35. Double Blind Procedure/
36. Crossover Procedure/
37. random$.tw.
38. factorial$.tw.
39. crossover$.tw.
40. cross over$.tw.
41. placebo$.tw.
42. (doubl$ adj blind$).tw.
43. (singl$ adj blind$).tw.
44. assign$.tw.
45. allocat$.tw.
46. volunteer$.tw.
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47. or/33-46
48. Human/
49. 47 and 48
50. 49 and 32
Appendix 4. CINAHL search strategy
1. Contracture/
2. contracture$.tw.
3. exp Muscle Hypertonia/
4. (spasticity or rigid$).tw.
5. exp Elasticity/
6. elastic$.tw.
7. stiff$.tw.
8. extensib$.tw.
9. flexibil$.tw.
10. “Range of Motion”/
11. (range$ adj3 (motion$ or movement or joint$)).tw.
12. or/1-11
13. Stretching/
14. stretch$.tw.
15. Splints/
16. splint$.tw.
17. Casts/
18. cast$.tw.
19. positioning.tw.
20. Orthoses/
21. orthotic$.tw.
22. orthos$.tw.
23. Therapeutic Exercise/
24. thermoplastic$.tw.
25. bracing.tw.
26. brace$.tw.
27. Yoga/
28. yoga.tw.
29. or/13-28
30. 12 and 29
31. exp Clinical Trials/
32. clinical trial.pt.
33. (clinic$ adj trial$1).tw.
34. ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$3 or mask$3)).tw.
35. randomi?ed control$ trial$.tw.
36. Random assignment/
37. random$ allocat$.tw.
38. placebo$.tw.
39. Placebos/
40. Quantitative studies/
41. allocat$ random$.tw.
42. or/31-41
43. 30 and 42
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Appendix 5. SCI-EXPANDED search strategy
#1 Topic=(contracture*)
#2 Topic=(spasticity) OR Topic=(rigid*)
#3 Topic=(elastic*)
#4 Topic=(stiff*)
#5 Topic=(extensib*)
#6 Topic=(flexibil*)
#7 Topic=(range* SAME (motion* OR movement OR joint*))
#8 #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1
#9 Topic=(stretch*)
#10 Topic=(splint*)
#11 Topic=(cast*)
#12 Topic=(positioning)
#13 Topic=(orthotic* OR orthos*)
#14 Topic=(thermoplastic*)
#15 Topic=(bracing OR brace*)
#16 Topic=(yoga)
#17 #16 OR #15 OR #14 OR #13 OR #12 OR #11 OR #10 OR #9
#18 #17 AND #8
#19 TS= clinical trial* OR TS=research design OR TS=comparative stud* OR TS=evaluation stud* OR TS=controlled trial* OR
TS=follow-up stud* OR TS=prospective stud* OR TS=random* OR TS=placebo* OR TS=(single blind*) OR TS=(double blind*)
#20 #19 AND #18
Appendix 6. PEDro search strategies
The first PEDro search will combine the following terms using “OR”: [Abstract & Title field] stretch*, splint*, cast*, position*, brace*,
bracing*, orthos*, orthotic*.
The second PEDro search will combine the following terms using “AND”: [Therapy field] stretching, mobilisation, manipulation,
massage [Problem field] muscle shortening, reduced joint compliance.
The third PEDro search will combine the following terms using “AND”: [Therapy field] orthosis, taping, splinting [Problem field]
muscle shortening, reduced joint compliance
WH A T ’ S N E W
Last assessed as up-to-date: 1 November 2015.
Date Event Description
20 December 2016 New citation required but conclusions have not
changed
Methods were updated in accordance with current rec-
ommendations of The Cochrane Collaboration: ’Risk
of bias’ assessment and ’Summary of findings’ tables
were added
12 December 2016 New search has been performed This is an updated version of the original 2010
Cochrane Review. In the original 2010 Review we di-
vided effects for all outcomes into immediate (less than
one day), short-term (less than one week) and long-
term effects (more than one week). In the 2016 up-
dated version we divided effects for all outcomes into
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(Continued)
short-term (less than one week) and long-term (more
than one week) effects. That is, we combined the im-
mediate and short-term effects into one category
This updated version contains an additional 14 stud-
ies (744 participants). Most of the additional studies
(10 studies) involve people with non-neurological con-
ditions and hence provides more conclusive evidence
about the effects of stretch in this population. This
updated version (like the original 2010 Review) indi-
cates that there is high quality evidence that stretch
does not have clinically important effects on joint mo-
bility in people with and without neurological con-
ditions. However, this updated version provides addi-
tional moderate and high quality evidence that stretch
does not have clinically important short-term effects
on quality of life or pain, respectively, in people with
non-neurological conditions
H I S T O R Y
Protocol first published: Issue 4, 2008
Review first published: Issue 9, 2010
Date Event Description
1 June 2008 Amended CMSG ID A030-R
C O N T R I B U T I O N S O F A U T H O R S
Original review
OwenMKatalinic was responsible for designing the review protocol, writing the protocol and report, conducting the search, screening
potentially eligible studies, extracting and analysing data, interpreting results, updating reference lists and creating ’Summary of findings’
tables.
Lisa A Harvey was responsible for designing the review protocol and screening potentially eligible studies. She contributed to writing
the report, extracting and analysing data, interpreting results and creating ’Summary of findings’ tables.
Robert D Herbert conducted the meta-regression analyses and contributed to the design of the review protocol, writing the report,
arbitrating potentially eligible studies, extracting and analysing data and interpreting results.
Natasha A Lannin contributed to data extraction and provided feedback on the report.
Anne M Moseley and Karl Schurr provided feedback on the report.
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2016 revised review
OwenM Katalinic was responsible for checking some analyses and data extraction, arbitrating potentially eligible studies, contributing
to the interpretation of results and providing feedback on the report.
Lisa A Harvey was responsible for changes to the protocol, conducting the updated search, screening potentially eligible studies,
extracting and analysing data, extracting study details for the ’Characteristics of included studies’ tables, assessing risk of bias, interpreting
results, updating the report, updating reference lists and creating ’Summary of findings’ tables.
Robert DHerbert was responsible for extracting data, arbitrating potentially eligible studies, contributing to the interpretation of results
and providing feedback on the report.
Natasha A Lannin and Anne MMoseley were responsible for extracting study details for the ’Characteristics of included studies’ tables,
assessing risk of bias, contributing to the interpretation of results and providing feedback on the report.
Karl Schurr was responsible for screening potentially eligible studies, contributing to the interpretation of results and providing feedback
on the report.
D E C L A R A T I O N S O F I N T E R E S T
Lisa A Harvey: no financial interest in this intervention but has authored trials reported in this review.
Owen M Katalinic: no financial interest in this intervention and has not authored trials reported in this review
Robert D Herbert: no financial interest in this intervention but has authored trials reported in this review.
Anne M Moseley: no financial interest in this intervention but has authored trials reported in this review.
Natasha A Lannin: no financial interest in this intervention but has authored trials reported in this review.
Karl Schurr: no financial interest in this intervention and has not authored trials reported in this review.
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• The George Institute for Global Health, The University of Sydney, Australia.
• Department of Physiotherapy, Greater Newcastle Sector, Hunter New England Health, Australia.
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• John Walsh Centre for Rehabilitation Research, Kolling Institute, The University of Sydney, Australia., Australia.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Differences between original 2010 Review and protocol
In the protocol we intended to include studies that compared the effects of competing interventions (that is, compared one type of
stretch to a different type of stretch). This produced an unmanageable number of comparisons. Therefore we elected to exclude studies
comparing the effects of competing interventions.
In the protocol we also stated that we would utilise first-period data for cross-over studies as first preference. In the review, we used
combined data in preference to first-period data. This method of using combined data yields more accurate weighting for cross-over
studies in meta-analyses than using first period data only (Curtin 2002).
In the protocol we stated that we would include data from all time points. In the review, we used one set of data per time point. This
was always our intention but poorly expressed in our protocol.
180Stretch for the treatment and prevention of contractures (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
The changes to the protocol were approved by Cochrane Musculoskeletal Editorial Board.
Differences between original 2010 Review and the 2016 updated version
In the original 2010 Review we divided effects for all outcomes into immediate (less than one day), short-term (less than one week)
and long-term effects (more than one week). In the 2016 updated version we divided effects for all outcomes into short-term (less than
one week) and long-term (more than one week) effects. That is, we combined the immediate and short-term effects into one category.
We used a sensitivity analysis to explore the possibility of immediate effects of stretch due to viscous deformation.
In the 2016 updated version we also made a change to the ’Risk of bias’ assessment on the recommendation of Cochrane. That is, we
assessed the risk of detection bias separately for measurements of objective and self-reported outcomes.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Range of Motion, Articular; Contracture [prevention & control; ∗therapy]; Joints; Muscle Stretching Exercises [∗methods]; Quality
of Life; Randomized Controlled Trials as Topic; Time Factors
MeSH check words
Humans
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